
<html lang="en"     class="pb-page"  data-request-id="20aeea06-5fc1-4cea-a643-6e0162effa9e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-10;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.7b00328;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies" /></meta><meta name="dc.Creator" content="Kap-Sun  Yeung" /></meta><meta name="dc.Creator" content="Brett R.  Beno" /></meta><meta name="dc.Creator" content="Kyle  Parcella" /></meta><meta name="dc.Creator" content="John A.  Bender" /></meta><meta name="dc.Creator" content="Katherine A.  Grant-Young" /></meta><meta name="dc.Creator" content="Andrew  Nickel" /></meta><meta name="dc.Creator" content="Prashantha  Gunaga" /></meta><meta name="dc.Creator" content="Prakash  Anjanappa" /></meta><meta name="dc.Creator" content="Rajesh Onkardas  Bora" /></meta><meta name="dc.Creator" content="Kumaravel  Selvakumar" /></meta><meta name="dc.Creator" content="Karen  Rigat" /></meta><meta name="dc.Creator" content="Ying-Kai  Wang" /></meta><meta name="dc.Creator" content="Mengping  Liu" /></meta><meta name="dc.Creator" content="Julie  Lemm" /></meta><meta name="dc.Creator" content="Kathy  Mosure" /></meta><meta name="dc.Creator" content="Steven  Sheriff" /></meta><meta name="dc.Creator" content="Changhong  Wan" /></meta><meta name="dc.Creator" content="Mark  Witmer" /></meta><meta name="dc.Creator" content="Kevin  Kish" /></meta><meta name="dc.Creator" content="Umesh  Hanumegowda" /></meta><meta name="dc.Creator" content="Xiaoliang  Zhuo" /></meta><meta name="dc.Creator" content="Yue-Zhong  Shu" /></meta><meta name="dc.Creator" content="Dawn  Parker" /></meta><meta name="dc.Creator" content="Roy  Haskell" /></meta><meta name="dc.Creator" content="Alicia  Ng" /></meta><meta name="dc.Creator" content="Qi  Gao" /></meta><meta name="dc.Creator" content="Elizabeth  Colston" /></meta><meta name="dc.Creator" content="Joseph  Raybon" /></meta><meta name="dc.Creator" content="Dennis M.  Grasela" /></meta><meta name="dc.Creator" content="Kenneth  Santone" /></meta><meta name="dc.Creator" content="Min  Gao" /></meta><meta name="dc.Creator" content="Nicholas A.  Meanwell" /></meta><meta name="dc.Creator" content="Michael  Sinz" /></meta><meta name="dc.Creator" content="Matthew G.  Soars" /></meta><meta name="dc.Creator" content="Jay O.  Knipe" /></meta><meta name="dc.Creator" content="Susan B.  Roberts" /></meta><meta name="dc.Creator" content="John F.  Kadow" /></meta><meta name="dc.Description" content="The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection. Inspired by the overlay of bound struct..." /></meta><meta name="Description" content="The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection. Inspired by the overlay of bound struct..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 4, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00328" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00328" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00328" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00328" /></link>
        
    
    

<title>Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00328" /></meta><meta property="og:title" content="Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0023.jpeg" /></meta><meta property="og:description" content="The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection. Inspired by the overlay of bound structures of three structurally distinct NS5B palm site allosteric inhibitors, the high-throughput screening hit anthranilic acid 4, the known benzofuran analogue 5, and the benzothiadiazine derivative 6, an optimization process utilizing the simple benzofuran template 7 as a starting point for a fragment growing approach was pursued. A delicate balance of molecular properties achieved via disciplined lipophilicity changes was essential to achieve both high affinity binding and a stringent targeted absorption, distribution, metabolism, and excretion profile. These efforts led to the discovery of BMS-929075 (37), which maintained ligand efficiency relative to early leads, demonstrated efficacy in a triple combination regimen in HCV replicon cells, and exhibited consistently high oral bioavailability and pharmacokinetic parameters across preclinical animal species. The human PK properties from the Phase I clinical studies of 37 were better than anticipated and suggest promising potential for QD administration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00328"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00328">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00328&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00328&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00328&amp;href=/doi/10.1021/acs.jmedchem.7b00328" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4369-4385</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00313" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00359" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kap-Sun++Yeung">Kap-Sun Yeung</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3995-6555" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brett+R.++Beno">Brett R. Beno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyle++Parcella">Kyle Parcella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Bender">John A. Bender</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katherine+A.++Grant-Young">Katherine A. Grant-Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Nickel">Andrew Nickel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Prashantha++Gunaga">Prashantha Gunaga</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Prakash++Anjanappa">Prakash Anjanappa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajesh+Onkardas++Bora">Rajesh Onkardas Bora</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kumaravel++Selvakumar">Kumaravel Selvakumar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Rigat">Karen Rigat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying-Kai++Wang">Ying-Kai Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mengping++Liu">Mengping Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Lemm">Julie Lemm</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Mosure">Kathy Mosure</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Sheriff">Steven Sheriff</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Changhong++Wan">Changhong Wan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Witmer">Mark Witmer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Kish">Kevin Kish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Umesh++Hanumegowda">Umesh Hanumegowda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoliang++Zhuo">Xiaoliang Zhuo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yue-Zhong++Shu">Yue-Zhong Shu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dawn++Parker">Dawn Parker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roy++Haskell">Roy Haskell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alicia++Ng">Alicia Ng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Gao">Qi Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Colston">Elizabeth Colston</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Raybon">Joseph Raybon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+M.++Grasela">Dennis M. Grasela</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth++Santone">Kenneth Santone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Gao">Min Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+A.++Meanwell">Nicholas A. Meanwell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Sinz">Michael Sinz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+G.++Soars">Matthew G. Soars</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+O.++Knipe">Jay O. Knipe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+B.++Roberts">Susan B. Roberts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+F.++Kadow">John F. Kadow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Bristol-Myers Squibb Research and Development, P.O. Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Discovery Chemistry, Biocon Bristol-Myers Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">#</span> <span class="aff-text">Bristol-Myers Squibb Research and Development, 1 Squibb Drive, New Brunswick, New Jersey 08901, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3259534241475c1c4b57475c5572505f411c515d5f"><span class="__cf_email__" data-cfemail="a7ccc6d7d4d2c989dec2d2c9c0e7c5cad489c4c8ca">[email protected]</span></a>; Phone: +1 (203) 677-6897.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00328&amp;href=/doi/10.1021%2Facs.jmedchem.7b00328" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4369–4385</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 21, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 March 2017</li><li><span class="item_label"><b>Published</b> online</span>4 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 May 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00328" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00328</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4369%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKap-Sun%2BYeung%252C%2BBrett%2BR.%2BBeno%252C%2BKyle%2BParcella%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D10%26contentID%3Dacs.jmedchem.7b00328%26title%3DDiscovery%2Bof%2Ba%2BHepatitis%2BC%2BVirus%2BNS5B%2BReplicase%2BPalm%2BSite%2BAllosteric%2BInhibitor%2B%2528BMS-929075%2529%2BAdvanced%2Bto%2BPhase%2B1%2BClinical%2BStudies%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4385%26publicationDate%3DMay%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00328"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1705</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00328" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kap-Sun&quot;,&quot;last_name&quot;:&quot;Yeung&quot;},{&quot;first_name&quot;:&quot;Brett&quot;,&quot;last_name&quot;:&quot;R. Beno&quot;},{&quot;first_name&quot;:&quot;Kyle&quot;,&quot;last_name&quot;:&quot;Parcella&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Bender&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;A. Grant-Young&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Nickel&quot;},{&quot;first_name&quot;:&quot;Prashantha&quot;,&quot;last_name&quot;:&quot;Gunaga&quot;},{&quot;first_name&quot;:&quot;Prakash&quot;,&quot;last_name&quot;:&quot;Anjanappa&quot;},{&quot;first_name&quot;:&quot;Rajesh&quot;,&quot;last_name&quot;:&quot;Onkardas Bora&quot;},{&quot;first_name&quot;:&quot;Kumaravel&quot;,&quot;last_name&quot;:&quot;Selvakumar&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Rigat&quot;},{&quot;first_name&quot;:&quot;Ying-Kai&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Mengping&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Lemm&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Mosure&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Sheriff&quot;},{&quot;first_name&quot;:&quot;Changhong&quot;,&quot;last_name&quot;:&quot;Wan&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Witmer&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Kish&quot;},{&quot;first_name&quot;:&quot;Umesh&quot;,&quot;last_name&quot;:&quot;Hanumegowda&quot;},{&quot;first_name&quot;:&quot;Xiaoliang&quot;,&quot;last_name&quot;:&quot;Zhuo&quot;},{&quot;first_name&quot;:&quot;Yue-Zhong&quot;,&quot;last_name&quot;:&quot;Shu&quot;},{&quot;first_name&quot;:&quot;Dawn&quot;,&quot;last_name&quot;:&quot;Parker&quot;},{&quot;first_name&quot;:&quot;Roy&quot;,&quot;last_name&quot;:&quot;Haskell&quot;},{&quot;first_name&quot;:&quot;Alicia&quot;,&quot;last_name&quot;:&quot;Ng&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Colston&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Raybon&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;M. Grasela&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;Santone&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;A. Meanwell&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Sinz&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;G. Soars&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;O. Knipe&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;B. Roberts&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;F. Kadow&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;4369-4385&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00328&quot;},&quot;abstract&quot;:&quot;The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection. Inspired by the overlay of bound structures of three structurally distinct NS5B palm site allosteric inhibitors, the high-throughput screening hit anthranilic acid 4, the known benzofuran analogue 5, and the benzothiadiazine derivative 6, an optimization process utilizing the simple benzofuran template 7 as a starting point for a fragment growing approach was pursued. A delicate balance of molecular properties achieved via disciplined lipophilicity changes was essential to achieve both high affinity binding and a stringent targeted absorption, distribution, metabolism, and excretion profile. These efforts led to the discovery of BMS-929075 (37), which maintained ligand efficiency relative to early leads, demonstrated efficacy in a triple combination regimen in HCV replicon cells, and exhibited consistently high oral bioavailability and pharmacokinetic pa&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00328&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00328" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00328&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00328" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00328&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00328" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00328&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00328&amp;href=/doi/10.1021/acs.jmedchem.7b00328" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00328" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00328" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00328%26sid%3Dliteratum%253Aachs%26pmid%3D28430437%26genre%3Darticle%26aulast%3DYeung%26date%3D2017%26atitle%3DDiscovery%2Bof%2Ba%2BHepatitis%2BC%2BVirus%2BNS5B%2BReplicase%2BPalm%2BSite%2BAllosteric%2BInhibitor%2B%2528BMS-929075%2529%2BAdvanced%2Bto%2BPhase%2B1%2BClinical%2BStudies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D10%26spage%3D4369%26epage%3D4385%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/jmcmar.2017.60.issue-10/20170525/jmcmar.2017.60.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection. Inspired by the overlay of bound structures of three structurally distinct NS5B palm site allosteric inhibitors, the high-throughput screening hit anthranilic acid <b>4</b>, the known benzofuran analogue <b>5</b>, and the benzothiadiazine derivative <b>6</b>, an optimization process utilizing the simple benzofuran template <b>7</b> as a starting point for a fragment growing approach was pursued. A delicate balance of molecular properties achieved via disciplined lipophilicity changes was essential to achieve both high affinity binding and a stringent targeted absorption, distribution, metabolism, and excretion profile. These efforts led to the discovery of BMS-929075 (<b>37</b>), which maintained ligand efficiency relative to early leads, demonstrated efficacy in a triple combination regimen in HCV replicon cells, and exhibited consistently high oral bioavailability and pharmacokinetic parameters across preclinical animal species. The human PK properties from the Phase I clinical studies of <b>37</b> were better than anticipated and suggest promising potential for QD administration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis C virus (HCV) infection is a major medical problem on a global scale. Between 130 and 150 million people are chronically infected with HCV worldwide with an estimated 2.7–3.9 million infections in the United States alone.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Patients with HCV-related chronic liver diseases are at a very high risk of developing liver cirrhosis and progressing to hepatocellular carcinoma. Chronic HCV infection is therefore the leading cause of liver transplantation in the US and is responsible for approximately 700,000 deaths per year worldwide.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a></div><div class="NLM_p">HCV was identified in 1989.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> It is a single-stranded positive-sense RNA virus belonging to the <i>Hepacivirus</i> genus within the <i>Flaviviridae</i> family. HCV has been classified into six major genotypes with multiple subtypes, and a seventh genotype was identified recently.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Genotypes 1a and 1b predominate in the Americas, Europe, and Asia, followed by genotypes 2 and 3, whereas genotypes 4 and 5 are more prevalent in Africa. The HCV genome encodes a single polyprotein of ∼3000 amino acids. Over the past 25 years, significant efforts have been invested in understanding the HCV replication cycle and the structures and functions of the viral proteins with the goal of identifying viable therapies for treating HCV infection.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In particular, three of the HCV nonstructural proteins, the NS3/4A serine protease, the NS5A replication cofactor, and the NS5B replicase, have been extensively exploited as drug targets.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This intensive research has culminated in the approval of several HCV-targeted direct-acting antiviral agents that are used in combination in the clinic to replace pegylated-interferon/ribavirin-based therapy.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These advanced all-oral treatment options offer a cure for chronic HCV infection with increased sustained virological response rates, shorter treatment durations, improved safety profiles, and expanded genotype coverage.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p">The HCV NS5B replicase is an RNA-dependent RNA polymerase that performs the synthesis of HCV genomic RNA within the HCV replication complex machinery and is therefore an indispensable enzyme for HCV replication.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> From the initial positive-sense RNA template, a negative-sense RNA intermediate is synthesized, which in turn is used to generate progeny positive-sense RNA for further translation and packaging into new virions. Early on, three X-ray crystallographic structures of constructs of HCV genotype 1b (gt-1b) BK strain NS5B with the C-terminal membrane anchor region truncated were determined.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> The structures revealed that the catalytic domain adopts a right-hand configuration with fingers, palm, and thumb domains typical of polymerase enzymes (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a). The highly conserved active site that harbors the GDD aspartic acid motif, Gly317-Asp318-Asp319, is located within the palm domain. The pivotal role of the NS5B replicase in the HCV replication cycle and the absence of a mammalian counterpart together with the structural information that enables structure-based drug design have made NS5B an excellent anti-HCV drug target. The discovery and development of HCV NS5B replicase active site-directed nucleoside and nucleotide inhibitors and their prodrugs, as well as non-nucleoside inhibitors that bind in the three allosteric sites (thumb I, thumb II, and palm site), have been comprehensively reviewed.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structure of the HCV NS5B protein.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The finger loops are colored cyan, and the fingers, palm, thumb, and C-terminal domains are depicted in green, blue, red, and white, respectively. The “primer grip” and active site GDD motif are shown in yellow and orange, respectively, and the location of the palm site is denoted with a magenta sphere. (b) Close-up view of the HCV NS5B active site and palm binding pocket highlighting key residues and structural features. α-Helices are labeled according to the nomenclature in ref <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>. Image generated with The PyMol Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The palm binding pocket is near the active site and is surrounded by the Tyr448 β-hairpin loop from the thumb domain, the Ile363-Asn369 primer grip loop, and two α-helices (αI, Pro197-Ala210 and αP, Ser407-Tyr410) from the palm domain. The side chain of residue 316 on the β-sheet preceding the catalytic Gly317-Asp318-Asp319 loop extends into the binding site, and movement of the Arg200 side chain accommodates inhibitor binding (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b). The palm site is the largest of the three allosteric binding sites and is deeply recessed and hydrophobic in nature. The palm site has been divided into site I and site II in some publications. However, unlike thumb site I and site II, the two palm pockets are overlapping and contiguous; thus, a single palm site naming is adopted in this report.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> Several different structural classes of palm site inhibitors have been reported to be in various stages of clinical development.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> These include nesbuvir (HCV-796, <b>1</b>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), which established clinical proof of concept in HCV-infected patients for benzofuran-based inhibitors that bind to the allosteric palm site. A boronic acid derivative <b>2</b> (GSK-5852)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and a tetracyclic analogue <b>3</b> (MK-8876)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> have also been reported recently.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of benzofuran NS5B palm site inhibitors <b>1</b>–<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Medicinal Chemistry Strategy</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A high-throughput screening campaign conducted against HCV gt-1b NS5B enzyme identified an anthranilic acid hit compound <b>4</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). An X-ray cocrystal structure of <b>4</b> in complex with the ΔC18 truncated gt-1b Con1 strain NS5B protein revealed that <b>4</b> bound in the palm site of the enzyme.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Interestingly, the bound structure of <b>4</b> partially overlapped with that of benzofuran analogue <b>5</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> as observed in an NS5B/<b>5</b> cocrystal structure, with its benzoic acid moiety projecting from the direction of the benzofuran C5 position of <b>5</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a). Another NS5B complex structure with <b>6</b> in the benzothiadiazine series of NS5B inhibitors<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was determined and showed that the bound structure of <b>6</b> intersected with both of those of <b>4</b> and <b>5</b> with its thiadiazine ring placed in the location of the benzoic acid of <b>4</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a). Overall, the three-dimensional structures of the protein molecules in the three complexes were very similar with pairwise RMSD values derived from protein structural alignments varying from 0.3 to 0.7 Å. The protein molecules were also structurally similar in the vicinity of the bound ligands with variations observed in a few flexible loops. The overlapping structures created an opportunity to merge the three chemotypes by growing a benzofuran inhibitor into available binding regions via substitution at the benzofuran C5 position. The primary objective of the project was to identify an NS5B replicase palm site inhibitor clinical candidate that could be utilized in combination with NS5A and NS3/4A inhibitors. Moreover, included in this goal was to achieve activity toward the pre-existing C316N mutant, which is present in approximately 40% of gt-1b HCV-infected patients. Benzofuran <b>1</b> was reported to exhibit 26-fold resistance in a BB7 gt-1bC316N cell-based replicon assay compared to that of wild-type.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This was considered to be a deficiency in the profile of <b>1</b>, which would substantially limit its clinical application.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of NS5B palm site inhibitors <b>4</b>–<b>7</b> and HCV inhibitory potency toward gt-1b NS5B enzyme (IC<sub>50</sub>) and replicons (EC<sub>50</sub>) for <b>4</b> and <b>7</b> (the IC<sub>50</sub> value for <b>4</b> was the average of <i>n</i> ≥ 2 independent experiments; values for <b>7</b> were from a single experiment performed in duplicate).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Overlay of the bound structures of anthranilic acid <b>4</b> (magenta), benzofuran <b>5</b> (orange), and benzothiadiazine <b>6</b> (green) in the palm site of the wild-type (WT) gt-1b NS5B protein. (b) X-ray structure of <b>5</b> bound to the gt-1b NS5B WT protein illustrating key interactions of <b>5</b> with palm site residues. Images generated with The PyMol Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As exhibited in the NS5B/<b>5</b> complex cocrystal structure, the NH and carbonyl of the methyl amide from the inhibitor engage in two key hydrogen bonding interactions with the side chains of Ser365 in the primer grip loop and Arg200, respectively (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b), whereas the 4-fluorophenyl substituent forms tight van der Waals contacts with the surrounding hydrophobic residues in the binding site. These two moieties together serve to anchor the core benzofuran ring to the palm site. The initial chemistry strategy was therefore to utilize the structurally simpler C6-unsubstituted benzofuran analogue <b>7</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), which showed weak but detectable activity in both the in vitro enzymatic assay and cell-based HCV replicon assay, as a template to explore the structure–activity relationship (SAR) at the benzofuran C5 position in the palm binding site. The C5 oxygen atom provided a convenient handle for library synthesis, and reagent selection was facilitated by iterative molecular modeling based on NS5B/inhibitor complex structures. Although the molecular weight (MW = 327) and lipophilicity (cLog<i>P</i> = 4.18) of <b>7</b> are somewhat outside of the boundaries of those associated with a good fragment,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> its ligand efficiency (LE) value of 0.27 (calculated from (1.37/HAC) × pIC<sub>50</sub>, IC<sub>50</sub> determined from the gt-1b NS5B enzymatic assay and HAC = heavy atom count)<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> was considered a suitable starting point for a fragment growing approach.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An initial benzofuran C5 aryl library obtained from Suzuki cross-coupling between the C5-triflate derivative of compound <b>7</b> and commercially available aryl boronic acids or esters quickly established the importance of a carboxylate anion group for enhancing inhibitory activity against the NS5B enzyme, as summarized in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. Both the <i>meta</i>-benzoic acid <b>8</b> and <i>para</i>-analogue <b>9</b> were equally active with >20-fold improvements in IC<sub>50</sub> values against gt-1b as compared to that of the starting benzofuran <b>7</b>. However, <i>ortho</i>-analogue <b>11</b> was essentially inactive, reflecting the importance of both the hydrogen bonding distance and angle for interaction in the binding site.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The desired position of the acid group for inhibitory activity was recapitulated in thiophene-2-carboxylic acid <b>10</b> in which the 5<b>-</b>membered thiophene ring with its longer C–S bond and smaller C–S–C bond angle served as a suitable isostere for the phenyl ring of <b>8</b> and <b>9</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The loss in activity of ester <b>12</b> and benzyl alcohol <b>13</b> suggested that an oxygen atom with strong hydrogen bond-accepting potential<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was necessary for potency against the enzyme. These SAR results were consistent with a strong hydrogen bond between the carboxylate of the inhibitor and backbone N–H (O–N distance 2.8 Å) of Tyr448, as observed in the cocrystal structure of the NS5B/<b>8</b> complex that was obtained subsequently. The existence of a binding pocket adjacent to the carboxylate group, as revealed in the complex structure, provided an opportunity to further functionalize the acid moiety via amide coupling and potentially form additional interactions with the enzyme. Such modification could also convert these polar anionic compounds to neutral species that were anticipated to show enhanced cell permeability for increasing potency in the cell-based replicon assay, which was far from satisfactory in the initial acidic lead compounds <b>8</b> and <b>9</b> (gt-1b EC<sub>50</sub> = 12 and 4.5 μM, respectively, and gt-1a EC<sub>50</sub> > 20 μM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. HCV Inhibitory Potency towards NS5B Enzyme (IC<sub>50</sub>) for Compounds <b>8</b>–<b>13</b> (Data Obtained from Single Experiment Performed in Duplicate)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup>Table a</sup><p class="last">Average value of <i>n</i> ≥ 2 independent experiments.</p></div></div><div></div></div><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, a notable improvement in the activity against gt-1b and gt-1a replicon cells was obtained starting from methyl amide <b>15</b>. This was attributed to a combination of increased inhibition of the NS5B enzyme and improved cell penetration, reflected by the ∼2-fold ratio between the gt-1b enzyme IC<sub>50</sub> and replicon EC<sub>50</sub> values. A key discovery from this amide library SAR exercise was that successive addition of a methyl group to the α-carbon of the alkyl amide series (from <b>15</b> to <b>18</b>) as well as the benzyl amide analogues (from <b>21</b> to <b>23</b>) enhanced the potency both toward the enzyme and in replicon cells. Pleasingly, potent activity in the nanomolar range in the replicon was achieved with these compounds (gt-1b EC<sub>50</sub> = 18 nM for <b>18</b> and 10 nM for <b>23</b>). <i>N</i>-Methylation of the secondary amide NH decreased the potency by 3-fold in the enzymatic assay, and this decline translated into the replicon assay as exemplified by <b>19</b>, the <i>N</i>-methyl analogue of <b>18</b>. This was subsequently rationalized by the fact that the amide NH engaged in hydrogen bonding with the hydroxyl group of the side chain from Tyr452 and the backbone carbonyl of Ile447 via a water bridge (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a). The change in the amide conformation from a secondary to a tertiary amide could also affect the favorable interaction. In general, compounds from the <i>meta</i>-amide series provided better potency profiles than the corresponding <i>para</i>-amides, which were more than 10-fold less active as represented by <b>20</b>, the <i>para</i>-isomer of <b>18</b>. Thus, subsequent SAR studies were concentrated on the <i>meta</i>-amide series. The Me to Ph matched molecular pair transformation on the amide moiety improved the potency against the gt-1b NS5B enzyme by up to 9-fold (compare <b>16</b> and <b>21</b>, <b>17</b> and <b>22</b>, and <b>18</b> and <b>23</b>). This phenomenon was attributed to a favorable π-stacking interaction between the amide phenyl ring and the phenyl ring from the Phe551 side chain. However, the 1.4 unit Log<i>P</i> increase in lipophilicity<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> associated with a Me → Ph transform in this molecular context might also play a role. Although the activity in the replicon cells, particularly in gt-1a, was not as sensitive to the introduction of an amide phenyl ring, when the <i>gem</i>-dimethyl group of <b>23</b> was cyclized into a cyclopropyl ring, single digit nanomolar potency against both the NS5B enzyme and gt-1b replicon cells was realized, as represented by <b>24</b>. The cyclopropyl ring in <b>24</b> presumably fills the volume enclosed by Met414, Ile447, and Tyr452 more effectively, resulting in improved van der Waals contacts. Encouragingly, the potency against the gt-1a replicon cells was also driven below 50 nM in phenylcyclopropyl analogue <b>24</b>, which became the new lead structure for further optimization. Compared to starting template <b>7</b>, the ligand efficiency was improved (LE = 0.31 for <b>18</b> and 0.30 for <b>24</b>) even though the heavy atom count was increased by 38% in <b>18</b> and as much as 58% in <b>24</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. HCV Inhibitory Potency towards NS5B Enzyme (IC<sub>50</sub>) and Replicon (EC<sub>50</sub>) for Compounds <b>14</b>–<b>24</b> (Data Are Average Values of <i>n</i> ≥ 2 Independent Experiments)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0016.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn2"><div class="footnote" id="t2fn2"><sup>Table a</sup><p class="last">Data from a single experiment performed in duplicate; ND = not determined.</p></div></div><div></div></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) X-ray crystal structure of <b>18</b> bound to gt-1b NS5B WT protein showing direct and water-bridged hydrogen bonds between the protein and ligand. Hydrogen bonds are indicated with blue dashes. (b) Overlay of cocrystal structures of NS5B complexed with <b>8</b> (green) and <b>18</b> (orange) highlighting the Y448 loop, C-terminal region, and F551, which adopt different conformations depending on the identity of the benzofuran C5 substituent. (c) The hydrophobic cavity proximal to the 2′-position of the inhibitor amide phenyl ring and formed by the side chains from F193, C316, C366, and Y448 as illustrated in the close-up view of that region in the NS5B/<b>18</b> complex structure in (a). Images generated with The PyMol Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During the course of the SAR studies, multiple inhibitor/NS5B complex cocrystal structures were determined. In these structures, remarkable conformational flexibility of the NS5B C-terminal region and Tyr448 loop that comprise part of the palm site was observed. Because of this plasticity, the size and shape of the binding pocket vary significantly in response to different sizes and shapes of benzofuran inhibitor C5 substituents, as illustrated in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b. Thus, the NS5B palm site offers an interesting example of an inducible binding pocket.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> This conformational flexibility suggested that diverse amide structures could be accommodated, providing an opportunity for further optimization focused on potency enhancement and/or modulation of physicochemical properties for an improved absorption, distribution, metabolism, and excretion (ADME) profile as noted below and to be disclosed in future publications.</div><div class="NLM_p">Subsequent optimization performed on inhibitor <b>24</b> was again guided by observations from the NS5B/inhibitor complex cocrystal structures. Ligand elaboration to fill a small hydrophobic cavity proximal to the 2′-position of the amide phenyl ring and formed by the side chains from Phe193, Cys316, Cys366, and Tyr448 appeared to be feasible (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>c). Indeed, substitution at the 2′-position with small groups of increasing size (<b>25</b>–<b>28</b>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) not only maintained the single digit nanomolar potency against gt-1b in the replicon assay but also led to a stepwise increase in the activity against both gt-1a replicon and gt-1bC316N mutant replicon. The 2′-methyl analogue <b>28</b> emerged from these SAR studies with a more balanced inhibitory potency profile and exhibited a favorable cytotoxicity window (CC<sub>50</sub> > 25 μM in the replicon Huh-7 host cell line). However, a major drawback to the in vitro profile of this series of potent inhibitors was their low metabolic stability in liver microsomes. For example, only 68 and 39% of lead compound <b>28</b> remained unmetabolized in human and rat liver microsomes (HLM and RLM), respectively, after a 10 min incubation in a high-throughput metabolism screen (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Met-ID studies on the earlier compound <b>23</b> identified the electron-rich <i>gem</i>-dimethyl phenyl moiety as the major metabolic soft spot, thus suggesting the introduction of a heteroatom to the phenyl ring to increase polarity and potentially block metabolic sites could be a viable approach for solving this problem. Incorporation of a nitrogen atom into the phenyl ring to increase polarity of the molecule would be desirable in light of the already high lipophilicity of the 2′-methyl lead compound <b>28</b> (cLog<i>P</i> = 6.28).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> It was determined that the 2-pyridyl analogue <b>29</b> with a reduced cLog<i>P</i> value of 5.44 provided excellent stability in both HLM and RLM while maintaining the potency profile of <b>28</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) compared to the 3- and 4-pyridyl analogues <b>30</b> and <b>31</b>, respectively. The microsomal stability of <b>29</b> in RLM (<i>t</i><sub>1/2</sub> = 61 min) together with its high membrane permeability (999 nm/s, pH 7.4) as measured in a parallel artificial membrane permeability assay (PAMPA) translated into good plasma exposure following oral administration of the compound to rats in a 6 h pharmacokinetic screen. A high concentration of <b>29</b> (15.7 μM) was also obtained in rat liver at the 6 h time point (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), indicating a favorable exposure level in the target organ could be achieved with this compound series. The clearance estimated from the screen was a modest 14 mL min<sup>–1</sup> kg<sup>–1</sup>. These encouraging data established the direction for further optimization.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Potency towards HCV Replicon (EC<sub>50</sub>) for Compounds <b>24</b>–<b>28</b> (Data Are Average Values of <i>n</i> ≥ 2 Independent Experiments)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0018.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">replicon EC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">gt-1b</th><th class="colsep0 rowsep0" align="center" char=".">gt-1a</th><th class="colsep0 rowsep0" align="center" char=".">gt-1bC316N</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">ND<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">ND = Not determined.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Potency towards HCV Replicon (EC<sub>50</sub>) and In Vitro Profiling for Compounds <b>28</b>–<b>31</b> (Data Are Average Values of <i>n</i> ≥ 2 Independent Experiments)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0019.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">replicon EC<sub>50</sub> (nM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char="/">H/R LM<a class="ref internalNav" href="#t4fn2" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">N–Ar</th><th class="colsep0 rowsep0" align="center" char=".">gt-1b</th><th class="colsep0 rowsep0" align="center" char=".">gt-1a</th><th class="colsep0 rowsep0" align="center" char=".">gt-1bC316N</th><th class="colsep0 rowsep0" align="center" char="/">% remain</th><th class="colsep0 rowsep0" align="center" char="/"><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">cLog<i>P</i><a class="ref internalNav" href="#t4fn3" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">cp<i>K</i><sub>a</sub><a class="ref internalNav" href="#t4fn3" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">CYP3A4 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C8 IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char="/">68/39</td><td class="colsep0 rowsep0" align="char" char="/">11/ND</td><td class="colsep0 rowsep0" align="char" char=".">6.28</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char="/">89/82</td><td class="colsep0 rowsep0" align="char" char="/">108/61</td><td class="colsep0 rowsep0" align="char" char=".">5.44</td><td class="colsep0 rowsep0" align="char" char=".">3.95</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">193</td><td class="colsep0 rowsep0" align="char" char="/">0.7/0.6</td><td class="colsep0 rowsep0" align="char" char="/">ND</td><td class="colsep0 rowsep0" align="char" char=".">5.05</td><td class="colsep0 rowsep0" align="char" char=".">4.77</td><td class="colsep0 rowsep0" align="char" char=".">0.063</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">4-pyridyl</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char="/">11/11</td><td class="colsep0 rowsep0" align="char" char="/">ND</td><td class="colsep0 rowsep0" align="char" char=".">5.05</td><td class="colsep0 rowsep0" align="char" char=".">5.01</td><td class="colsep0 rowsep0" align="char" char=".">0.073</td><td class="colsep0 rowsep0" align="char" char=".">0.026</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn2"><div class="footnote" id="t4fn2"><sup>a</sup><p class="last">H/R LM = human and rat liver microsomes.</p></div><div class="footnote" id="t4fn3"><sup>b</sup><p class="last">Calculated values;<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> ND = not determined.</p></div></div></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Six hour rat pharmacokinetic screen of 2-pyridyl analogue <b>29</b> (IV, 2 mg/kg; PO, 6 mg/kg; 9:1 PEG400/EtOH; <i>n</i> = 2); PO exposure at the 6 h time point: plasma = 1.64 μM and liver = 15.7 μM. The open and filled circles and diamonds indicate IV data obtained from two individual rats; the open and filled squares and triangles indicate PO data obtained from two individual rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During these SAR studies, it was noted that the 3- and 4-pyridyl analogues <b>30</b> and <b>31</b> appeared to be almost instantly metabolized in liver microsomes and were significantly less stable than the 2-pyridyl lead <b>29</b> and the parent phenyl analogue <b>28</b>, although both <b>30</b> and <b>31</b> are less lipophilic than <b>29</b> and <b>28</b> by approximately 0.4–1.5 calculated Log<i>P</i> units (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Quantum chemical calculations performed at the MP2/6-31+G** level on the <i>N</i>-(1-(pyridin-2-yl)cyclopropyl)benzamide model system predict a 0.8 kcal/mol preference for a conformation in which the plane of the pyridine ring bisects the cyclopropyl C2–C3 bond (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> This is in contrast to the corresponding phenyl model system, which prefers a perpendicular conformation.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> It is possible that shielding of the pyridyl nitrogen lone pair in <b>29</b> by the cyclopropyl methylene moiety is partially responsible for the reduced basicity of <b>29</b> relative to <b>30</b> and <b>31</b>, where the pyridyl nitrogen atoms are more accessible. Diminished steric encumbrance and higher basicity together contribute to the greater susceptibility of the pyridine rings in <b>30</b> and <b>31</b> toward potential N-oxidation by microsomal CYP enzymes and potent inhibition of CYPs by <b>30</b> and <b>31</b> via coordination to the heme iron at the nanomolar level in an in vitro assay using recombinant CYPs (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). These findings are in line with the general trend observed in the change in lipophilicity and CYP3A4 inhibition when a monosubstituted phenyl ring is replaced by the three pyridine regioisomers.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Relative energies of aryl-cyclopropyl bond rotamers for model systems (left) and bisected and perpendicular conformers of the 2-pyridyl model (right) calculated at the MP2/-6-31+G** level of theory.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the 2-pyridyl lead compound <b>29</b> exhibited promising replicon potency, microsomal stability in HLM and RLM, membrane permeability, and oral exposure, other in vitro parameters still required optimization. For example, <b>29</b> was not as metabolically stable in dog and monkey liver microsomes (<i>t</i><sub>1/2</sub> = 14 and 20 min, respectively), possessed low micromolar inhibition of CYP3A4 and CYP2C8 enzymes, hERG inhibition in a Tl<sup>+</sup> ion flux assay with an IC<sub>50</sub> of 5.8 μM, and activity in a pregnane X receptor (PXR) transactivation assay with an EC<sub>50</sub> of 1.6 μM. Controlling the lipophilicity of the molecule (cLog<i>P</i> for <b>29</b> = 5.44, shake flask Log<i>D</i><sub>pH6.5</sub> = 5.42) to avoid these off-target liabilities while preserving the good qualities of <b>29</b> was desirable at this stage of the optimization process. However, this represented a challenge because the palm site is deeply recessed and highly hydrophobic, and a trend of decreasing potency particularly against gt-1a and the gt-1bC316N mutant was noted in molecules with reduced lipophilicity. A subtle balance of molecular properties was thus needed to achieve both potent antiviral activity and favorable ADME properties. It was anticipated that the conformational flexibility of the NS5B C-terminal region, in which the cyclopropyl amide portion of the molecule resides as described above, would allow productive structural modifications of the inhibitor that improved potency while permitting optimization of molecular properties. Thus, further introduction of heteroatoms into the amide region by surveying 5- and 6-membered heterocycles was pursued. One avenue that proved to be effective was the addition of a second nitrogen atom into the pyridine ring of <b>29</b>, and walking the nitrogen atom around the ring to deliver the four isomeric diazine analogues <b>32</b>–<b>35</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Among them, only the more lipophilic 2-pyrimidinyl analogue <b>32</b> (cLog<i>P</i> = 4.83, shake flask Log<i>D</i><sub>pH6.5</sub> = 4.76) maintained the activity profile of the 2-pyridyl parent compound <b>29</b>. The replicon activity against gt-1a and the gt-1bC316N mutant deteriorated with increasing polarity in the other three isomers. Other analogues possessing 5-membered heterocyclic rings (e.g., imidazole, pyrazole, triazole, tetrazole, oxazole, isoxazole) were also inferior primarily due to unfavorable replicon potency against the gt-1bC316N mutant (EC<sub>50</sub> values ranged from 100 nM to >1 μM) occasionally accompanied by an undesirable CYP inhibition profile (IC<sub>50</sub> < 1 μM). The oxadiazole analogue <b>36</b>, which interestingly has the same cLog<i>P</i> value as the 2-pyrimidyl derivative <b>32</b>, was the only heterocyclic analogue surveyed in this series that exhibited a potency profile comparable to <b>32</b>. However, <b>36</b> lacked stability in rat and monkey liver microsomes (<i>t</i><sub>1/2</sub> = 10 and 25 min, respectively). New lead compound <b>32</b> not only maintained good stability in HLM and RLM and high membrane permeability compared to parent compound <b>29</b> but also improved upon the metabolic stability in dog and monkey liver microsomes, off-target activity against CYP enzymes, and PXR transactivation (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). In a 24 h pharmacokinetic study in rats, compound <b>32</b> exhibited low clearance and a high oral bioavailability. Although the concentration of <b>32</b> in the liver at the 6 h time point (8.7 μM) following oral dosing was approximately half of that obtained with <b>29</b>, distribution into the liver was still favored for the neutral molecule (<i>C</i><sub>24</sub> liver/plasma ratio = 2.4). These in vitro and in vivo properties, together with a modest 4-fold shift in potency in the presence of 40% human serum and favorable cytotoxicity (CC<sub>50</sub> = 20 μM in Huh-7 cells) exhibited by <b>32</b>, set the stage for fine-tuning toward a viable development candidate.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Potency towards HCV Replicon (EC<sub>50</sub>) and cLog<i>P</i> Values for Compounds <b>29</b> and <b>32</b>–<b>36</b> (Data Obtained from Single Experiment Performed in Duplicate)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0020.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0021.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn2"><div class="footnote" id="t5fn2"><sup>Table a</sup><p class="last">Average value of <i>n</i> ≥ 2 independent experiments.</p></div><div class="footnote" id="t5fn3"><sup>Table b</sup><p class="last">Calculated values.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Profiling Data and Pharmacokinetic Parameters in Rats (0 to 24 h) for <b>32</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">H/R/Mk/D LM<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center">PAMPA pH 7.4 (nm/s)</th><th class="colsep0 rowsep0" align="center">CYP3A4 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">CYP2C8 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hERG flux IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hERG patch clamp</th><th class="colsep0 rowsep0" align="center">PXR-TA EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">>120/86/51/46</td><td class="colsep0 rowsep0" align="center">769</td><td class="colsep0 rowsep0" align="center">11.4</td><td class="colsep0 rowsep0" align="center">3.9</td><td class="colsep0 rowsep0" align="center">4.8</td><td class="colsep0 rowsep0" align="center">96% Inh @10 μM</td><td class="colsep0 rowsep0" align="center">>50</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">IV</th><th class="rowsep1 colsep0" colspan="6" align="center">PO</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">IV <i>t</i><sub>1/2</sub> (hr)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (hr)</th><th class="colsep0 rowsep0" align="center">AUC (μM h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>6</sub> liver (μM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>24</sub> liver (μM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>24</sub> liver/plasma</th><th class="colsep0 rowsep0" align="center">% <i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">5.5</td><td class="colsep0 rowsep0" align="center">5.3</td><td class="colsep0 rowsep0" align="center">6.1</td><td class="colsep0 rowsep0" align="center">6.7</td><td class="colsep0 rowsep0" align="center">4.7</td><td class="colsep0 rowsep0" align="center">48.7</td><td class="colsep0 rowsep0" align="center">8.7</td><td class="colsep0 rowsep0" align="center">0.614</td><td class="colsep0 rowsep0" align="center">2.4</td><td class="colsep0 rowsep0" align="center">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">IV, 2 mg/kg; PO, 6 mg/kg; 9:1 PEG400/EtOH; <i>n</i> = 3.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">H/R/Mk/D LM denotes human, rat, monkey, and dog liver microsomes, respectively.</p></div></div></div><div class="NLM_p">At this point, improving inhibitory potency against the gt-1bC316N mutant to an EC<sub>50</sub> value of less than 50 nM without increasing lipophilicity, while minimizing hERG activity (Tl<sup>+</sup> flux IC<sub>50</sub> = 4.8 μM; whole cell patch clamp: 96% inhibition @10 μM for <b>32</b>) in this class of neutral molecules was challenging. Improving the gt-1bC316N inhibitory potency and resolving the hERG off-target liability represented a dilemma because modulation of the two parameters involved opposing lipophilicity requirements. One approach that had been contemplated to increase gt-1bC316N inhibition was to engage the N316 residue via a direct interaction with the inhibitor. It was observed from crystal structures of NS5B WT/inhibitor complexes that the C–H bond at the benzofuran 4-position points directly toward the side chain of the C316 residue with approximately 3.0 Å separating the benzofuran C4–H and the C316 sulfur atom. Thus, introduction of a dipole at the benzofuran 4-position could potentially capture a dipole–dipole or a hydrogen bonding interaction with the N316 side chain. Installation of a fluorine atom that can fit into the binding space (C–F bond length = ∼1.35 Å) as a dipole probe at the 4-position of the benzofuran ring of <b>32</b> provided compound <b>37</b> (BMS-929075),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> which exhibited a 2.8-fold improvement in the activity against the gt-1bC316N mutant (EC<sub>50</sub> = 18 nM, <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Attempts to obtain a cocrystal structure of <b>37</b> bound to gt-1bC316N mutant protein to provide direct structural evidence for interaction between the 4-F and N316 side chain were not successful. However, a model of a 4-F-benzofuran analogue bound to the gt-1bC316N mutant protein based on a cocrystal structure of a gt-1bC316N/inhibitor complex (<a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>) that was subsequently determined revealed that the negatively polarized fluorine atom at the 4-position of the benzofuran ring can form a favorable electrostatic interaction with the positively polarized carbonyl carbon in the primary amide group of the N316 side chain (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Both the angle (82°) and distance (2.8 Å) are favorable for a C–F···C═O interaction and consistent with those values reported by Banner, Müller, and Diederich.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> It is conceivable that this atypical molecular interaction contributed to the enhancement, though modest, of the potency against the gt-1bC316N mutant.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Inhibitory Potency towards HCV Replicons (EC<sub>50</sub>) Representing Genotypes <b>1</b>–<b>6</b> for Compound <b>37</b> (Data Are Average Values of <i>n</i> ≥ 2 Independent Experiments)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0022.gif" alt="" id="fx10" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="9" align="center">replicon EC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">1a</th><th class="colsep0 rowsep0" align="center">1b</th><th class="colsep0 rowsep0" align="center">1bC316N</th><th class="colsep0 rowsep0" align="center">2a</th><th class="colsep0 rowsep0" align="center">2b</th><th class="colsep0 rowsep0" align="center">3a</th><th class="colsep0 rowsep0" align="center">4a</th><th class="colsep0 rowsep0" align="center">5a</th><th class="colsep0 rowsep0" align="center">6a</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">9</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">481</td><td class="colsep0 rowsep0" align="center">115</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center">2<a class="ref internalNav" href="#t7fn2" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn2"><div class="footnote" id="t7fn2"><sup>a</sup><p class="last">HCV NS5B enzyme IC<sub>50</sub>.</p></div></div></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Computer model of a 4-fluorobenzofuran analogue in complex with N316 mutant enzyme based on a cocrystal structure of gt-1bC316N/inhibitor complex. Image generated with The PyMol Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although <b>37</b> is 98.2% bound in human serum, it exhibited only a modest 5.5-fold right shift in the replicon EC<sub>50</sub> against gt-1a and gt-1b in the presence of 40% human serum. At the onset of the project, the targeted antiviral profile was for coverage of both WT gt-1 virus and the pre-existing gt-1bC316N mutant. Further evaluation of <b>37</b> in hybrid replicons representing the NS5B replicase of other HCV genotypes that became available in the later stages of the project revealed that the compound retained high inhibitory potency against genotypes 3–6 but was less potent toward gt-2 (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Combination studies of <b>37</b> with the approved NS5A inhibitor daclatasvir<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and the NS3/4A protease inhibitor asunaprevir<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> in a colony elimination experiment<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> revealed that the triple combination eradicated HCV gt-1b replicons more effectively than the dual combination of daclatasvir/asunaprevir or monotherapy with any of the single inhibitors at similar total concentrations of ≥10 times the replicon EC<sub>50</sub> value, suggesting that <b>37</b> can be a very effective agent for combination therapy.</div><div class="NLM_p">In the optimization from simple template <b>7</b> to the initial <i>meta</i>-amide lead compound <b>18</b> and eventually to the clinical candidate <b>37</b>, ligand efficiency was maintained if not improved despite a significant increase in HAC (38 and 67%, <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). This is in contrast to the generally observed trend that LE often decreases as ligand size increases.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> The conservation of LE as HAC increased during this lead optimization process is because of the fact that each additional functional moiety growing out from template <b>7</b> was optimally deployed based on SAR analysis coupled with insights from molecular modeling. Each part of <b>37</b> engages the protein in the palm binding pocket as observed in the gt-1b NS5B/<b>37</b> complex cocrystal structure (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>a), maximizing the enthalpic gain in binding: The 4-fluorophenyl ring makes tight van der Waals contacts. The methyl amide forms two strong hydrogen bonds, one as an acceptor with Arg200 and one as a donor to Ser365. The 4-fluorine atom on the benzofuran ring is in close contact with the thiol of the Cys316 side chain in a hydrogen bonding-type interaction. The benzofuran ring and the <i>meta</i>-amide phenyl ring form favorable electrostatic interactions with Arg200 and the phenyl ring of Tyr448. The 2′-methyl group fills a hydrophobic hole. The cyclopropyl ring projects into a hydrophobic pocket, and the pyrimidine ring forms an edge-to-face interaction with the phenyl ring of the Phe551 side chain. Based on the higher-resolution X-ray structures of similar compounds bound to gt-1b NS5B WT protein, it is likely that the secondary <i>meta</i>-amide forms two water-bridged hydrogen bonds: one to Arg200 and one to the hydroxyl group of the Tyr452 side chain. The small molecule crystal structure of the unsolvated neat form of <b>37</b> exhibits two conformers per asymmetric unit (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>b). The relative three-dimensional arrangements of the two conformers are largely the same, with subtle differences in the orientation of the C2-methyl amide and the 4-fluorophenyl ring, and are close to the NS5B-bound conformation of <b>37</b>. The bound and unbound molecular conformations of <b>37</b> differ in the positioning of the pyrimidinylcyclopropyl moiety by a 180° rotation about the cyclopropane-amide C1–N bond. However, in both the bound and unbound forms, the pyrimidinylcyclopropyl group adopts a bisected conformation, which is predicted to be the only energy minimum for rotation about the cyclopropane–pyrimidine bond based on MP2/6-31+G** calculations on a model system (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These observations on the solid state structures of <b>37</b> suggest that the entropic cost of binding of <b>37</b> to NS5B can be substantially reduced. The extended structure of <b>37</b> as displayed in both the bound and unbound states suggests the solvent accessible surface area of <b>37</b> can be maximized for binding. Here, maximization of enthalpic gain and accessible surface area combined with reduction of entropic cost as ligand size increases are beneficial design approaches for improving ligand efficiency in this fragment-growing optimization process.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ligand efficiency of HCV NS5B inhibitors <b>7</b>, <b>18</b>, and <b>37</b> with the % increase in HAC indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) gt-1b NS5B/<b>37</b> complex cocrystal structure with key interacting residues highlighted (see text). The omit Fo-Fc electron density is contoured at 3 RMSD in magenta mesh, and hydrogen bonding, π-cation, and π-stacking interactions are denoted with blue, red, and cyan dashes, respectively. (b) Small molecule crystal structure of the unsolvated neat form of <b>37</b>, showing the two conformers per asymmetric unit. Images generated with The PyMOL Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The incorporation of the 4-F atom on the benzofuran ring also served to mitigate hERG inhibition (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>) despite an increase in the lipophilicity of the neutral molecule (cLog<i>P</i> = 4.98, shake flask Log<i>D</i><sub>pH6.5</sub> = 5.09 for <b>37</b>) compared to that of 4-H analogue <b>32</b>. Compound <b>37</b> exhibited an IC<sub>50</sub> of 24 μM in the hERG ion flux assay, which was consistent with an IC<sub>50</sub> of 18 μM in a whole cell patch clamp electrophysiology assessment. This favorably compared to the 96% inhibition @10 μM observed with <b>32</b>. The lipophilicity value of <b>37</b> is also above the upper limit (cLog<i>P</i> = 4, Log<i>D</i> = 3.3) estimated for a neutral molecule to ensure an hERG inhibition IC<sub>50</sub> value of >10 μM.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Further analysis of the benzofuran series suggested that the small structural change from benzofuran to 4-F-benzofuran constituted a matched pair transformation for attenuation of hERG inhibition although accompanied by a 0.2–0.3 unit increase in measured Log<i>D</i> or cLog<i>P</i> value.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> As shown in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>, the 4-F atom reduces the negative electrostatic potential in the benzofuran ring relative to the 4-unsubstituted benzofuran ring. This could potentially impact the electrostatic complementarity with the hERG channel pore binding pocket, thus disrupting the affinity of the inhibitor to the hERG channel.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Compound <b>37</b> also exhibited no significant inhibition of the cardiac sodium Nav1.5 and L-type calcium Cav1.2 channels.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vitro Profiling Data for Compound <b>37</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cLog<i>P</i><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Log<i>D</i><sub>pH6.5</sub> (shake flask)</th><th class="colsep0 rowsep0" align="center">H/R/Mk/D LM<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center">PAMPA pH 7.4 (nm/s)</th><th class="colsep0 rowsep0" align="center">Caco Pc A to B (nm/s)</th><th class="colsep0 rowsep0" align="center">H/R/Mk/D<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a> protein binding (% bound)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">4.98</td><td class="colsep0 rowsep0" align="center">5.09</td><td class="colsep0 rowsep0" align="center">>120/>120/>120/>120</td><td class="colsep0 rowsep0" align="center">972</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">98.2/99.7/97.2/98.1</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">CYP3A4 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">CYP2C8 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hERG Flux IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hERG patch clamp IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">PXR-TA EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">Huh-7 CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">HepG2 CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">primary human hepatocytes CC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">>13</td><td class="colsep0 rowsep0" align="center">6.7</td><td class="colsep0 rowsep0" align="center">24</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">60</td><td class="colsep0 rowsep0" align="center">>12.5</td><td class="colsep0 rowsep0" align="center">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Calculated values.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">H/R/Mk/D LM denotes human, rat, monkey, and dog liver microsomes, respectively.</p></div></div></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Comparison of electrostatic potentials for similar conformers of the comparably substituted benzofuran (top) and 4-F-benzofuran (bottom) moieties calculated at the MP2/6-31+G** level including PCM H<sub>2</sub>O solvation and contoured at 0.001 au.<a onclick="showRef(event, 'ref32 ref46'); return false;" href="javascript:void(0);" class="ref ref32 ref46">(32, 46)</a> Areas of negative and positive potential are indicated by red and blue, respectively. Image generated with The PyMOL Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>37</b> exhibited a favorable cytotoxicity window as indicated by the lack of significant activity in primary human hepatocytes and the liver-related cell lines Huh-7 and HepG2 (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). It preserved the promising in vitro CYP inhibition and PXR transactivation profile of <b>32</b> while improving upon microsomal stability. The molecule was equally stable in liver microsomes across all species (LM <i>t</i><sub>1/2</sub> > 120 min, <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>) while maintaining good intrinsic membrane permeability as indicated by the high PAMPA value (972 nm/s, pH 7.4). In a multiconcentration bidirectional Caco-2 permeability assay, <b>37</b> displayed an A to B value of >100 nm/s with insignificant efflux. These properties translated into promising oral exposure in rats. The exposure of <b>37</b> in rat liver following oral dosing was increased by 2-fold at the 6 h time point (15.1 μM) compared to that of <b>32</b>, an improvement that extended to the 24 h time point (1.12 vs 0.614 μM). The PO exposure in rat plasma as measured by <i>C</i><sub>max</sub> and AUC were also higher for <b>37</b> (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>). The improved IV clearance (1.7 mL min<sup>–1</sup> kg<sup>–1</sup>) exhibited by <b>37</b> likely contributed to its higher exposure. Thus, the introduction of a single fluorine atom to <b>32</b> yielding <b>37</b> imparted multiple beneficial effects including improved potency, metabolic stability, and oral exposure.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetic Parameters in Rats for <b>37</b> (0–24 h)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IV</th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">PO</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">IV <i>t</i><sub>1/2</sub> (hr)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (hr)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μM h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>6</sub> liver (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>24</sub> liver (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>24</sub> liver/plasma<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">% <i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">54.5</td><td class="colsep0 rowsep0" align="char" char=".">15.1</td><td class="colsep0 rowsep0" align="char" char=".">1.12</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">140.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">IV, 2 mg/kg; PO, 6 mg/kg; 9:1 PEG400/EtOH, <i>n</i> = 3.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">ASD formulation with 10% (W/W) drug loading in 0.02:0.5:99.48 docusate sodium/methocel/water.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">The liver/plasma ratio was obtained in separate in vivo studies; ND = not determined.</p></div></div></div><div class="NLM_p">Subsequent pharmacokinetic studies in dogs and monkeys revealed low IV clearance across species for <b>37</b> with generally good oral exposure and good to excellent bioavailability. Remarkably, the curves in both the dose-normalized IV and PO plasma concentration/time profiles of compound <b>37</b> in rats, dogs, and monkeys appeared to be superimposable.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> However, this consistent in vivo performance of <b>37</b> in the three different preclinical species came with a caveat. Although <b>37</b> has excellent permeability as mentioned above, because of its low crystalline aqueous solubility (<1 μg/mL) (BCS Class II) throughout the physiological pH range, plasma exposure dramatically declined at higher doses following oral administration of the drug in a precipitation-resistant solution formulation or nanoparticle suspension to rats. This dissolution-limited absorption was circumvented by the use of a stable amorphous solid dispersion (ASD) formulation<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> employing a hydroxypropylmethyl cellulose acetate succinate matrix. The ASD formulation of <b>37</b> provided approximately 2- to 3-fold higher oral exposure compared to the solution formulation as measured by <i>C</i><sub>max</sub> and AUC values (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>). Encouraging dose proportional increase in the oral AUC in rats up to doses of 100 mg/kg and 50% drug loading was achieved. The consistency in metabolic stability and low IV clearance in vivo across preclinical animal species exhibited by <b>37</b> predicted similar pharmacokinetic parameters in humans with a comparably low clearance value. The projected efficacious human dose, which would surpass by 10-fold the gt-1bC316N EC<sub>50</sub> at <i>C</i><sub>24</sub> in the liver, was 79 mg QD. Although, except for the topological polar surface area, the molecular properties of <b>37</b> (Log<i>D</i><sub>pH6.5</sub> = 5.09, cLog<i>P</i> = 4.98; MW = 538; tPSA = 86; H-bond donors = 2, N/O count = 7; no. of rotatable bonds = 6; no. of aromatic rings = 5) are at the upper limits of those considered for orally bioavailable drugs,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> compound <b>37</b> exhibited consistently high oral bioavailability in preclinical animal species that projected a similar pharmacokinetic performance in humans. The dissolution-limited absorption was adequately addressed by utilizing an ASD formulation with stable high drug loading that enabled flexibility for dose escalation.</div><div class="NLM_p">Compound <b>37</b> was evaluated in an in-house safety screening panel of 43 off-targets that included receptors, ion channels, and enzymes, and no significant response was observed. In a single-dose oral toxicokinetic/tolerability study in rats and dogs, compound <b>37</b> was well tolerated at doses ≤100 mg/kg. In a 2-week toxicity study in rats, there were no significant findings at doses ≤100 mg/kg/day. At 100 mg/kg/day on day 14, the mean plasma AUC values of compound <b>37</b> in rats were up to 231-fold higher than the projected human efficacious AUC value. In the one month IND toxicology studies in rats and dogs, the exposures at NOAELs were 7- to 55-fold higher, respectively, than the human AUC at the predicted efficacious dose. The promising preclinical pharmacokinetic results and favorable toxicological profile supported the advancement of <b>37</b> into Phase I clinical studies.</div><div class="NLM_p last">In a randomized, double-blind, placebo-controlled Phase I clinical evaluation using the ASD formulation with 30% drug loading, compound <b>37</b> was safe and well-tolerated in normal healthy volunteers in a single ascending dose (SAD) study at doses up to 400 mg as well as in a multiple ascending dose (MAD) study at doses up to 400 mg/day for 14 days. The human pharmacokinetic parameters were better than projected with a dose proportional increase in plasma exposure and a longer human <i>t</i><sub>1/2</sub>.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The <i>C</i><sub>max</sub>/<i>C</i><sub>24</sub> exhibited a characteristic small ratio in both the SAD and MAD studies. At doses of 25 mg and higher, the <i>C</i><sub>24</sub> concentration in the SAD study and the steady state <i>C</i><sub>24</sub> values from the MAD study were at or above 10-fold the EC<sub>50</sub> value for the gt-1bC316N replicon. These results suggest that <b>37</b> has promising potential as a QD drug.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47773" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47773" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Insights from the superposition of bound structures of the three structurally different NS5B palm site allosteric inhibitors, anthranilic acid <b>4</b>, benzofuran <b>5</b>, and benzothiadiazine <b>6</b>, inspired an optimization process originating with the simple benzofuran template <b>7</b>. Elaboration of the C5 position in <b>7</b> through a fragment growing approach ultimately resulted in the identification of clinical candidate <b>37</b>. The recessed and hydrophobic nature of the palm site binding pocket necessitated a careful modulation of lipophilicity to achieve a balance of high inhibitory potency and favorable ADME properties. The conformational flexibility of the Tyr448 loop and C-terminal region residues that form part of the binding pocket and adapt to the inhibitor structure was exploited for productive structural modifications. Noteworthy SAR observations include the multiple advantageous effects conferred by a single fluorine atom strategically deployed in the molecule, and the impact of electrostatic potential modulation on hERG channel affinity of a lipophilic neutral molecule. The pyrimidinylcyclopropyl moiety emerged from the different pyridine and diazine regioisomers as a metabolically stable group across species. Compound <b>37</b> maintained the ligand efficiency of <b>7</b> even though the HAC was increased significantly by ∼70%. This was realized by maximizing binding interactions and minimizing ligand reorganization. Compound <b>37</b> expressed potent HCV inhibition toward all genotypes with the exception of gt-2. The activity against gt-2 of this and related series was subsequently improved during a second generation optimization process.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Triple combination of <b>37</b> with NS5A and NS3/4A inhibitors demonstrated efficacy against HCV gt-1b replicon cells. Compound <b>37</b> exhibited consistent high oral bioavailability and promising pharmacokinetic parameters across the three preclinical animal species, which predicted a similar pharmacokinetic performance in humans. The dissolution-limited absorption of this BCS class II compound was resolved by utilizing a stable amorphous solid dispersion formulation and, together with the flexibility of high drug loading, allowed dose escalation. The human PK properties in normal healthy volunteers from both the SAD and MAD Phase I clinical studies were better than projected, suggesting that <b>37</b> has promising potential as a QD drug.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery synthesis of <b>37</b> to provide sufficient quantities of materials at the required purity for all biological activity assays, in vitro profiling, initial PK studies in rat, dog, and monkey, evaluations in different formulations, and an initial 4-day mini-tox study in rat is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The Suzuki cross-coupling of triflate <b>42</b> with boronic ester <b>43</b> to provide penultimate acid <b>44</b>, followed by amide coupling with 1-(pyrimidin-2-yl)cyclopropan-1-amine <b>45</b> to deliver <b>37</b>, is representative of the general synthetic approach for the synthesis of the analogues described in this report. Coupling intermediates <b>43</b><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and <b>45</b><a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> were prepared in large scale by following literature procedures. The key intermediate triflate <b>42</b> was derived from 5-hydroxybenzofuran <b>38</b>, synthesized according to ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>. Fluorination of <b>38</b> with Selectfluor provided a crude mixture of desired 4-F intermediate <b>39</b> and the 6-F isomer in ∼3:1 ratio. A pure sample of <b>39</b> was obtained after purification to confirm its identity by NMR studies. The crude mixture of the fluorinated product was subjected to ester hydrolysis and then purification to provide desired compound <b>40</b> in 24% overall yield for the two steps. Methyl amide formation at C3 followed by installation of the triflate at C5 converted <b>40</b> smoothly to triflate <b>42</b> in almost quantitative yield. After consecutive coupling of <b>42</b> with boronic ester <b>43</b> and then amine <b>45</b> and recrystallization of the crude product from methanol/water mixture, <b>37</b> was obtained in 79% yield.</div><figure id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Discovery Synthesis of <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Selectfluor (1.2 equiv), MeCN, rt, 24 h; (b) NaOH (1N, aq), 1:1 MeOH/THF, 90 °C, 24% 2 steps; (c) MeNH<sub>2</sub>·HCl, HOBT·H<sub>2</sub>O, EDC, <i>i</i>-Pr<sub>2</sub>NEt, DMF, rt, 93%; (d) PhN(OTf)<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 98%, (e) (PPh<sub>3</sub>)<sub>4</sub>Pd, Cs<sub>2</sub>CO<sub>3</sub>, 1:10 H<sub>2</sub>O/Dioxane, 95 °C, 58%; (f) TBTU, <i>i</i>-Pr<sub>2</sub>NEt, DMF, rt 79%.</p></p></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Biological methods and the preparation of analogues presented in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> can be found in ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>. The 1-(diazin-2-yl)cyclopropan-1-amines for analogues <b>33</b>–<b>35</b> were prepared as described in ref <a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">53</a>.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General</h3><div class="NLM_p">All reagents were purchased from commercial suppliers and used without purification unless otherwise stated. All anhydrous reactions were performed under a nitrogen atmosphere using anhydrous solvents from commercial sources. Reaction progress was monitored by analytical TLC or LC/MS. <sup>1</sup>H NMR spectra were recorded on a Bruker AvanceIII 500 MHz spectrometer or a Bruker Ultrashield 400 MHz spectrometer. All spectra were determined in the deuterated solvent indicated, and residual protic solvent was used as an internal standard for chemical shift assignments. Proton coupling constants were reported in hertz (Hz) and chemical shifts δ in ppm. Multiplicity patterns were designated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad; dd, doublet of doublets; dt, doublet of triplets; dq, doublet of quartets. All compounds were determined to be ≥95% purity as detemined by liquid chromatography methodologies. LC/MS were performed using a Shimadzu-VP instrument with UV detection at 220 nm and Waters Micromass. Analytical HPLC were performed using a Shimadzu-VP instrument with UV detection at 220 and 254 nm. HPLC conditions are as indicated for each compound. <i>R</i><sub>t</sub> denotes retention time in minutes.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 5-(2-Fluoro-5-(1-phenylcyclopropylcarbamoyl)phenyl)-2-(4-fluorophenyl)-<i>N</i>-methylbenzofuran-3-carboxamide (<b>25</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.33 (s, 1H), 8.51 (q, <i>J</i> = 4.58, 1H), 8.15 (dd, <i>J</i> = 7.48, 2.29, 1H), 8.00 (dd, <i>J</i> = 9.00, 5.34, 2H), 7.97 (m, 1H), 7.83 (s, 1H), 7.82 (d, <i>J</i> = 8.60, 1H), 7.64 (d, <i>J</i> = 8.55, 1H), 7.46 (dd, <i>J</i> = 10.22, 8.70, 1H), 7.41 (t, <i>J</i> = 9.00, 2H), 7.29 (t, <i>J</i> = 7.63, 1H), 7.28 (d, <i>J</i> = 7.32, 1H,), 7.23 (apparent d, <i>J</i> = 7.10, 2H), 7.17 (t, <i>J</i> = 7.17, 1H), 2.85 (appeared as d, <i>J</i> = 4.58, 3H), 1.30 (appeared as d, 4H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 4 mL/min. Column: Xterra MS 7 μm, C18, 3.0 × 50 mm. (ES+) <i>m</i>/<i>z</i> = 523.44 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.803 min.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 5-(2-Chloro-5-(1-phenylcyclopropylcarbamoyl)phenyl)-2-(4-fluorophenyl)-<i>N</i>-methylbenzofuran-3-carboxamide (<b>26</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.36 (broad s, 1H), 7.98–7.94 (overlapping m, 3H), 7.85 (dd, <i>J</i> = 8.39, 2.29, 1H), 7.75 (d, <i>J</i> = 1.83, 1H), 7.66 (d, <i>J</i> = 8.55, 1H), 7.63 (d, <i>J</i> = 8.00, 1H), 7.48 (dd, <i>J</i> = 8.55, 1.83, 1H), 7.29–7.25 (overlapping m, 6H), 7.17 (m, 1H), 2.95 (s, 3H), 1.36–1.34 (appeared as d, 4H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 4 mL/min. Column: Xterra MS 7 μm, C18, 3.0 × 50 mm. (ES+) <i>m</i>/<i>z</i> = 539.37, 541.38 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.868 min. Analytical HPLC method: solvent A = 5% MeCN–95% H<sub>2</sub>O–0.1% TFA, solvent B = 95% MeCN–5% H<sub>2</sub>O–0.1% TFA, start % B = 50, final % B = 100, gradient time = 15 min, stop time = 18 min, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 10.84 min. Column: Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 8.37 min.</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-(4-Fluorophenyl)-5-(2-methoxy-5-(1-phenylcyclopropylcarbamoyl)phenyl)-<i>N</i>-methylbenzofuran-3-carboxamide (<b>27</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.05–7.94 (m, 4H), 7.85 (d, <i>J</i> = 1.51, 1H), 7.67–7.62 (m, 1H), 7.62–7.56 (m, 1H), 7.38–7.28 (m, 6H), 7.26–7.18 (m, 2H), 3.94 (s, 3H), 3.01 (s, 3H), 1.40 (dd, <i>J</i> = 7.03, 2.01, 4H). LC/MS method: solvent A = 10% MeCN–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeCN–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 3 min, stop time = 4 min, flow rate = 4 mL/min. Column: Waters Sunfire 5 μm C18, 4.6 × 50 mm. (ES+) <i>m</i>/<i>z</i> = 535.16 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 2.373 min. Analytical HPLC method: solvent A = 5% MeCN–95% H<sub>2</sub>O–0.1% TFA, solvent B = 95% MeCN–5% H<sub>2</sub>O–0.1% TFA, start % B = 10, final % B = 100, gradient time = 10 min, stop time = 20 min, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 10.31 min. Column: Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 12.23 min.</div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-phenylcyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide (<b>28</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.97 (dd, <i>J</i> = 8.85, 5.49, 2H), 7.79 (m, 2H), 7.65–7.64 (d overlapping s, 1H), 7.64 (s, 1H), 7.42 (m, 1H), 7.37 (dd, <i>J</i> = 8.24, 1.83, 1H), 7.29–7.26 (overlapping m, 6H), 7.16 (m, 1H), 2.95 (s, 3H), 2.34 (s, 3H), 1.36–1.33 (appeared as d, 4H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 4 mL/min. Column: Xterra MS 7 μm, C18, 3.0 × 50 mm. (ES+) <i>m</i>/<i>z</i> = 519.40 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.832 min. Analytical HPLC method: solvent A = 5% MeCN–95% H<sub>2</sub>O–0.1% TFA, solvent B = 95% MeCN–5% H<sub>2</sub>O–0.1% TFA, start % B = 50, final % B = 100, gradient time = 15 min, stop time = 18 min, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 9.93 min. Column: Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 7.64 min.</div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(pyridin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide (<b>29</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.61 (d, <i>J</i> = 5.80, 1H), 8.44 (t, <i>J</i> = 7.32, 1H), 7.97 (dd, <i>J</i> = 8.85, 5.19, 2H), 7.87 (s, 1H), 7.85 (d, <i>J</i> = 6.71, 1H), 7.83–7.81 (m, 2H), 7.67 (d, <i>J</i> = 8.24, 1H), 7.64 (d, <i>J</i> = 0.92, 1H), 7.47 (d, <i>J</i> = 8.55, 1H), 7.38 (dd, <i>J</i> = 8.39, 1.68, 1H), 7.29 (t, <i>J</i> = 8.85, 2H), 2.95 (s, 3H), 2.36 (s, 3H), 1.82 (m, 2H), 1.75 (m, 2H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 4 mL/min. Column: Xterra MS 7 μm, C18, 3.0 × 50 mm. (ES+) <i>m</i>/<i>z</i> = 520.41 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.513 min. Analytical HPLC method: solvent A = 5% MeCN–95% H<sub>2</sub>O–0.1% TFA, solvent B = 95% MeCN–5% H<sub>2</sub>O–0.1% TFA, start % B = 10, final % B = 100, gradient time = 15 min, stop time = 18 min, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 8.90 min. Column: Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 9.43 min.</div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(pyridin-3-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide (<b>30</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.76 (d, <i>J</i> = 2.44, 1H), 8.71 (dd, <i>J</i> = 5.80, 0.92, 1H), 8.50 (ddd, <i>J</i> = 8.32, 2.21, 1.37, 1H), 8.04 (dd, <i>J</i> = 8.39, 5.65, 1H), 7.96 (dd, <i>J</i> = 9.00, 5.34, 2H), 7.83 (d, <i>J</i> = 1.53, 1H), 7.82 (m overlapped with d, 1H), 7.66 (d, <i>J</i> = 8.24, 1H), 7.64 (d, <i>J</i> = 1.83, 1H), 7.45 (d, <i>J</i> = 8.55, 1H), 7.28 (t, <i>J</i> = 8.70, 2H), 2.95 (s, 3H), 2.35 (s, 3H), 1.60 (dt, <i>J</i> = 4.20, 2.59, 4H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 520.08 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.482 min.</div></div><div id="sec6_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(pyridin-4-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide (<b>31</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.68 (d, <i>J</i> = 7.32, 1H), 7.97 (dd, <i>J</i> = 8.85, 5.19, 2H), 7.87 (d, <i>J</i> = 2.14, 1H), 7.86 (m overlapped with d, 1H), 7.81 (d, <i>J</i> = 7.02, 1H), 7.67 (d, <i>J</i> = 8.55, 1H), 7.65 (d, <i>J</i> = 1.22, 1H), 7.48 (d, <i>J</i> = 8.55, 1H), 7.39 (dd, <i>J</i> = 8.39, 1.68, 1H), 7.28 (t, <i>J</i> = 8.85, 2H), 2.95 (s, 3H), 2.37 (s, 3H), 1.83 (appeared as d, 4H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 520.15 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.435 min. Analytical HPLC method: solvent A = 5% MeCN–95% H<sub>2</sub>O–0.1% TFA, solvent B = 95% MeCN–5% H<sub>2</sub>O–0.1% TFA, start % B = 50, final % B = 100, gradient time = 15 min, stop time = 18 min, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 8.03 min. Column: Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm (start % B = 10, final % B = 100); <i>R</i><sub>t</sub> = 14.09 min.</div></div><div id="sec6_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(pyrimidin-2-yl)cyclopropylcarbamoyl) phenyl) benzofuran-3-carboxamide (<b>32</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (s, 1H), 8.68–8.67 (d, <i>J</i> = 4.8, 2H), 8.50–8.47 (m, 1H), 8.02–7.98 (m, 2H), 7.87–7.86 (d, <i>J</i> = 4.4, 2H), 7.78–7.76 (d, <i>J</i> = 8.4, 1H), 7.59 (s, 1H), 7.45–7.39 (m, 4H), 7.29–7.26 (t, <i>J</i> = 4.8, 1H), 2.83–2.82 (d, <i>J</i> = 4.8, 3H), 2.31 (s, 3H), 1.61–1.59 (m, 2H), 1.36–1.33 (m, 2H). LC/MS method: solvent A = 2% MeCN–98% H<sub>2</sub>O–10 mM NH<sub>4</sub>CHO<sub>2</sub>, solvent B = 98% MeCN–2% H<sub>2</sub>O–10 mM NH<sub>4</sub>CHO<sub>2</sub>, time (min)/% B = 0/0, 1.5/100, 3.2/100, 3.6/0, flow rate = 1 mL/min. Column: Ascentis Express C18 5 × 2.1 mm, 2.7 μm. (ES+) <i>m</i>/<i>z</i> = 521.2 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.883 min. Analytical HPLC method: solvent A = 5% MeCN–95% H<sub>2</sub>O–0.05% TFA, solvent B = 95% MeCN–5% H<sub>2</sub>O–0.05% TFA, time (min)/% B = 0/10, 25/100, 30/100, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 17.12 min; Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 15.73 min.</div></div><div id="sec6_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(pyrazin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide (<b>33</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.59 (s, 1H), 8.52 (t, 1 H), 8.37 (d, <i>J</i> = 2.4, 1H), 8.00–7.95 (m, 2H), 7.87–7.84 (m, 2H), 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.66 (s, 1H), 7.47 (d, <i>J</i> = 8.4, 1H), 7.40 (dd, <i>J</i> = 8.4, 2.0, 1H), 7.31–7.25 (m, 2H), 2.95 (s, 3H), 2.37 (s, 3H), 1.74–1.71 (m, 2H), 1.46–1.43 (m, 2H). <sup>19</sup>F NMR (376.51 MHz, CD<sub>3</sub>OD): δ −113.35. LC/MS method: solvent A = 2% MeCN–98% H<sub>2</sub>O–10 mM NH<sub>4</sub>CHO<sub>2</sub>, solvent B = 98% MeCN–2% H<sub>2</sub>O–10 mM NH<sub>4</sub>CHO<sub>2</sub>, time (min)/% B = 0/0, 1.5/100, 3.2/100, flow rate = 1 mL/min. Column: Ascentis Express C18, 5 × 2.1 mm, 2.7 μm. (ES+) <i>m</i>/<i>z</i> = 521.2 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.902 min. Analytical HPLC method: buffer, 0.05% TFA in water, pH 2.5; mobile phase A, 95:5 buffer/MeCN; mobile phase B, 95:5 MeCN/buffer, time (min)/% B = 0/10, 12/100, 15/100, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 10.81 min; Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 9.90 min.</div></div><div id="sec6_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(pyrimidin-4-yl)cyclopropyl carbamoyl)phenyl)benzofuran-3-carboxamide (<b>34</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.03 (d, <i>J</i> = 1.0, 1 H), 8.61 (d, <i>J</i> = 5.8, 1 H), 8.04–7.94 (m, 2 H), 7.91–7.83 (m, 2 H), 7.72–7.64 (m, 2 H), 7.57–7.45 (m, 2 H), 7.43–7.37 (m, 1 H), 7.34–7.24 (m, 2 H), 2.96 (s, 3 H), 2.37 (s, 3 H), 1.90–1.81 (m, 2 H), 1.57–1.49 (m, 2 H). <sup>19</sup>F NMR (376.51 MHz, CD<sub>3</sub>OD): δ −113.31. LC/MS method: solvent A = 10% MeCN–90% H<sub>2</sub>O–20 mM NH<sub>4</sub>OAc, solvent B = 90% MeCN–10% H<sub>2</sub>O–20 mM NH<sub>4</sub>OAc, time (min)/% B = 0/0, 2/100, 2.5/100, 3/0, flow rate = 2.5 mL/min. Column: Purospher STAR RP-18 (4 × 55) mm, 3 μm. (ES+) <i>m</i>/<i>z</i> = 521.2 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.828 min. Analytical HPLC method: buffer, 0.05% TFA in water, pH 2.5; mobile phase A: 95:5 buffer/MeCN; mobile phase B: 95:5 MeCN/buffer, time (min)/% B = 0/10, 25/100, 30/100, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 16.43 min; Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 15.27 min.</div></div><div id="sec6_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(pyridazin-3-yl)cyclo propylcarbamoyl)phenyl)benzofuran-3-carboxamide (<b>35</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.17 (s, 1 H), 7.92–7.96 (m, 3 H), 7.77–7.69 (m, 4 H), 7.65 (s, 1 H), 7.56 (d, <i>J</i> = 8.4, 1 H), 7.38 (d, <i>J</i> = 8.0, 1 H), 7.30 (dd, <i>J</i> = 8.4, 1.6, 1H), 7.23–7.19 (m, 2 H), 5.94 (bs, 1 H), 3.0 (s, 3 H), 2.33 (s, 3 H), 1.89–1.86 (m, 2 H), 1.60–1.57 (m, 2 H). <sup>19</sup>F NMR (376.47 MHz, CDCl<sub>3</sub>): δ −109.29. LC/MS method: solvent A = 2% MeCN–98% H<sub>2</sub>O–10 mM NH<sub>4</sub>CHO<sub>2</sub>, solvent B = 98% MeCN–2% H<sub>2</sub>O–10 mM NH<sub>4</sub>CHO<sub>2</sub>, time (min)/% B = 0/0, 1.5/100, 3.2/100, flow rate = 1 mL/min. Column: Ascentis Express C18 5 × 2.1 mm, 2.7 μm. (ES+) <i>m</i>/<i>z</i> = 521.0 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.858 min. Analytical HPLC method: buffer, 0.05% TFA in water, pH 2.5; mobile phase A: 95:5 buffer/MeCN; mobile phase B: 95:5 MeCN/buffer, time (min)/% B = 10/10, 12/100, 15/100, flow rate = 1 mL/min. Column: Sunfire C18, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 9.77 min; Xbridge Phenyl, 3.5 μm, 4.6 × 150 mm; <i>R</i><sub>t</sub> = 9.33 min.</div></div><div id="sec6_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-(4-Fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(3-methyl-1,2,4-oxadiazol-5-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide (<b>36</b>)</h4><div class="NLM_p last">A mixture of methyl 1-(3-(2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-5-yl)-4-methylbenzamido)cyclopropanecarboxylate (25.3 mg, 0.051 mmol), <i>N</i>′-hydroxyacetimidamide (11.23 mg, 0.152 mmol), and K<sub>2</sub>CO<sub>3</sub> (41.9 mg, 0.303 mmol) in toluene (1 mL) under N<sub>2</sub> in a reusable sealed tube was stirred at 150 °C for 2 h. The mixture was evaporated, diluted with MeOH, and purified by Shimadzu-VP preparative reverse-phase HPLC using the separation method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 50, final % B = 100, gradient time = 10 min, stop time = 12 min, flow rate = 25 mL/min. Column: Waters-Sunfire 19 × 100 mm S5. Fraction collection: 7.54–8.08 min (UV detection at 220 nm) to give the product as a white solid (19.9 mg, 75%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.98 (m, <i>J</i> = 9.00, 5.34, 2H), 7.82 (d, <i>J</i> = 2.14, 1H), 7.81 (m, 1H), 7.66 (d, <i>J</i> = 8.55, 1H), 7.65 (d, <i>J</i> = 1.50, 1H), 7.44 (d, <i>J</i> = 8.55, 1H), 7.38 (dd, <i>J</i> = 8.24, 1.83, 1H), 7.28 (m, <i>J</i> = 8.85, 2H), 2.95 (s, 3H), 2.36 (s, 3H), 2.31 (s, 3H), 1.75 (m, 2H), 1.58 (m, 2H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 525.12 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.700 min.</div></div><div id="sec6_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-Fluoro-2-(4-fluorophenyl)-<i>N</i>-methyl-5-(2-methyl-5-(1-(pyrimidin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide (<b>37</b>)</h4><div class="NLM_p">To a mixture of 3-(4-fluoro-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-5-yl)-4-methylbenzoic acid (<b>44</b>) (1.87 g, 4.44 mmol), 1-(pyrimidin-2-yl)cyclopropanamine·2HCl (<b>45</b>) (1.108 g, 5.33 mmol), and 2-(1<i>H</i>-benzo[<i>d</i>][1,2,3]triazol-1-yl)-1,1,3,3-tetramethylisouronium tetrafluoroborate (2.85 g, 8.88 mmol) in DMF (40 mL) at rt under N<sub>2</sub> was added <i>N</i>,<i>N</i>-diisopropylethylamine (3.10 mL, 17.75 mmol) dropwise. The mixture was stirred at rt for 25 h. The mixture was then added with H<sub>2</sub>O (210 mL) slowly, and the light pinkish-white solid was filtered, washed with H<sub>2</sub>O (4 × 55 mL), and dried. The solid was further washed with CH<sub>2</sub>Cl<sub>2</sub> (3 × 21 mL) (during the first wash, the solid first appeared to dissolve in CH<sub>2</sub>Cl<sub>2</sub> and then reappeared as solid), and dried to give a white solid (2.03 g). The solid was dissolved in MeOH (200 mL) and filtered through a sintered glass funnel (with 2 × 10 mL washings with MeOH). H<sub>2</sub>O was added to the solution while being rigorously swirled (with 2.5–5 mL each time (total 170 mL)) until it turned cloudy. The round-bottom flask was covered with a wiper tissue paper and left standing at rt for 25 h. The white crystalline solids were filtered and washed with a mixture of 4.5:3.5 MeOH/H<sub>2</sub>O (2 × 40 mL) and dried under high vacuum overnight for four days (1.9036 g, 79%).</div><div class="NLM_p last">HRMS (ES+) <i>m</i>/<i>z</i> observed 539.1873 [M + H]<sup>+</sup>; calculated for C<sub>31</sub>H<sub>25</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub>, 539.1889. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.65 (d, <i>J</i> = 5.04, 2 H), 7.96 (dd, <i>J</i> = 9.14, 5.36, 2 H), 7.91 (dd, <i>J</i> = 8.04, 2.05, 1 H), 7.85 (d, <i>J</i> = 1.89, 1 H), 7.54 (d, <i>J</i> = 8.51, 1 H), 7.46 (d, <i>J</i> = 7.88, 1 H), 7.33 (dd, <i>J</i> = 8.35, 7.09, 1 H), 7.30 (t, <i>J</i> = 8.83, 2 H), 7.23 (t, <i>J</i> = 4.89, 1 H), 2.96 (s, 3 H), 2.29 (s, 3 H), 1.77 (m, 2 H), 1.46 (m, 2 H); <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 171.48, 171.23, 167.11, 165.13 (d, <i>J</i> = 249.80), 158.38, 156.30 (d, <i>J</i> = 9.09), 154.14, 153.34 (d, <i>J</i> = 249.80), 142.48, 137.09, 133.40, 131.30, 130.92, 130.33, 130.26, 129.42 (d, <i>J</i> = 2.73), 128.42, 126.83 (d, <i>J</i> = 3.63), 124.47 (d, <i>J</i> = 15.44), 119.66, 118.01 (d, <i>J</i> = 20.90), 117.20 (d, <i>J</i> = 22.70), 112.11, 108.80 (d, <i>J</i> = 4.54), 38.24, 27.04, 20.57, 20.37; <sup>19</sup>F NMR (470.45 MHz, CD<sub>3</sub>OD) δ −112.73, −123.11. Analytical HPLC was performed using a Waters Acquity HPLC with Waters PDA UV–vis detection and Waters SQ MS (ESCI probe). Flow = 0.35 mL/min. Gradient: hold 10% B 0–1 min, 10–98% B 1–32 min, hold 98% B 32–35 min, 98–10% B 35–35.5 min, hold 10% B 35.5–40 min. UV detection: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3a6f6c7a08030f">[email protected]</a> nm (220 nm was also checked: no additional impurities were observed at 220 nm). Column: Waters Acquity BEH C18, 1.7 μm, 150 × 2.1 mm ID (at 35 °C). Mobile phase A: water with 0.05% TFA; mobile phase B: acetonitrile with 0.05% TFA; 99.6% purity. (ES+) <i>m</i>/<i>z</i> = 539.33 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 16.2 min. Column: Waters Acquity BEH C18, 1.7 μm, 150 × 2.1 mm ID (at 35 °C). Mobile phase A: 30 mM ammonium bicarbonate in water, pH 9.5; mobile phase B: acetonitrile; 99.6% purity; <i>R</i><sub>t</sub> = 16.3 min.</div></div><div id="sec6_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Ethyl 4-Fluoro-2-(4-fluorophenyl)-5-hydroxybenzofuran-3-carboxylate (<b>39</b>)</h4><div class="NLM_p last">To a mixture of ethyl 2-(4-fluorophenyl)-5-hydroxybenzofuran-3-carboxylate (<b>38</b>) (500 mg, 1.665 mmol) in acetonitrile (10 mL) at rt under N<sub>2</sub> was added 1-(chloromethyl)-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane tetrafluoroborate (708 mg, 1.998 mmol). The mixture was stirred at rt for 20 h and then evaporated. The residue was added with H<sub>2</sub>O (10 mL). The aqueous layer was decanted, and the residue was further washed with H<sub>2</sub>O (2 × 5 mL). The mixture was dissolved in MeOH (∼10 mL), and the insoluble portion was filtered. The filtrate was purified by Shimadzu-VP preparative reverse-phase HPLC using the separation method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 60, final % B = 100, gradient time = 10 min, stop time = 12 min, flow rate = 25 mL/min. Column: Waters-Sunfire 19 × 100 mm S5. Fraction collection: 6.44–7.24 min (UV detection at 220 nm). The desired fractions were combined and evaporated to give a yellow solid. The yellow solid was further purified by Biotage Horizon flash chromatography (0–70% EtOAc/hexane, 3 × 80 g silica gel columns) to give <b>39</b> as a light yellow solid (108.9 mg). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.95 (m, 2H), 7.26 (t overlapping with dd, 2H), 7.25 (dd, 1H), 7.03 (t, <i>J</i> = 8.39, 1H), 4.39 (q, <i>J</i> = 7.17, 2H), 1.36 (t, <i>J</i> = 7.17, 3H). <sup>19</sup>F NMR (470.45 MHz, CD<sub>3</sub>OD) δ −112.36, −142.29 (the <sup>19</sup>F chemical shift was referenced to CFCl<sub>3</sub> at 0.0 ppm). The position of the F atom at C4 was confirmed by <sup>1</sup>H–<sup>1</sup>H through bond correlation between H6 and H7, <sup>1</sup>H–<sup>13</sup>C HMBC, and F–C4 coupling in <sup>13</sup>C NMR (125.75 MHz, CD<sub>3</sub>OD) (δ 144.8 ppm, d, <i>J</i> = 247, C4). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 319.14 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.718 min. The minor fractions collected at approximately 7.69–8.20 min were confirmed by <sup>1</sup>H–<sup>1</sup>H through bond correlation, <sup>1</sup>H–<sup>13</sup>C HMBC, and F–C6 coupling in <sup>13</sup>C NMR (125.75 MHz, CD<sub>3</sub>OD) (δ 152.5 ppm, d, <i>J</i> = 242 Hz, C6) to be the isomer of the F atom at C6 (∼3:1 C4/ C6 based on preparative HPLC % area of the UV trace). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.04 (dd, <i>J</i> = 8.55, 5.49, 2H), 7.59 (d, <i>J</i> = 8.85, 1H), 7.38 (d, <i>J</i> = 10.07, 1H), 7.25 (t, <i>J</i> = 8.70, 2H), 4.40 (q, <i>J</i> = 7.17, 2H), 1.41 (t, <i>J</i> = 7.17, 3H). <sup>19</sup>F NMR (470.45 MHz, CD<sub>3</sub>OD) δ −112.29, −138.52. LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 319.14 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.798 min.</div></div><div id="sec6_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-Fluoro-2-(4-fluorophenyl)-5-hydroxybenzofuran-3-carboxylic Acid (<b>40</b>)</h4><div class="NLM_p">To a mixture of ethyl 2-(4-fluorophenyl)-5-hydroxybenzofuran-3-carboxylate (<b>38</b>) (3 g, 9.99 mmol) in acetonitrile (200 mL) at rt under N<sub>2</sub> was added 1-(chloromethyl)-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane tetrafluoroborate (4.25 g, 11.99 mmol) portion-wise. The mixture was stirred at rt for 24 h. The mixture was then filtered to remove the white insoluble portion, and the filtrate was evaporated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and purified by Biotage Horizon chromatography (0–70% EtOAc/hexane, 3 × 160 g silica gel columns, 18 mm tube–27 mL × 48 tubes) to give an orange solid (1.89 g).</div><div class="NLM_p last">To a mixure of the solid obtained from above (1.89 g, 5.94 mmol) in a mixture of MeOH (35 mL)/THF (35 mL) at rt under N<sub>2</sub> was added sodium hydroxide (17.81 mL, 17.81 mmol, 1 N aqueous). The mixture was stirred at 90 °C for 6 h. The mixture was cooled to rt, acidified with 1 N HCl (20 mL), and then evaporated to dryness. To the solid residue was added H<sub>2</sub>O (30 mL); the light brown solid was filtered, washed with H<sub>2</sub>O (4 × 10 mL), and dried. To the solid was added MeOH (30 mL), which was purified by Shimadzu-VP preparative reverse-phase HPLC using the separation method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 40, final % B = 100, gradient time = 10 min, stop time = 12 min, flow rate = 25 mL/min. Column: Sunfire Prep C18 19 × 100 5um. Fraction collection: 6.80–7.40 min (UV detection at 220 nm). Evaporation of the combined desired fractions gave desired C4–F product <b>40</b> as an off-white solid (690 mg, 24% 2 steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.98 (m, 2H), 7.25 (t overlapping with dd, 2H), 7.24 (dd, 1H), 7.02 (t, <i>J</i> = 8.39, 1H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 291.01 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.478 min.</div></div><div id="sec6_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-Fluoro-2-(4-fluorophenyl)-5-hydroxy-<i>N</i>-methylbenzofuran-3-carboxamide (<b>41</b>)</h4><div class="NLM_p last">To a mixture of 4-fluoro-2-(4-fluorophenyl)-5-hydroxybenzofuran-3-carboxylic acid (<b>40</b>) (546.5 mg, 1.883 mmol), methylamine·HCl (191 mg, 2.82 mmol), HOBT hydrate (490 mg, 3.20 mmol), and EDC hydrochloride (650 mg, 3.39 mmol) in DMF (20 mL) at rt under N<sub>2</sub> was added <i>N</i>,<i>N</i>-diisopropylethylamine (1.644 mL, 9.42 mmol). The mixture was stirred at rt for 19.5 h. The mixture was concentrated to approximately half of the volume, and then 1 N HCl (30 mL) was added, and the solution was further diluted with H<sub>2</sub>O (120 mL). The off-white solid was filtered, washed with H<sub>2</sub>O (3 × 30 mL), and dried (528.5 mg, 93%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.89 (dd, <i>J</i> = 8.09, 5.34, 2H), 7.25 (t overlapping with dd, 2H), 7.23 (dd, 1H), 6.99 (t, <i>J</i> = 8.55, 1H), 2.96 (s, 3H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 304.06 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.262 min.</div></div><div id="sec6_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-Fluoro-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-5-yl trifluoromethanesulfonate (<b>42</b>)</h4><div class="NLM_p last">To a mixture of 4-fluoro-2-(4-fluorophenyl)-5-hydroxy-<i>N</i>-methylbenzofuran-3-carboxamide (<b>41</b>) (1 g, 3.30 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) at rt under N<sub>2</sub> was added triethylamine (0.914 mL, 6.59 mmol) dropwise. The white suspension was cooled to 0 °C using an ice–water bath, and then 1,1,1-trifluoro-<i>N</i>-phenyl-<i>N</i>-(trifluoromethylsulfonyl)methanesulfonamide (1.767 g, 4.95 mmol) was added portion-wise. The mixture, which slowly turned to a clear light yellow solution, was stirred at rt for 6 h. The mixture was evaporated to dryness, and H<sub>2</sub>O (30 mL) was added. The white powder was filtered, washed with H<sub>2</sub>O (4 × 15 mL), and dried (1.4121 g, 98%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.95 (m, 2H), 7.59 (dd, <i>J</i> = 9.00, 1.00, 1H), 7.50 (dd, <i>J</i> = 9.00, 7.50, 1H), 7.30 (t, <i>J</i> = 8.55, 2H), 2.99 (s, 3H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 436.04 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.678 min.</div></div><div id="sec6_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(4-Fluoro-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-5-yl)-4-methylbenzoic Acid (<b>44</b>)</h4><div class="NLM_p last">A mixture of 4-fluoro-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-5-yl trifluoromethanesulfonate (<b>42</b>) (1.563 g, 3.59 mmol), 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid (<b>43</b>) (1.129 g, 4.31 mmol), (Ph<sub>3</sub>P)<sub>4</sub>Pd (0.415 g, 0.359 mmol), and cesium carbonate (1.755 g, 5.39 mmol) in a mixture of water (5 mL)/dioxane (25 mL) under N<sub>2</sub> was stirred at 90 °C for 6 h. The mixture was left standing at rt for 17 h. To the mixture was added 1,4-dioxane (50 mL), which was filtered through a short plug of Celite (with 4 × 10 mL washings with dioxane). The filtrate was concentrated to approximately half of the volume until precipitates started to form. The mixture was cooled in an ice–water bath, and 1 N HCl (70 mL) was added slowly, upon which yellow solids deposited on the wall of the flask. To the mixture was added H<sub>2</sub>O (150 mL), which was left to stand at rt for 45 min. The aqueous layer was decanted, and the yellow residue was washed with H<sub>2</sub>O (3 × 20 mL) and dried. To the residue was added MeOH (10 mL), which was filtered, and the solid was washed with MeOH (2 × 5 mL) to give an off-white solid of the product (620 mg). The MeOH filtrate was evaporated, and to the obtained residue was added Et<sub>2</sub>O (15 mL). The solids were filtered, washed with 1:5 MeOH/Et<sub>2</sub>O (∼5 mL) followed by Et<sub>2</sub>O (5 mL), and dried to give a further amount (260 mg) of the product as a white solid (880 mg total, 58%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.99–7.95 (m, 3H), 7.89 (s, 1H), 7.54 (d, <i>J</i> = 8.55, 1H), 7.45 (d, <i>J</i> = 7.93, 1H), 7.31–7.27 (m, 3H), 2.96 (s, 3H), 2.29 (s, 3H). LC/MS method: solvent A = 10% MeOH–90% H<sub>2</sub>O–0.1% TFA, solvent B = 90% MeOH–10% H<sub>2</sub>O–0.1% TFA, start % B = 0, final % B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 5 mL/min. Column: Phenomenex-Luna, 3.0 × 50 mm, S10. (ES+) <i>m</i>/<i>z</i> = 422.19 (M + H)<sup>+</sup>; <i>R</i><sub>t</sub> = 1.653 min.</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> In Vivo Rat Pharmacokinetic Studies</h3><div class="NLM_p">All animal studies were performed under the approval of the Bristol-Myers Squibb Animal Care and Use Committee and in accordance with the American Association for Accreditation of Laboratory Animal Care (AAALAC). Male Sprague–Dawley rats (300–350 g) with dual indwelling cannulae implanted in the jugular or intraportal veins were used in the pharmacokinetic studies. After dosing, serial blood samples (0.3 mL) were obtained from the appropriate cannula of each rat by collection into EDTA-containing tubes (Becton Dickinson, Franklin Lakes, NJ) and centrifuged to separate plasma. Plasma was frozen until analysis. For IV studies, compound <b>32</b> or <b>37</b> was dosed (2 mg/kg) in a vehicle of 90:10 PEG-400/ethanol (v/v) as a 10 min constant rate infusion into the jugular vein with serial blood samples collected before dosing and at 10, 15, 30, 45, and 60 min and 2, 4, 6, 8, and 24 h after dosing (<i>n</i> = 3 rats/dose group). For PO dosing, the compound was administered (6 mg/kg) by gastric gavage as an aqueous solution (90:10 PEG-400/ethanol (v/v) or by a suspension formulation using a spray-dried dispersion (10% w/w drug loading of compound <b>37</b> in 0.02:0.5:99.48 docusate/methocel/water). Serial blood samples were collected before dosing and at 15, 30, 45, and 60 min and 2, 4, 6, 8, and 24 h after dosing (<i>n</i> = 3 rats/dose group). Prior to all PO dosing, the rats were fasted overnight with free access to water. For assessing liver exposure, livers were removed from rats at 24 h after IV dosing and 6 (using satellite animals) and 24 h after PO dosing. The tissues were rinsed, blotted dry, weighed, and stored frozen until analysis. Processing included addition of 2 volumes of 80% acetonitrile in Hanks balanced salt solution (HBSS) buffer per gram of tissue, homogenization with a T25 basic S1 generator (IKA Works, Wilminton, NC) using an S25N-8G dispersing tool, and centrifugation (IEC Centra-8R at 3,000 rpm for 10 min). Aliquots of supernatant were removed and stored frozen until analysis by LC/MS/MS. Screening studies of compound <b>29</b> were conducted as described above with truncated time points (0 (predose), 0.17 (IV only), 0.5, 1, 2, 4, and 6 h with livers taken at the terminal time point) and with <i>n</i> = 2 rats/dose group.</div><div class="NLM_p last">The pharmacokinetics parameters were obtained by noncompartmental analysis of plasma concentration versus time data (KINETICA software, version 2.4, InnaPhase Corporation, Philadelphia, PA). The peak concentration (<i>C</i><sub>max</sub>) and time for <i>C</i><sub>max</sub> (<i>T</i><sub>max</sub>) were recorded directly from experimental observations. The area under the curve from time zero to the last sampling time (AUC<sub>0–<i>T</i></sub>) and the area under the curve from time zero to infinity (AUC<sub>INF</sub>) were calculated using a combination of linear and log trapezoidal summations. The whole body plasma clearance (CL), steady-state volume of distribution (<i>V</i><sub>ss</sub>), apparent terminal <i>t</i><sub>1/2</sub>, and mean residence time (MRT) were estimated following intravenous administration. The absolute oral bioavailability (<i>F</i>) was estimated as the ratio of dose-normalized AUC values following PO and IV doses.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Computational Methodology</h3><div id="sec6_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Quantum Chemical Calculations</h4><div class="NLM_p last">Geometry optimizations for the different conformations of the model systems included in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a> were performed using the Gaussian 09 program at the MP2/6-31+G** level of theory with default convergence criteria.<a onclick="showRef(event, 'ref32 ref54'); return false;" href="javascript:void(0);" class="ref ref32 ref54">(32, 54)</a> Optimized structures were confirmed as minima via vibrational frequency calculations. The electrostatic potential surfaces displayed in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a> were calculated at the MP2/6-31+G** level, and geometry optimization of the models included PCM solvation (H<sub>2</sub>O).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec6_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 4-Fluorobenzofuran Analogue Model</h4><div class="NLM_p last">The A-chain of the X-ray structure of the HCV NS5B 1bC316N protein in complex with the des-fluoro analogue <b>46</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_001.pdf" class="ext-link">Figure S1</a>) of the compound shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> and an additional compound occupying the P495 site (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3Q0Z">3Q0Z</a>) was imported into Maestro and processed using the Protein Preparation Wizard. The model was then subjected to three stages of energy minimization with MacroModel, all of which utilized the OPLS3 force-field and an implicit water solvation model.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> In the first stage, all nonhydrogen atoms were constrained, and 500 steps of PRCG energy minimization were performed. In the second stage, protein backbone atoms were constrained, and the model was subjected to 100 steps of steepest descent energy minimization. Finally, all constraints were removed, and 100 steps of steepest descent energy minimization were performed. Default convergence criteria were included at each stage. The resulting model was modified by replacing the benzofuran 4-position hydrogen atom with a fluorine atom followed by 100 steps of steepest descent energy minimization during which all atoms except the ligand were constrained.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00328">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00328" class="ext-link">10.1021/acs.jmedchem.7b00328</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Production of the recombinant protein, crystallization conditions, crystallographic methods, and crystallographic statistics for complexes of HCV gt-1b NS5B protein (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_001.pdf">jm7b00328_si_001.pdf (311.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_002.csv">jm7b00328_si_002.csv (3.05 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code for <b>5</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZK">5PZK</a>, <b>6</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZL">5PZL</a>, <b>8</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZM">5PZM</a>, <b>18</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZN">5PZN</a>, <b>37</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZP">5PZP</a>, and <b>46</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZO">5PZO</a>. CCDC 1541557 contains the supplementary crystallographic data for the unsolvated neat form of <b>37</b>. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via <a href="http://www.ccdc.cam.ac.uk/structures" class="extLink">www.ccdc.cam.ac.uk/structures</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00328" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kap-Sun Yeung</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3995-6555" title="Orcid link">http://orcid.org/0000-0003-3995-6555</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#503b312023253e7e2935253e3710323d237e333f3d"><span class="__cf_email__" data-cfemail="a9c2c8d9dadcc787d0ccdcc7cee9cbc4da87cac6c4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brett R. Beno</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyle Parcella</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Bender</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine A. Grant-Young</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Nickel</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prashantha Gunaga</span> - <span class="hlFld-Affiliation affiliation">Department
of Discovery Chemistry, Biocon Bristol-Myers
Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prakash Anjanappa</span> - <span class="hlFld-Affiliation affiliation">Department
of Discovery Chemistry, Biocon Bristol-Myers
Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajesh Onkardas Bora</span> - <span class="hlFld-Affiliation affiliation">Department
of Discovery Chemistry, Biocon Bristol-Myers
Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kumaravel Selvakumar</span> - <span class="hlFld-Affiliation affiliation">Department
of Discovery Chemistry, Biocon Bristol-Myers
Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Rigat</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying-Kai Wang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mengping Liu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Lemm</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Mosure</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Sheriff</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Changhong Wan</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Witmer</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Kish</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Umesh Hanumegowda</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoliang Zhuo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yue-Zhong Shu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dawn Parker</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roy Haskell</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alicia Ng</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Gao</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, 1 Squibb Drive, New Brunswick, New Jersey 08901, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Colston</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Raybon</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis M. Grasela</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth Santone</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Gao</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas A. Meanwell</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Sinz</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew G. Soars</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay O. Knipe</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan B. Roberts</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John F. Kadow</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O.
Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d119e4980-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to thank colleagues in Lead Profiling for collecting in vitro profiling data, Discovery Analytical Science for performing the key compound characterizations on <b>37</b>, the Discovery Chemistry Synthesis group for scale-up synthesis, and Process R&D for support. Use of the IMCA-CAT beamline 17-ID and 17-BM at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> Abbreviations</h2><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion</p></td></tr><tr><td class="NLM_term">ASD</td><td class="NLM_def"><p class="first last">amorphous solid dispersion</p></td></tr><tr><td class="NLM_term">BCS</td><td class="NLM_def"><p class="first last">biopharmaceutics classification system</p></td></tr><tr><td class="NLM_term">gt</td><td class="NLM_def"><p class="first last">genotype</p></td></tr><tr><td class="NLM_term">HAC</td><td class="NLM_def"><p class="first last">heavy atom count</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">investigational new drug</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">RMSD</td><td class="NLM_def"><p class="first last">root-mean-square deviation</p></td></tr><tr><td class="NLM_term">NOAEL</td><td class="NLM_def"><p class="first last">no observed adverse effect level</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">WHO</span><span class="NLM_x"> Hepatitis C Fact Sheet No. 164, </span><a href="http://www.who.int/mediacentre/factsheets/fs164/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs164/en/</a> (updated July 2016; accessed February 5,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO+Hepatitis+C+Fact+Sheet+No.+164%2C+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs164%2Fen%2F+%28updated+July+2016%3B+accessed+February+5%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>Centers for Diseases Control and Prevention: Viral Hepatitis - Hepatitis C Information, <a href="http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm" class="extLink">http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm</a> (updated January 27, 2017; accessed February 5,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Centers+for+Diseases+Control+and+Prevention%3A+Viral+Hepatitis+-+Hepatitis+C+Information%2C+http%3A%2F%2Fwww.cdc.gov%2Fhepatitis%2Fhcv%2Fhcvfaq.htm+%28updated+January+27%2C+2017%3B+accessed+February+5%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1126/science.2523562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood+borne+non-A%2C+non-B+viral+hepatitis+genome&doi=10.1126%2Fscience.2523562"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood%2520borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362%26doi%3D10.1126%2Fscience.2523562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuiken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muerhoff, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonds, P.</span><span> </span><span class="NLM_article-title">Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1002/hep.26744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1002%2Fhep.26744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=24115039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FktFWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=318-327&author=D.+B.+Smithauthor=J.+Bukhauthor=C.+Kuikenauthor=A.+S.+Muerhoffauthor=C.+M.+Riceauthor=J.+T.+Stapletonauthor=P.+Simmonds&title=Expanded+classification+of+hepatitis+C+virus+into+7+genotypes+and+67+subtypes%3A+updated+criteria+and+genotype+assignment+web+resource&doi=10.1002%2Fhep.26744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource</span></div><div class="casAuthors">Smith Donald B; Bukh Jens; Kuiken Carla; Muerhoff A Scott; Rice Charles M; Stapleton Jack T; Simmonds Peter</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Baltimore, Md.)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">318-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  The 2005 consensus proposal for the classification of hepatitis C virus (HCV) presented an agreed and uniform nomenclature for HCV variants and the criteria for their assignment into genotypes and subtypes.  Since its publication, the available dataset of HCV sequences has vastly expanded through advancement in nucleotide sequencing technologies and an increasing focus on the role of HCV genetic variation in disease and treatment outcomes.  The current study represents a major update to the previous consensus HCV classification, incorporating additional sequence information derived from over 1,300 (near-)complete genome sequences of HCV available on public databases in May 2013.  Analysis resolved several nomenclature conflicts between genotype designations and using consensus criteria created a classification of HCV into seven confirmed genotypes and 67 subtypes.  There are 21 additional complete coding region sequences of unassigned subtype.  The study additionally describes the development of a Web resource hosted by the International Committee for Taxonomy of Viruses (ICTV) that maintains and regularly updates tables of reference isolates, accession numbers, and annotated alignments (http://talk.ictvonline.org/links/hcv/hcv-classification.htm).  The Flaviviridae Study Group urges those who need to check or propose new genotypes or subtypes of HCV to contact the Study Group in advance of publication to avoid nomenclature conflicts appearing in the literature.  While the criteria for assigning genotypes and subtypes remain unchanged from previous consensus proposals, changes are proposed in the assignment of provisional subtypes, subtype numbering beyond "w," and the nomenclature of intergenotypic recombinant.  CONCLUSION:  This study represents an important reference point for the consensus classification of HCV variants that will be of value to researchers working in clinical and basic science fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgofAQo7eS9BWfpMXQLRstfW6udTcc2eYBXEK6JGlo_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FktFWnsg%253D%253D&md5=b0bfea063822f132a1204a8973081876</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fhep.26744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26744%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DBukh%26aufirst%3DJ.%26aulast%3DKuiken%26aufirst%3DC.%26aulast%3DMuerhoff%26aufirst%3DA.%2BS.%26aulast%3DRice%26aufirst%3DC.%2BM.%26aulast%3DStapleton%26aufirst%3DJ.%2BT.%26aulast%3DSimmonds%26aufirst%3DP.%26atitle%3DExpanded%2520classification%2520of%2520hepatitis%2520C%2520virus%2520into%25207%2520genotypes%2520and%252067%2520subtypes%253A%2520updated%2520criteria%2520and%2520genotype%2520assignment%2520web%2520resource%26jtitle%3DHepatology%26date%3D2014%26volume%3D59%26spage%3D318%26epage%3D327%26doi%3D10.1002%2Fhep.26744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Scheel, T. K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span><span class="refDoi"> DOI: 10.1038/nm.3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2Fnm.3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=23836234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=837-849&author=T.+K.+H.+Scheelauthor=C.+M.+Rice&title=Understanding+the+hepatitis+C+virus+life+cycle+paves+the+way+for+highly+effective+therapies&doi=10.1038%2Fnm.3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span></div><div class="casAuthors">Scheel, Troels K. H.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">837-849</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  More than two decades of intense research has provided a detailed understanding of hepatitis C virus (HCV), which chronically infects 2% of the world's population.  This effort has paved the way for the development of antiviral compds. to spare patients from life-threatening liver disease.  An exciting new era in HCV therapy dawned with the recent approval of two viral protease inhibitors, used in combination with pegylated interferon-α and ribavirin; however, this is just the beginning.  Multiple classes of antivirals with distinct targets promise highly efficient combinations, and interferon-free regimens with short treatment duration and fewer side effects are the future of HCV therapy.  Ongoing and future trials will det. the best antiviral combinations and whether the current seemingly rich pipeline is sufficient for successful treatment of all patients in the face of major challenges, such as HCV diversity, viral resistance, the influence of host genetics, advanced liver disease and other co-morbidities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpde8altGxkeLVg90H21EOLACvtfcHk0lgzVT_bbMAphg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI&md5=dabc9fbc7dc0bc56115d5ede0d8ae072</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnm.3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3248%26sid%3Dliteratum%253Aachs%26aulast%3DScheel%26aufirst%3DT.%2BK.%2BH.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnderstanding%2520the%2520hepatitis%2520C%2520virus%2520life%2520cycle%2520paves%2520the%2520way%2520for%2520highly%2520effective%2520therapies%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D837%26epage%3D849%26doi%3D10.1038%2Fnm.3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penin, F.</span><span> </span><span class="NLM_article-title">The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1038/nrmicro3046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2Fnrmicro3046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=23748342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVamtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=482-496&author=R.+Bartenschlagerauthor=V.+Lohmannauthor=F.+Penin&title=The+molecular+and+structural+basis+of+advanced+antiviral+therapy+for+hepatitis+C+virus+infection&doi=10.1038%2Fnrmicro3046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection</span></div><div class="casAuthors">Bartenschlager, Ralf; Lohmann, Volker; Penin, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">482-496</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The availability of the first mol. clone of the hepatitis C virus (HCV) genome allowed the identification and biochem. characterization of two viral enzymes that are targets for antiviral therapy: the protease NS3-4A and the RNA-dependent RNA polymerase NS5B.  With the advent of cell culture systems that can recapitulate either the intracellular steps of the viral replication cycle or the complete cycle, addnl. drug targets have been identified, most notably the phosphoprotein NS5A, but also host cell factors that promote viral replication, such as cyclophilin A.  Here, we review insights into the structures of these proteins and the mechanisms by which they contribute to the HCV replication cycle, and discuss how these insights have facilitated the development of new, directly acting antiviral compds. that have started to enter the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_HJeAAUvvrVg90H21EOLACvtfcHk0lgzVT_bbMAphg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVamtbs%253D&md5=3be643822234ebc9e4773c78ec9f3ee5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3046%26sid%3Dliteratum%253Aachs%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DPenin%26aufirst%3DF.%26atitle%3DThe%2520molecular%2520and%2520structural%2520basis%2520of%2520advanced%2520antiviral%2520therapy%2520for%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2013%26volume%3D11%26spage%3D482%26epage%3D496%26doi%3D10.1038%2Fnrmicro3046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span>2015 Hepatitis C Online, <span class="NLM_publisher-name">University of Washington</span>; <a href="http://www.hepatitisc.uw.edu/page/treatment/drugs" class="extLink">http://www.hepatitisc.uw.edu/page/treatment/drugs</a> (accessed October 7,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2015+Hepatitis+C+Online%2C+University+of+Washington%3B+http%3A%2F%2Fwww.hepatitisc.uw.edu%2Fpage%2Ftreatment%2Fdrugs+%28accessed+October+7%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DUniversity%2520of%2520Washington%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Götte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feld, J. J.</span><span> </span><span class="NLM_article-title">Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1038/nrgastro.2016.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2Fnrgastro.2016.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=27147491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1artbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=338-351&author=M.+G%C3%B6tteauthor=J.+J.+Feld&title=Direct-acting+antiviral+agents+for+hepatitis+C%3A+structural+and+mechanistic+insights&doi=10.1038%2Fnrgastro.2016.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights</span></div><div class="casAuthors">Gotte, Matthias; Feld, Jordan J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Gastroenterology & Hepatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">338-351</span>CODEN:
                <span class="NLM_cas:coden">NRGHA9</span>;
        ISSN:<span class="NLM_cas:issn">1759-5045</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The treatment of HCV infection has evolved at an extremely rapid pace over the past few years.  The development of direct-acting antiviral agents, which potently inhibit different stages in the viral life cycle, has led to the replacement of interferon with well-tolerated oral therapies with cure rates of >90% in most patient populations.  Understanding the mechanisms of action of the various agents as well as related issues, including the mol. basis for resistance, helps to guide drug development and clin. use.  In this Review, we provide a mechanistic description of NS3/4A protease inhibitors, nucleotide and non-nucleotide inhibitors of the NS5B viral polymerase and inhibitors of the NS5A protein, followed by a summary of clin. data from studies of each drug class alone and in combination.  Remaining challenges in drug development efforts are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIGsNzAYth1LVg90H21EOLACvtfcHk0ljoAGj7-mLQhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1artbs%253D&md5=76c5779393707d1b993fe0146884d7ed</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2016.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2016.60%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DFeld%26aufirst%3DJ.%2BJ.%26atitle%3DDirect-acting%2520antiviral%2520agents%2520for%2520hepatitis%2520C%253A%2520structural%2520and%2520mechanistic%2520insights%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2016%26volume%3D13%26spage%3D338%26epage%3D351%26doi%3D10.1038%2Fnrgastro.2016.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing hepatitis C virus infection with direct-acting antiviral agents: The arc of a medicinal chemistry triumph</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7311</span><span class="NLM_x">–</span> <span class="NLM_lpage">7351</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00915</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12itr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7311-7351&author=N.+A.+Meanwell&title=2015+Philip+S.+Portoghese+Medicinal+Chemistry+Lectureship.+Curing+hepatitis+C+virus+infection+with+direct-acting+antiviral+agents%3A+The+arc+of+a+medicinal+chemistry+triumph&doi=10.1021%2Facs.jmedchem.6b00915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7311-7351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of direct-acting antiviral agents that can cure a chronic hepatitis C virus (HCV) infection after 8-12 wk of daily, well-tolerated therapy has revolutionized the treatment of this insidious disease.  In this article, three of Bristol-Myers Squibb's HCV programs are summarized, each of which produced a clin. candidate: the NS3 protease inhibitor asunaprevir (64), marketed as Sunvepra, the NS5A replication complex inhibitor daclatasvir (117), marketed as Daklinza, and the allosteric NS5B polymerase inhibitor beclabuvir (142), which is in late stage clin. studies.  A clin. study with 64 and 117 established for the first time that a chronic HCV infection could be cured by treatment with direct-acting antiviral agents alone in the absence of interferon.  The development of small mol. HCV therapeutics, designed by medicinal chemists, has been hailed as "the arc of a medical triumph" but may equally well be described as "the arc of a medicinal chem. triumph".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-IMg2ReRMArVg90H21EOLACvtfcHk0ljoAGj7-mLQhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12itr%252FO&md5=c8232aba85caf67bf38494bc5ddeb508</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00915%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3D2015%2520Philip%2520S.%2520Portoghese%2520Medicinal%2520Chemistry%2520Lectureship.%2520Curing%2520hepatitis%2520C%2520virus%2520infection%2520with%2520direct-acting%2520antiviral%2520agents%253A%2520The%2520arc%2520of%2520a%2520medicinal%2520chemistry%2520triumph%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7311%26epage%3D7351%26doi%3D10.1021%2Facs.jmedchem.6b00915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannarino, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span><span class="refDoi"> DOI: 10.1038/13305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2F13305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10504728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADyaK1MXmslCktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=937-943&author=C.+A.+Lesburgauthor=M.+B.+Cableauthor=E.+Ferrariauthor=Z.+Hongauthor=A.+F.+Mannarinoauthor=P.+C.+Weber&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+from+hepatitis+C+virus+reveals+a+fully+encircled+active+site&doi=10.1038%2F13305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span></div><div class="casAuthors">Lesburg, Charles A.; Cable, Michael B.; Ferrari, Eric; Hong, Zhi; Mannarino, Anthony F.; Weber, Patricia C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">937-943</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Various classes of nucleotidyl polymerases with different transcriptional roles contain a conserved core structure.  Less is known, however, about the distinguishing features of these enzymes, particularly those of the RNA-dependent RNA polymerase class.  The 1.9 Å resoln. crystal structure of hepatitis C virus (HCV) nonstructural protein 5B (NS5B) presented here provides the first complete and detailed view of an RNA-dependent RNA polymerase.  While canonical polymerase features exist in the structure, NS5B adopts a unique shape due to extensive interactions between the fingers and thumb polymerase subdomains that serve to encircle the enzyme active site.  Several insertions in the fingers subdomain account for intersubdomain linkages that include two extended loops and a pair of antiparallel α-helixes.  The HCV NS5B apoenzyme structure reported here can accommodate a template:primer duplex without global conformational changes, supporting the hypothesis that this structure is essentially preserved during the reaction pathway.  This NS5B template:primer model also allows identification of a new structural motif involved in stabilizing the nascent base pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnLsPABmT0XbVg90H21EOLACvtfcHk0lgYXVFTWgXYyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslCktLo%253D&md5=210fd9e96e7ca8d342ed1ae87f0b4acc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F13305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F13305%26sid%3Dliteratum%253Aachs%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DCable%26aufirst%3DM.%2BB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DMannarino%26aufirst%3DA.%2BF.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520hepatitis%2520C%2520virus%2520reveals%2520a%2520fully%2520encircled%2520active%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D937%26epage%3D943%26doi%3D10.1038%2F13305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsunami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span><span class="refDoi"> DOI: 10.1016/S0969-2126(00)80031-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2FS0969-2126%2800%2980031-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10574802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1417-1426&author=H.+Agoauthor=T.+Adachiauthor=A.+Yoshidaauthor=M.+Yamamotoauthor=N.+Habukaauthor=K.+Yatsunamiauthor=M.+Miyano&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus&doi=10.1016%2FS0969-2126%2800%2980031-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Ago, Hideo; Adachi, Tsuyoshi; Yoshida, Atsuhito; Yamamoto, Masaki; Habuka, Noriyuki; Yatsunami, Kimio; Miyano, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1417-1426</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is the major etiol. agent of hepatocellular carcinoma, and HCV RNA-dependent RNA polymerase (RNA replicase) (I) is one of the main potential targets for anti-HCV agents.  HCV I performs run-off copying replication in an RNA-selective manner for the template-primer duplex and the substrate, but the structural basis of this reaction mechanism has still to be elucidated.  Here, the 3-dimensional structure of HCV I was detd. by x-ray crystallog. at 2.5 Å resoln.  The compact HCV I structure resembled a right hand, but had more complicated fingers and thumb domains than those of the other known polymerases, with a novel α-helix-rich subdomain (α fingers) as an addn. to the fingers domain.  The other fingers subdomain (β fingers) was folded in the same manner as the fingers domain of HIV virus reverse transcriptase, another RNA-dependent polymerase.  The ribose-recognition site of HCV I was constructed of hydrophilic residues, unlike those of DNA polymerases.  The C-terminal region of HCV I occupied the putative RNA-duplex-binding cleft.  The structural basis of the RNA selectivity of HCV I was elucidated from its crystal structure.  The putative substrate-binding site with a shallow hydrophilic cavity should have ribonucleoside triphosphate as the preferred substrate.  The authors propose that the unique α fingers might represent a common structural discriminator of the template-primer duplex that distinguishes between RNA and DNA during the replication of pos. single-stranded RNA by viral I enzymes.  The C-terminal region might exert a regulatory function on the initiation and activity of HCV I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKp1aOmXjMKLVg90H21EOLACvtfcHk0lgYXVFTWgXYyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D&md5=95fcc20ce2f28dab4d76d8dfac0aa4ee</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2800%2980031-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252800%252980031-3%26sid%3Dliteratum%253Aachs%26aulast%3DAgo%26aufirst%3DH.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DYatsunami%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D1417%26epage%3D1426%26doi%3D10.1016%2FS0969-2126%2800%2980031-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bressanelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incitti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, F. A.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">13034</span><span class="NLM_x">–</span> <span class="NLM_lpage">13039</span><span class="refDoi"> DOI: 10.1073/pnas.96.23.13034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1073%2Fpnas.96.23.13034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10557268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13034-13039&author=S.+Bressanelliauthor=L.+Tomeiauthor=A.+Rousselauthor=I.+Incittiauthor=R.+L.+Vitaleauthor=M.+Mathieuauthor=R.+De+Francescoauthor=F.+A.+Rey&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus&doi=10.1073%2Fpnas.96.23.13034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Bressanelli, Stephane; Tomei, Licia; Roussel, Alain; Incitti, Ilario; Vitale, Rosa Letizia; Mathieu, Magali; De Francesco, Raffaele; Rey, Felix A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13034-13039</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The crystal structure of the RNA-dependent RNA polymerase (RNA replicase) (I) of hepatitis C virus, a major human pathogen, is reported to 2.8 Å resoln.  I is a key target for developing specific antiviral therapy.  The structure of the catalytic domain contained 531 residues folded in the characteristic fingers, palm, and thumb subdomains.  The fingers subdomain contained a region, the "fingertips," that shared the same fold with reverse transcriptases.  Superposition to the available structures of the latter showed that residues from the palm and fingertips were structurally equiv.  In addn., it showed that hepatitis C virus I was crystd. in a closed fingers conformation, similar to HIV-1 reverse transcriptase in ternary complex with DNA and dTTP.  This superposition revealed the majority of the amino acid residues of the hepatitis C virus enzyme that are likely to be implicated in binding to the replicating RNA mol. and to the incoming NTP.  It also suggested a rearrangement of the thumb domain as well as a possible concerted movement of thumb and fingertips during translocation of the RNA template-primer in successive polymn. rounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMMlZvielKLVg90H21EOLACvtfcHk0lgmgxmLSEFjcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D&md5=2ba97997c8a8e24c0db560260fb5ea9a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.23.13034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.23.13034%26sid%3Dliteratum%253Aachs%26aulast%3DBressanelli%26aufirst%3DS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DRoussel%26aufirst%3DA.%26aulast%3DIncitti%26aufirst%3DI.%26aulast%3DVitale%26aufirst%3DR.%2BL.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRey%26aufirst%3DF.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D13034%26epage%3D13039%26doi%3D10.1073%2Fpnas.96.23.13034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span> </span><span class="NLM_article-title">Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2481</span><span class="NLM_x">–</span> <span class="NLM_lpage">2531</span><span class="refDoi"> DOI: 10.1021/jm201384j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201384j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1aqu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2481-2531&author=M.+J.+Sofiaauthor=W.+Changauthor=P.+A.+Furmanauthor=R.+T.+Mosleyauthor=B.+S.+Ross&title=Nucleoside%2C+nucleotide%2C+and+non-nucleoside+inhibitors+of+hepatitis+C+virus+NS5B+RNA-dependent+RNA-polymerase&doi=10.1021%2Fjm201384j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase</span></div><div class="casAuthors">Sofia, Michael J.; Chang, Wonsuk; Furman, Phillip A.; Mosley, Ralph T.; Ross, Bruce S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2481-2531</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This is a Perspectives review and does not require an abstr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWh0maPUC6grVg90H21EOLACvtfcHk0lgmgxmLSEFjcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1aqu7rF&md5=3236ff10d16104b1a39d77f04774ac77</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm201384j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201384j%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26atitle%3DNucleoside%252C%2520nucleotide%252C%2520and%2520non-nucleoside%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA-polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2481%26epage%3D2531%26doi%3D10.1021%2Fjm201384j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV Polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+Polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520Polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Beaulieu, P.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the HCV NS5B polymerase: Progress in the discovery and development of novel agents for the treatment of HCV infections</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=17668364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+Beaulieu&title=Non-nucleoside+inhibitors+of+the+HCV+NS5B+polymerase%3A+Progress+in+the+discovery+and+development+of+novel+agents+for+the+treatment+of+HCV+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">614-634</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The severe health conditions assocd. with chronic HCV infection remain a global concern.  Small-mol. drugs that specifically target essential virally encoded enzymes have not yet progressed to market, and the current std. of care continues to rely on a combination of pegylated IFN with ribavirin.  This therapy has serious side effects and a significant proportion of patients infected with HCV genotype 1 (the major genotype in industrialized countries) have an unsatisfactory outcome with this therapy.  Major advances have been realized in the development of specific non-nucleoside inhibitors of the viral NS5B RNA-dependent RNA polymerase.  This well-characterized replicative enzyme is a highly drugable target that, in addn. to its active site, features at least three known allosteric binding pockets that regulate RNA synthesis and are suitable for inhibitor design.  Clin. proof-of-concept for allosteric non-nucleoside HCV polymerase inhibitors has been reported and several compds. have progressed into preclin. studies.  It is likely that in the future NS5B inhibitors will form an integral part of more effective anti-HCV therapies, combining the use of small-mol. antiviral drugs with or without the assistance of immune modulators such as IFNs in order to minimize the emergence of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTl5U1TLVJ57Vg90H21EOLACvtfcHk0liUXtmikE6NRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK&md5=347a7983497b1b50bba61a455783f302</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520Progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520agents%2520for%2520the%2520treatment%2520of%2520HCV%2520infections%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span> </span><span class="NLM_article-title">HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span><span class="refDoi"> DOI: 10.1002/hep.22717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1002%2Fhep.22717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=19072827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=745-752&author=N.+M.+Knetemanauthor=A.+Y.+M.+Howeauthor=T.+Gaoauthor=J.+Lewisauthor=D.+Pevearauthor=G.+Lundauthor=D.+Douglasauthor=D.+F.+Mercerauthor=D.+L.+J.+Tyrrellauthor=F.+Immermannauthor=I.+Chaudharyauthor=J.+Spethauthor=S.+A.+Villanoauthor=J.+O%E2%80%99Connellauthor=M.+Collett&title=HCV796%3A+A+selective+nonstructural+protein+5B+polymerase+inhibitor+with+potent+anti-hepatitis+C+virus+activity+in+vitro%2C+in+mice+with+chimeric+human+livers%2C+and+in+humans+infected+with+hepatitis+C+virus&doi=10.1002%2Fhep.22717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">HCCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span></div><div class="casAuthors">Kneteman, Norman M.; Howe, Anita Y. M.; Gao, Tiejun; Lewis, Jamie; Pevear, Dan; Lund, Gary; Douglas, Donna; Mercer, David F.; Tyrrell, D. Lorne J.; Immermann, Frederick; Chaudhary, Inder; Speth, John; Villano, Stephen A.; O'Connell, John; Collett, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clin. study.  This manuscript outlines activity and correlation across such a spectrum of models and into clin. trials with a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, HCV796.  Enzyme assays yielded median inhibitory concn. (IC50) values of 0.01 to 0.14 μM for genotype 1, with half maximal effective concn. (EC50s) of 5 nM and 9 nM against genotype 1a and 1b replicons.  In the chimeric mouse model, a 2.02 ± 0.55 log redn. in HCV titer was seen with monotherapy, whereas a suboptimal dose of 30 mg/kg three times per day in combination with interferon demonstrated a 2.44 log redn. (P = 0.001 vs. interferon alone) Clin. outcomes in combination with pegylated interferon and ribavirin have revealed additive efficacy in treatment naive patients.  Abnormal liver function test results were obsd. in 8% of HCV-796 patients treated for over 8 wk, resulting in suspension of further trial activity.  Conclusion: The RNA-dependent RNA polymerase inhibitor HCV796 demonstrated potent anti-HCV activity consistently through enzyme inhibition assays, subgenomic replicon, and chimeric mouse studies.  Strong correlations of outcomes in the mouse model were seen with subsequent clin. trials, including a plateau in dose-related antiviral activity and additive impact from combination therapy with interferon.  These outcomes demonstrate the utility of the range of in vitro and in vivo models now available for anti-HCV drug development and support the potential utility of polymerase inhibitors in future combination therapies for HCV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ZCtNeI0RLLVg90H21EOLACvtfcHk0liUXtmikE6NRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D&md5=0dcebc9c1e93051ad46eae43b352e7cf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fhep.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22717%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DHowe%26aufirst%3DA.%2BY.%2BM.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DMercer%26aufirst%3DD.%2BF.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%2BJ.%26aulast%3DImmermann%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DSpeth%26aufirst%3DJ.%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26atitle%3DHCV796%253A%2520A%2520selective%2520nonstructural%2520protein%25205B%2520polymerase%2520inhibitor%2520with%2520potent%2520anti-hepatitis%2520C%2520virus%2520activity%2520in%2520vitro%252C%2520in%2520mice%2520with%2520chimeric%2520human%2520livers%252C%2520and%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D745%26epage%3D752%26doi%3D10.1002%2Fhep.22717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Maynard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koble, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leivers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leivers, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouliot, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thommes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voitenleitner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waitt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shotwell, J. B.</span><span> </span><span class="NLM_article-title">Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1902</span><span class="NLM_x">–</span> <span class="NLM_lpage">1913</span><span class="refDoi"> DOI: 10.1021/jm400317w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400317w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1902-1913&author=A.+Maynardauthor=R.+M.+Crosbyauthor=B.+Ellisauthor=R.+Hamatakeauthor=Z.+Hongauthor=B.+A.+Johnsauthor=K.+M.+Kahlerauthor=C.+Kobleauthor=A.+Leiversauthor=M.+R.+Leiversauthor=A.+Mathisauthor=A.+J.+Peatauthor=J.+J.+Pouliotauthor=C.+D.+Robertsauthor=V.+Samanoauthor=R.+M.+Schmidtauthor=G.+K.+Smithauthor=A.+Spaltensteinauthor=E.+L.+Stewartauthor=P.+Thommesauthor=E.+M.+Turnerauthor=C.+Voitenleitnerauthor=J.+T.+Walkerauthor=G.+Waittauthor=J.+Weatherheadauthor=K.+Weaverauthor=S.+Williamsauthor=L.+Wrightauthor=Z.+Z.+Xiongauthor=D.+Haighauthor=J.+B.+Shotwell&title=Discovery+of+a+potent+boronic+acid+derived+inhibitor+of+the+HCV+RNA-dependent+RNA+polymerase&doi=10.1021%2Fjm400317w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400317w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400317w%26sid%3Dliteratum%253Aachs%26aulast%3DMaynard%26aufirst%3DA.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DKoble%26aufirst%3DC.%26aulast%3DLeivers%26aufirst%3DA.%26aulast%3DLeivers%26aufirst%3DM.%2BR.%26aulast%3DMathis%26aufirst%3DA.%26aulast%3DPeat%26aufirst%3DA.%2BJ.%26aulast%3DPouliot%26aufirst%3DJ.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BD.%26aulast%3DSamano%26aufirst%3DV.%26aulast%3DSchmidt%26aufirst%3DR.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DThommes%26aufirst%3DP.%26aulast%3DTurner%26aufirst%3DE.%2BM.%26aulast%3DVoitenleitner%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DJ.%2BT.%26aulast%3DWaitt%26aufirst%3DG.%26aulast%3DWeatherhead%26aufirst%3DJ.%26aulast%3DWeaver%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DXiong%26aufirst%3DZ.%2BZ.%26aulast%3DHaigh%26aufirst%3DD.%26aulast%3DShotwell%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520boronic%2520acid%2520derived%2520inhibitor%2520of%2520the%2520HCV%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1902%26epage%3D1913%26doi%3D10.1021%2Fjm400317w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McComas, C. C.; Liverton, N. J.; Habermann, J.; Koch, U.; Narjes, F.; Li, P.; Peng, X.; Soll, R.; Wu, H.; Palani, A.; He, S.; Dai, X.; Liu, H.; Lai, Z.; London, C.; Xiao, D.; Zorn, N.; Nargund, R.</span><span> </span><span class="NLM_article-title">Preparation of pyridooxazinoindole derivatives and analogs for use as antiviral agents</span>. World Patent Application WO 2013/033971 A1, March 14,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+C.+McComas&author=N.+J.+Liverton&author=J.+Habermann&author=U.+Koch&author=F.+Narjes&author=P.+Li&author=X.+Peng&author=R.+Soll&author=H.+Wu&author=A.+Palani&author=S.+He&author=X.+Dai&author=H.+Liu&author=Z.+Lai&author=C.+London&author=D.+Xiao&author=N.+Zorn&author=R.+Nargund&title=Preparation+of+pyridooxazinoindole+derivatives+and+analogs+for+use+as+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26atitle%3DPreparation%2520of%2520pyridooxazinoindole%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520antiviral%2520agents%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McComas, C. C.; Liverton, N. J.; Habermann, J.; Koch, U.; Narjes, F.; Li, P.; Peng, X.; Soll, R.; Wu, H.</span><span> </span><span class="NLM_article-title">Preparation of tetracyclic heterocycle compounds for the treatment of HCV infection</span>. World Patent Application WO 2013/033900 A1, March 14,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+C.+McComas&author=N.+J.+Liverton&author=J.+Habermann&author=U.+Koch&author=F.+Narjes&author=P.+Li&author=X.+Peng&author=R.+Soll&author=H.+Wu&title=Preparation+of+tetracyclic+heterocycle+compounds+for+the+treatment+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26atitle%3DPreparation%2520of%2520tetracyclic%2520heterocycle%2520compounds%2520for%2520the%2520treatment%2520of%2520HCV%2520infection%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">A class of analogues of benzofuran <b>1</b> with extension from the 2-(4-fluorophenyl) substituent can be found in</p></div><span class="NLM_contrib-group">Labadie, S. S.; Lin, C. J. J.; Talamas, F. X.; Weikert, R. J.</span><span> </span><span class="NLM_article-title">Heterocyclic antiviral compounds</span>. World Patent Application WO 2009/101022 Al, August 20,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+S.+Labadie&author=C.+J.+J.+Lin&author=F.+X.+Talamas&author=R.+J.+Weikert&title=Heterocyclic+antiviral+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLabadie%26aufirst%3DS.%2BS.%26atitle%3DHeterocyclic%2520antiviral%2520compounds%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Parcella, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2016.11.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=295-298&author=K.+Parcellaauthor=A.+Nickelauthor=B.+R.+Benoauthor=S.+Sheriffauthor=C.+Wanauthor=Y.-K.+Wangauthor=S.+B.+Robertsauthor=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Discovery+and+initial+optimization+of+alkoxyanthranilic+acid+derivatives+as+inhibitors+of+HCV+NS5B+polymerase&doi=10.1016%2Fj.bmcl.2016.11.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.054%26sid%3Dliteratum%253Aachs%26aulast%3DParcella%26aufirst%3DK.%26aulast%3DNickel%26aufirst%3DA.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520and%2520initial%2520optimization%2520of%2520alkoxyanthranilic%2520acid%2520derivatives%2520as%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D295%26epage%3D298%26doi%3D10.1016%2Fj.bmcl.2016.11.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Burns, C. J.; Del Vecchio, A. M.; Bailey, T. R.; Kulkarni, B. A.; Faitg, T. H.; Sherk, S. R.; BlackLedge, C. W.; Rys, D. J.; Lessen, T. A.; Swestock, J.; Deng, Y.; Nitz, T. J.; Reinhardt, J. A.; Feng, H.; Saha, A. K.</span><span> </span><span class="NLM_article-title">Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases</span>. World Patent Application WO 2004/041201 A2, May 21,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+J.+Burns&author=A.+M.+Del+Vecchio&author=T.+R.+Bailey&author=B.+A.+Kulkarni&author=T.+H.+Faitg&author=S.+R.+Sherk&author=C.+W.+BlackLedge&author=D.+J.+Rys&author=T.+A.+Lessen&author=J.+Swestock&author=Y.+Deng&author=T.+J.+Nitz&author=J.+A.+Reinhardt&author=H.+Feng&author=A.+K.+Saha&title=Benzofuran+compounds%2C+compositions+and+methods+for+treatment+and+prophylaxis+of+hepatitis+C+viral+infections+and+associated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBenzofuran%2520compounds%252C%2520compositions%2520and%2520methods%2520for%2520treatment%2520and%2520prophylaxis%2520of%2520hepatitis%2520C%2520viral%2520infections%2520and%2520associated%2520diseases%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Shaw, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin-Goerke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarisky, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiggall, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, M. N.</span><span> </span><span class="NLM_article-title">Substituted benzothiadizine inhibitors of hepatitis C virus polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4350</span><span class="NLM_x">–</span> <span class="NLM_lpage">4353</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2009.05.091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4350-4353&author=A.+N.+Shawauthor=R.+Tedescoauthor=R.+Bambalauthor=D.+Chaiauthor=N.+O.+Conchaauthor=M.+G.+Darcyauthor=D.+Dhanakauthor=K.+J.+Duffyauthor=D.+M.+Fitchauthor=A.+Gatesauthor=V.+K.+Johnstonauthor=R.+M.+Keenanauthor=J.+Lin-Goerkeauthor=N.+Liuauthor=R.+T.+Sariskyauthor=K.+J.+Wiggallauthor=M.+N.+Zimmerman&title=Substituted+benzothiadizine+inhibitors+of+hepatitis+C+virus+polymerase&doi=10.1016%2Fj.bmcl.2009.05.091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.091%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BN.%26aulast%3DTedesco%26aufirst%3DR.%26aulast%3DBambal%26aufirst%3DR.%26aulast%3DChai%26aufirst%3DD.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26aulast%3DFitch%26aufirst%3DD.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DJohnston%26aufirst%3DV.%2BK.%26aulast%3DKeenan%26aufirst%3DR.%2BM.%26aulast%3DLin-Goerke%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DSarisky%26aufirst%3DR.%2BT.%26aulast%3DWiggall%26aufirst%3DK.%2BJ.%26aulast%3DZimmerman%26aufirst%3DM.%2BN.%26atitle%3DSubstituted%2520benzothiadizine%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4350%26epage%3D4353%26doi%3D10.1016%2Fj.bmcl.2009.05.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Howe, A. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span> </span><span class="NLM_article-title">Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3327</span><span class="NLM_x">–</span> <span class="NLM_lpage">3338</span><span class="refDoi"> DOI: 10.1128/AAC.00238-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1128%2FAAC.00238-08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3327-3338&author=A.+Y.+M.+Howeauthor=H.+Chengauthor=S.+Johannauthor=S.+Mullenauthor=S.+K.+Chunduruauthor=D.+C.+Youngauthor=J.+Bardauthor=R.+Chopraauthor=G.+Krishnamurthyauthor=T.+Mansourauthor=J.+O%E2%80%99Connell&title=Molecular+mechanism+of+hepatitis+C+virus+replicon+variants+with+reduced+susceptibility+to+a+benzofuran+inhibitor%2C+HCV-796&doi=10.1128%2FAAC.00238-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FAAC.00238-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00238-08%26sid%3Dliteratum%253Aachs%26aulast%3DHowe%26aufirst%3DA.%2BY.%2BM.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DJohann%26aufirst%3DS.%26aulast%3DMullen%26aufirst%3DS.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DYoung%26aufirst%3DD.%2BC.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanism%2520of%2520hepatitis%2520C%2520virus%2520replicon%2520variants%2520with%2520reduced%2520susceptibility%2520to%2520a%2520benzofuran%2520inhibitor%252C%2520HCV-796%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3327%26epage%3D3338%26doi%3D10.1128%2FAAC.00238-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span> </span><span class="NLM_article-title">Recent developments in fragment-based drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3661</span><span class="NLM_x">–</span> <span class="NLM_lpage">3680</span><span class="refDoi"> DOI: 10.1021/jm8000373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8000373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotFKisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3661-3680&author=M.+Congreveauthor=G.+Chessariauthor=D.+Tisiauthor=A.+J.+Woodhead&title=Recent+developments+in+fragment-based+drug+discovery&doi=10.1021%2Fjm8000373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in fragment-based drug discovery</span></div><div class="casAuthors">Congreve, Miles; Chessari, Gianni; Tisi, Dominic; Woodhead, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3661-3680</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of fragment-based drug discovery (FBDD) has developed significantly over the past 10 years and is now recognized as a tangible alternative to more traditional methods of hit identification, such as high throughput screening (HTS).  The authors discuss trends and developments of FBDD over the past 4 years.  Addnl., this review looks in some detail at representative protein-ligand complexes obsd. between fragment-sized mols. and their protein targets from the Protein Data Bank (PDB).  More than the underlying technol. itself, the legacy of FBDD will be conceptual and that "less is more"; breaking down the problem of finding a drug mol. into its smallest component parts opens up new opportunities to solve challenging problems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_YtOS7_glD7Vg90H21EOLACvtfcHk0lj-STlgg89JMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotFKisLg%253D&md5=41dbcf884305a190bffc683ae5ed9e45</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm8000373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8000373%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520developments%2520in%2520fragment-based%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3661%26epage%3D3680%26doi%3D10.1021%2Fjm8000373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZ0FAjMhHZCHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keserü, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keser%C3%BCauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0liz_yD43SQdcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span><span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0liz_yD43SQdcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">A synopsis of the properties and applications of heteroaromatic rings in medicinal chemistry</span> <span class="citation_source-journal">Adv. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1016/bs.aihch.2016.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fbs.aihch.2016.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1yiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2017&pages=245-361&author=N.+A.+Meanwell&title=A+synopsis+of+the+properties+and+applications+of+heteroaromatic+rings+in+medicinal+chemistry&doi=10.1016%2Fbs.aihch.2016.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A synopsis of the properties and applications of heteroaromatic rings in medicinal chemistry</span></div><div class="casAuthors">Meanwell, N. A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245-361</span>CODEN:
                <span class="NLM_cas:coden">AHTCAG</span>;
        ISSN:<span class="NLM_cas:issn">0065-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Five- and six-membered heteroarom. rings and their benzo-fused homologues are well established as important structural elements in drug design and are well represented in approved drugs.  The key properties of these heterocycles that are of interest to medicinal chemists Include lipophilicity, pKa, aromaticity, ionization potential, H-bond acceptor, and H-bond donor (N-H, 0-H, C-H) capability, electron withdrawing effects, dipole values, and bond angles.  The judicious and productive application of azoles and azines in drug design requires an understanding of the intrinsic phys. chem. properties of the individual heterocycles and how these interact with substituents.  In this article. the key properties of azole and azine heterocycles are summarized followed by a synopsis of applications where some of these factors play a role in drug-target interactions and/or potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqctUtT-Yo4X7Vg90H21EOLACvtfcHk0liz_yD43SQdcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1yiu7k%253D&md5=5ba7462bcd75ed022f4ea6b800ccef9d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fbs.aihch.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.aihch.2016.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DA%2520synopsis%2520of%2520the%2520properties%2520and%2520applications%2520of%2520heteroaromatic%2520rings%2520in%2520medicinal%2520chemistry%26jtitle%3DAdv.%2520Heterocycl.%2520Chem.%26date%3D2017%26volume%3D123%26spage%3D245%26epage%3D361%26doi%3D10.1016%2Fbs.aihch.2016.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Laurence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Questel, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, E.</span><span> </span><span class="NLM_article-title">The pK<sub>BHX</sub> Database: Toward a better understanding of hydrogen-bond basicity for medicinal chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4073</span><span class="NLM_x">–</span> <span class="NLM_lpage">4086</span><span class="refDoi"> DOI: 10.1021/jm801331y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801331y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4073-4086&author=C.+Laurenceauthor=K.+A.+Brameldauthor=J.+Gratonauthor=J.-Y.+Le+Questelauthor=E.+Renault&title=The+pKBHX+Database%3A+Toward+a+better+understanding+of+hydrogen-bond+basicity+for+medicinal+chemists&doi=10.1021%2Fjm801331y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists</span></div><div class="casAuthors">Laurence, Christian; Brameld, Ken A.; Graton, Jerome; Le Questel, Jean-Yves; Renault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4073-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pKBHX database is presented, which corresponds to three main fields of data: hydrogen bond donor identification, thermodn. data and spectroscopic data.  The pKBHX scale of hydrogen donor basicity differs considerable from the pKBH+ scale of proton transfer basicity.  The hydrogen bond basicities of functional groups relevant to medicinal chem. and drug design is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9OhmMu2VILVg90H21EOLACvtfcHk0lhesnpWnXlexw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D&md5=9ce4bea3e810752baba6ea5784b55ea0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm801331y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801331y%26sid%3Dliteratum%253Aachs%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DGraton%26aufirst%3DJ.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.-Y.%26aulast%3DRenault%26aufirst%3DE.%26atitle%3DThe%2520pKBHX%2520Database%253A%2520Toward%2520a%2520better%2520understanding%2520of%2520hydrogen-bond%2520basicity%2520for%2520medicinal%2520chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4073%26epage%3D4086%26doi%3D10.1021%2Fjm801331y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">cLog<i>P</i> and p<i>K</i><sub>a</sub> were calculated by using the molecular property calculator JChem-15.9.7.0 from ChemAxon.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao-Ieong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannetti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talamas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span> </span><span class="NLM_article-title">Slow binding inhibition and mechanism of resistance of nonnucleoside polymerase inhibitors of hepatitis C virus</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">15517</span><span class="NLM_x">–</span> <span class="NLM_lpage">15529</span><span class="refDoi"> DOI: 10.1074/jbc.M808889200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1074%2Fjbc.M808889200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=15517-15529&author=J.+Q.+Hangauthor=Y.+Yangauthor=S.+F.+Harrisauthor=V.+Levequeauthor=H.+J.+Whittingtonauthor=S.+Rajyaguruauthor=G.+Ao-Ieongauthor=M.+F.+McCownauthor=A.+Wongauthor=A.+M.+Giannettiauthor=S.+Le+Pogamauthor=F.+Talamasauthor=N.+Cammackauthor=I.+Najeraauthor=K.+Klumpp&title=Slow+binding+inhibition+and+mechanism+of+resistance+of+nonnucleoside+polymerase+inhibitors+of+hepatitis+C+virus&doi=10.1074%2Fjbc.M808889200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M808889200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M808889200%26sid%3Dliteratum%253Aachs%26aulast%3DHang%26aufirst%3DJ.%2BQ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DWhittington%26aufirst%3DH.%2BJ.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DAo-Ieong%26aufirst%3DG.%26aulast%3DMcCown%26aufirst%3DM.%2BF.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DTalamas%26aufirst%3DF.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26atitle%3DSlow%2520binding%2520inhibition%2520and%2520mechanism%2520of%2520resistance%2520of%2520nonnucleoside%2520polymerase%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D15517%26epage%3D15529%26doi%3D10.1074%2Fjbc.M808889200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hehre, W. J.; Radom, L.; Schleyer, P. v. R.; Pople, J. A.</span> <span class="citation_source-book">Ab Initio Molecular Orbital Theory</span>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">, </span>and references cited therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&author=W.+J.+Hehre&author=L.+Radom&author=P.+v.+R.+Schleyer&author=J.+A.+Pople&title=Ab+Initio+Molecular+Orbital+Theory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHehre%26aufirst%3DW.%2BJ.%26btitle%3DAb%2520Initio%2520Molecular%2520Orbital%2520Theory%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Qiao, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span> </span><span class="NLM_article-title">Achieving structural diversity using the perpendicular conformation of <i>alpha</i>-substituted phenylcyclopropanes to mimic the bioactive conformation of <i>ortho</i>-substituted biphenyl P4 moieties: Discovery of novel, highly potent inhibitors of Factor Xa</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4118</span><span class="NLM_x">–</span> <span class="NLM_lpage">4123</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.05.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2008.05.095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=18550370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslequ7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4118-4123&author=J.+X.+Qiaoauthor=D.+L.+Cheneyauthor=R.+S.+Alexanderauthor=A.+M.+Smallwoodauthor=S.+R.+Kingauthor=K.+Heauthor=A.+R.+Rendinaauthor=J.+M.+Luettgenauthor=R.+M.+Knabbauthor=R.+R.+Wexlerauthor=P.+Y.+S.+Lam&title=Achieving+structural+diversity+using+the+perpendicular+conformation+of+alpha-substituted+phenylcyclopropanes+to+mimic+the+bioactive+conformation+of+ortho-substituted+biphenyl+P4+moieties%3A+Discovery+of+novel%2C+highly+potent+inhibitors+of+Factor+Xa&doi=10.1016%2Fj.bmcl.2008.05.095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: Discovery of novel, highly potent inhibitors of Factor Xa</span></div><div class="casAuthors">Qiao, Jennifer X.; Cheney, Daniel L.; Alexander, Richard S.; Smallwood, Angela M.; King, Sarah R.; He, Kan; Rendina, Alan R.; Luettgen, Joseph M.; Knabb, Robert M.; Wexler, Ruth R.; Lam, Patrick Y. S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4118-4123</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ortho-substituted biphenyl moieties are widely used in drug design.  We herein report a successful use of the perpendicular conformation of the alpha-substituted phenylcyclopropyl groups to mimic the aplanar, biol. active conformation of the ortho-substituted biphenyl moieties to achieve structural diversity.  This is exemplified by the design and synthesis of a series of highly potent pyrazole bicyclic-based Factor Xa (FXa) inhibitors bearing alpha-substituted phenylcyclopropyl P4 moieties.  The designed perpendicular conformation was confirmed by the X-ray structure of FXa-bound compd. I.  The potential structural basis for the high FXa potency in the phenylcyclopropyl P4 analogs and their improved FXa inhibitory activities compared with the biphenyl P4 counterparts are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2wNc7asx8bVg90H21EOLACvtfcHk0lhesnpWnXlexw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslequ7o%253D&md5=4c06af32c061accffbed26a39031108e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.095%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DJ.%2BX.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DKing%26aufirst%3DS.%2BR.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26atitle%3DAchieving%2520structural%2520diversity%2520using%2520the%2520perpendicular%2520conformation%2520of%2520alpha-substituted%2520phenylcyclopropanes%2520to%2520mimic%2520the%2520bioactive%2520conformation%2520of%2520ortho-substituted%2520biphenyl%2520P4%2520moieties%253A%2520Discovery%2520of%2520novel%252C%2520highly%2520potent%2520inhibitors%2520of%2520Factor%2520Xa%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4118%26epage%3D4123%26doi%3D10.1016%2Fj.bmcl.2008.05.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span> </span><span class="NLM_article-title">Heterocyclic replacements for benzene: Maximising ADME benefits by considering individual ring isomers</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.ejmech.2016.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=27783976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKgu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=1057-1068&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonald&title=Heterocyclic+replacements+for+benzene%3A+Maximising+ADME+benefits+by+considering+individual+ring+isomers&doi=10.1016%2Fj.ejmech.2016.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic replacements for benzene: Maximizing ADME benefits by considering individual ring isomers</span></div><div class="casAuthors">Ritchie, Timothy J.; Macdonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1057-1068</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The impact of replacing a monosubstituted benzene (phenyl) ring with thirty three arom. and nine aliph. heterocycles on nine ADME-related screens (soly., lipophilicity, permeability, protein binding CYP450 inhibition and metabolic clearance) was assessed using matched mol. pair anal.  The results indicate that the influence on the ADME profile can differ significantly depending on the ring identity and importantly on the individual regioisomers that are possible for some rings.  This information enables the medicinal chemist to make an informed choice about which rings and regioisomers to employ as monosubstituted benzene replacements, based upon the knowledge of how such replacements are likely to influence ADME-related parameters, for example to target higher soly. while avoiding CYP450 liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWSOM3yUz8kbVg90H21EOLACvtfcHk0ljjA5YvUHF0Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKgu7bP&md5=127e1316b7bff0db030226548f96045c</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DHeterocyclic%2520replacements%2520for%2520benzene%253A%2520Maximising%2520ADME%2520benefits%2520by%2520considering%2520individual%2520ring%2520isomers%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D1057%26epage%3D1068%26doi%3D10.1016%2Fj.ejmech.2016.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gleeson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D.</span><span> </span><span class="NLM_article-title">ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5906</span><span class="NLM_x">–</span> <span class="NLM_lpage">5919</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmc.2009.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=19632124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Crs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=5906-5919&author=P.+Gleesonauthor=G.+Braviauthor=S.+Modiauthor=D.+Lowe&title=ADMET+rules+of+thumb+II%3A+A+comparison+of+the+effects+of+common+substituents+on+a+range+of+ADMET+parameters&doi=10.1016%2Fj.bmc.2009.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters</span></div><div class="casAuthors">Gleeson, Paul; Bravi, Gianpaolo; Modi, Sandeep; Lowe, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5906-5919</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A systematic anal. of data generated in key in vitro assays within GSK has been undertaken to identify what impact a range of common substituents have on a range of ADMET parameters.  These include; P 450 1A2, 2C9, 2C19, 2D6 and 3A4 inhibition, hERG inhibition, phosphate buffer soly. and artificial membrane permeability.  We do this by identifying all matched mol. pairs, differing by the replacement of a hydrogen atom with a list of predefined substituents.  For each substituent we calc. the mean difference in the ADMET parameter for all the matched mol. pairs identified, making a statistical assessment of the difference, as well as assessing the diversity for each example to ensure that the results can be generalized.  We also relate the change in activity obsd. for each substituent to differences in their mol. properties in an effort to identify any structural alerts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk7HA_bqdilrVg90H21EOLACvtfcHk0ljjA5YvUHF0Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Crs7o%253D&md5=fce672cbaadb66c4d7212aa1b92bd7d2</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DP.%26aulast%3DBravi%26aufirst%3DG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DLowe%26aufirst%3DD.%26atitle%3DADMET%2520rules%2520of%2520thumb%2520II%253A%2520A%2520comparison%2520of%2520the%2520effects%2520of%2520common%2520substituents%2520on%2520a%2520range%2520of%2520ADMET%2520parameters%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D5906%26epage%3D5919%26doi%3D10.1016%2Fj.bmc.2009.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Yeung, K.-S.; Parcella, K. E.; Bender, J. A.; Beno, B. R.; Grant-Young, K. A.; Han, Y.; Hewawasam, P.; Kadow, J. F.; Nickel, A.</span><span> </span><span class="NLM_article-title">Compounds for the treatment of hepatitis C</span>. World Patent Application WO 2010/030592 A1, March 18,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.-S.+Yeung&author=K.+E.+Parcella&author=J.+A.+Bender&author=B.+R.+Beno&author=K.+A.+Grant-Young&author=Y.+Han&author=P.+Hewawasam&author=J.+F.+Kadow&author=A.+Nickel&title=Compounds+for+the+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DK.-S.%26atitle%3DCompounds%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Olsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, U. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F···C═O interactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2511</span><span class="refDoi"> DOI: 10.1002/anie.200351268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1002%2Fanie.200351268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFCrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2507-2511&author=J.+A.+Olsenauthor=D.+W.+Bannerauthor=P.+Seilerauthor=U.+O.+Sanderauthor=A.+D%E2%80%99Arcyauthor=M.+Stihleauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=A+fluorine+scan+of+thrombin+inhibitors+to+map+the+fluorophilicity%2Ffluorophobicity+of+an+enzyme+active+site%3A+evidence+for+C-F%C2%B7%C2%B7%C2%B7C%E2%95%90O+interactions&doi=10.1002%2Fanie.200351268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: Evidence for C-F···C=O interactions</span></div><div class="casAuthors">Olsen, Jacob A.; Banner, David W.; Seiler, Paul; Sander, Ulrike Obst; D'Arcy, Allan; Stihle, Martine; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2507-2511</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A highly fluorophilic environment comprising the H-Cα-C=O unit of Asn 98 in the active site of thrombin was identified by X-ray crystallog. of a complex formed between the enzyme and a synthetic inhibitor (see partial X-ray structure, distances are in Angstroms).  Short C-F···H-Cα and C-F···C=O contacts involving H-Cα-C=O fragments were also frequently obsd. in small-mol. X-ray crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojeeRuEw83aLVg90H21EOLACvtfcHk0ljrvxxlTuHXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFCrt7k%253D&md5=f9851cb27f3e9d10152ad10abcd5c965</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351268%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DJ.%2BA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DSeiler%26aufirst%3DP.%26aulast%3DSander%26aufirst%3DU.%2BO.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DA%2520fluorine%2520scan%2520of%2520thrombin%2520inhibitors%2520to%2520map%2520the%2520fluorophilicity%252Ffluorophobicity%2520of%2520an%2520enzyme%2520active%2520site%253A%2520evidence%2520for%2520C-F%25C2%25B7%25C2%25B7%25C2%25B7C%25E2%2595%2590O%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2507%26epage%3D2511%26doi%3D10.1002%2Fanie.200351268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span> </span><span class="NLM_article-title">Fluorine multipolar interaction: Toward elucidating its energetics in binding recognition</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1016/j.jfluchem.2016.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.jfluchem.2016.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Xingauthor=C.+Keeferauthor=M.+F.+Brown&title=Fluorine+multipolar+interaction%3A+Toward+elucidating+its+energetics+in+binding+recognition&doi=10.1016%2Fj.jfluchem.2016.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2016.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2016.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DKeefer%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26atitle%3DFluorine%2520multipolar%2520interaction%253A%2520Toward%2520elucidating%2520its%2520energetics%2520in%2520binding%2520recognition%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2017%26doi%3D10.1016%2Fj.jfluchem.2016.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Discovery of daclatasvir, a pan-genotypic hepatitis C virus NS5A replication complex inhibitor with potent clinical effect</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5057</span><span class="NLM_x">–</span> <span class="NLM_lpage">5071</span><span class="refDoi"> DOI: 10.1021/jm500335h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500335h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5057-5071&author=M.+Belemaauthor=N.+A.+Meanwell&title=Discovery+of+daclatasvir%2C+a+pan-genotypic+hepatitis+C+virus+NS5A+replication+complex+inhibitor+with+potent+clinical+effect&doi=10.1021%2Fjm500335h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect</span></div><div class="casAuthors">Belema, Makonen; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5057-5071</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review. The discovery and development of the first-in-class hepatitis C virus (HCV) NS5A replication complex inhibitor daclatasvir provides a compelling example of the power of phenotypic screening to identify leads engaging novel targets in mechanistically unique ways.  HCV NS5A replication complex inhibitors are pan-genotypic in spectrum, and this mechanistic class provides the most potent HCV inhibitors in vitro that have been described to date.  Clin. trials with daclatasvir demonstrated a potent effect on reducing plasma viral load and, in combination with mechanistically orthogonal HCV inhibitors, established the ability to cure even the most difficult infections without the need for immune stimulation.  In this Drug Annotation, the authors describe the discovery of the original high-throughput screening lead BMS-858 and the chem. conundrum and challenges resolved in optimizing to daclatasvir as a clin. candidate and finally the authors summarize the results of select clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiU5qkfNyqXLVg90H21EOLACvtfcHk0ljrvxxlTuHXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurs%253D&md5=1428746b49ba356ce6993a58b143e5dc</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500335h%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520of%2520daclatasvir%252C%2520a%2520pan-genotypic%2520hepatitis%2520C%2520virus%2520NS5A%2520replication%2520complex%2520inhibitor%2520with%2520potent%2520clinical%2520effect%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5057%26epage%3D5071%26doi%3D10.1021%2Fjm500335h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Scola, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sit, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocuzza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilder, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewawasam, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friborg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schartman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donoso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvyaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredup, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span> </span><span class="NLM_article-title">The Discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1730</span><span class="NLM_x">–</span> <span class="NLM_lpage">1752</span><span class="refDoi"> DOI: 10.1021/jm500297k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500297k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1730-1752&author=P.+M.+Scolaauthor=L.-Q.+Sunauthor=A.+X.+Wangauthor=J.+Chenauthor=N.+Sinauthor=B.+L.+Venablesauthor=S.-Y.+Sitauthor=Y.+Chenauthor=A.+Cocuzzaauthor=D.+M.+Bilderauthor=S.+V.+D%E2%80%99Andreaauthor=B.+Zhengauthor=P.+Hewawasamauthor=Y.+Tuauthor=J.+Friborgauthor=P.+Falkauthor=D.+Hernandezauthor=S.+Levineauthor=C.+Chenauthor=F.+Yuauthor=A.+K.+Sheafferauthor=G.+Zhaiauthor=D.+Barryauthor=J.+O.+Knipeauthor=Y.-H.+Hanauthor=R.+Schartmanauthor=M.+Donosoauthor=K.+Mosureauthor=M.+W.+Sinzauthor=T.+Zvyagaauthor=A.+C.+Goodauthor=R.+Rajamaniauthor=K.+Kishauthor=J.+Tredupauthor=H.+E.+Kleiauthor=Q.+Gaoauthor=L.+Muellerauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=S.+P.+Adamsauthor=J.+Loyauthor=P.+C.+Levesqueauthor=H.+Sunauthor=H.+Shiauthor=L.+Sunauthor=W.+Warnerauthor=D.+Liauthor=J.+Zhuauthor=N.+A.+Meanwellauthor=F.+McPhee&title=The+Discovery+of+asunaprevir+%28BMS-650032%29%2C+an+orally+efficacious+NS3+protease+inhibitor+for+the+treatment+of+hepatitis+C+virus+infection&doi=10.1021%2Fjm500297k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span></div><div class="casAuthors">Scola, Paul M.; Sun, Li-Qiang; Wang, Alan Xiangdong; Chen, Jie; Sin, Ny; Venables, Brian L.; Sit, Sing-Yuen; Chen, Yan; Cocuzza, Anthony; Bilder, Donna M.; D'Andrea, Stanley V.; Zheng, Barbara; Hewawasam, Piyasena; Tu, Yong; Friborg, Jacques; Falk, Paul; Hernandez, Dennis; Levine, Steven; Chen, Chaoqun; Yu, Fei; Sheaffer, Amy K.; Zhai, Guangzhi; Barry, Diana; Knipe, Jay O.; Han, Yong-Hae; Schartman, Richard; Donoso, Maria; Mosure, Kathy; Sinz, Michael W.; Zvyaga, Tatyana; Good, Andrew C.; Rajamani, Ramkumar; Kish, Kevin; Tredup, Jeffrey; Klei, Herbert E.; Gao, Qi; Mueller, Luciano; Colonno, Richard J.; Grasela, Dennis M.; Adams, Stephen P.; Loy, James; Levesque, Paul C.; Sun, Huabin; Shi, Hong; Sun, Lucy; Warner, William; Li, Danshi; Zhu, Jialong; Meanwell, Nicholas A.; McPhee, Fiona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1730-1752</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of asunaprevir (BMS-650032) is described.  This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clin. trials for the treatment of hepatitis C virus infection.  The discovery of Asunaprevir was enabled by employing an isolated rabbit heart model to screen for the cardiovascular (CV) liabilities (changes to HR and SNRT) that were responsible for the discontinuation of an earlier lead from this chem. series, BMS-605339, from clin. trials.  The structure-activity relationships (SARs) developed with respect to CV effects established that small structural changes to the P2* subsite of the mol. had a significant impact on the CV profile of a given compd.  The antiviral activity, preclin. PK profile, and toxicol. studies in rat and dog supported clin. development of BMS-650032.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCzMFiXs8YO7Vg90H21EOLACvtfcHk0ljrvxxlTuHXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsLc%253D&md5=e8015d3874b80be645a9b80b5bd05865</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm500297k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500297k%26sid%3Dliteratum%253Aachs%26aulast%3DScola%26aufirst%3DP.%2BM.%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DWang%26aufirst%3DA.%2BX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSin%26aufirst%3DN.%26aulast%3DVenables%26aufirst%3DB.%2BL.%26aulast%3DSit%26aufirst%3DS.-Y.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCocuzza%26aufirst%3DA.%26aulast%3DBilder%26aufirst%3DD.%2BM.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DS.%2BV.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DHewawasam%26aufirst%3DP.%26aulast%3DTu%26aufirst%3DY.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DZhai%26aufirst%3DG.%26aulast%3DBarry%26aufirst%3DD.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DHan%26aufirst%3DY.-H.%26aulast%3DSchartman%26aufirst%3DR.%26aulast%3DDonoso%26aufirst%3DM.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSinz%26aufirst%3DM.%2BW.%26aulast%3DZvyaga%26aufirst%3DT.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DTredup%26aufirst%3DJ.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DAdams%26aufirst%3DS.%2BP.%26aulast%3DLoy%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWarner%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DMcPhee%26aufirst%3DF.%26atitle%3DThe%2520Discovery%2520of%2520asunaprevir%2520%2528BMS-650032%2529%252C%2520an%2520orally%2520efficacious%2520NS3%2520protease%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1730%26epage%3D1752%26doi%3D10.1021%2Fjm500297k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuttle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span> </span><span class="NLM_article-title">Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypes</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7416</span><span class="NLM_x">–</span> <span class="NLM_lpage">7423</span><span class="refDoi"> DOI: 10.1128/AAC.03851-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1128%2FAAC.03851-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=25267677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVymsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=7416-7423&author=M.+Liuauthor=M.+Tuttleauthor=M.+Gaoauthor=J.+A.+Lemm&title=Potency+and+resistance+analysis+of+hepatitis+C+virus+NS5B+polymerase+inhibitor+BMS-791325+on+all+major+genotypes&doi=10.1128%2FAAC.03851-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypes</span></div><div class="casAuthors">Liu, Mengping; Tuttle, Maria; Gao, Min; Lemm, Julie A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7416-7423, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">BMS-791325 is a hepatitis C virus (HCV) inhibitor binding to the thumb domain of the NS5B RNA-dependent RNA polymerase.  BMS-791325 is well characterized in genotype 1 (GT1) and exhibits good inhibitory activity (50% effective concn. [EC50], <10 nM) against hybrid replicons contg. patient NS5B sequences from GT3a, -4a, and -5a while potency against GT2 is significantly reduced.  BMS-791325 potency against GT6a hybrid replicons is more variable, with two of three hybrid clones having EC50s similar to that for GT1 while a third patient clone was ∼10 times less susceptible to BMS-791325.  To characterize the resistance profile of BMS-791325 beyond GT1, curing studies were performed across GT1a and -3a to -6a and demonstrated that GT1a has the highest resistance barrier vs. BMS-791325 while GT6a has the lowest.  Selection of GT3 to -6 NS5B chimeric replicon cells at different concns. of BMS-791325 revealed substitutions in the thumb domain of NS5B at residues 494 and 495 that conferred different levels of resistance to BMS-791325 but remained susceptible to NS5A or NS3 protease inhibitors.  In addn., we demonstrate that the reduced potency of BMS-791325 against one GT6a patient is due to an A494 polymorphism present in ∼21% of sequences in the European HCV database.  The results from this report suggest that BMS-791325 is a candidate for combination treatment of HCV GT3 to -6 chronic infections, and the resistance profiles identified will provide useful information for future clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5_mdXydNNWLVg90H21EOLACvtfcHk0ljefM2KsnQ_1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVymsLzL&md5=8c28943f5323ac850671503c57974cb0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FAAC.03851-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03851-14%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DTuttle%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26atitle%3DPotency%2520and%2520resistance%2520analysis%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520inhibitor%2520BMS-791325%2520on%2520all%2520major%2520genotypes%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D7416%26epage%3D7423%26doi%3D10.1128%2FAAC.03851-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span> </span><span class="NLM_article-title">The role of molecular size in ligand efficiency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4258</span><span class="NLM_x">–</span> <span class="NLM_lpage">4261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2007.05.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=17532632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4258-4261&author=C.+H.+Reynoldsauthor=S.+D.+Bembenekauthor=B.+A.+Tounge&title=The+role+of+molecular+size+in+ligand+efficiency&doi=10.1016%2Fj.bmcl.2007.05.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of molecular size in ligand efficiency</span></div><div class="casAuthors">Reynolds, Charles H.; Bembenek, Scott D.; Tounge, Brett A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4258-4261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ligand efficiency is a simple metric for assessing whether a ligand derives its potency from optimal fit with the protein target or simply by virtue of making many contacts.  Comparison of protein-ligand binding affinities for over 8000 ligands with 28 protein targets shows conclusively that the av. ligand binding affinities are not linear with mol. size.  It is therefore important to scale ligand efficiencies by the size of the ligand, particularly where small ligands (e.g., fragments) are involved.  The authors propose a simple 'fit quality' metric that removes this dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnIaZs8-gK1rVg90H21EOLACvtfcHk0ljefM2KsnQ_1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D&md5=2f95a0b64b1da0755d7f624dad18b2bc</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26atitle%3DThe%2520role%2520of%2520molecular%2520size%2520in%2520ligand%2520efficiency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4258%26epage%3D4261%26doi%3D10.1016%2Fj.bmcl.2007.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span> </span><span class="NLM_article-title">Ligand binding efficiency: trends, physical basis, and implications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2432</span><span class="NLM_x">–</span> <span class="NLM_lpage">2438</span><span class="refDoi"> DOI: 10.1021/jm701255b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701255b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2432-2438&author=C.+H.+Reynoldsauthor=B.+A.+Toungeauthor=S.+D.+Bembenek&title=Ligand+binding+efficiency%3A+trends%2C+physical+basis%2C+and+implications&doi=10.1021%2Fjm701255b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand binding efficiency: trends, physical basis, and implications</span></div><div class="casAuthors">Reynolds, Charles H.; Tounge, Brett A.; Bembenek, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2432-2438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand efficiency (i.e., potency/size) has emerged as an important metric in drug discovery.  In general, smaller, more efficient ligands are believed to have improved prospects for good drug properties (e.g., bioavailability).  Our anal. of thousands of ligands across a variety of targets shows that ligand efficiency is dependent on ligand size with smaller ligands having greater efficiencies, on av., than larger ligands.  We propose two primary causes for this size dependence: the inevitable redn. in the quality of fit between ligand and receptor as the ligand becomes larger and more complex and the redn. in accessible ligand surface area on a per atom basis as size increases.  These results have far-ranging implications for anal. of high-throughput screening hits, fragment-based approaches to drug discovery, and even computational models of potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkrPWFEZZEMrVg90H21EOLACvtfcHk0ljefM2KsnQ_1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFSgsbw%253D&md5=a9a41b44dbca7f34562c40b56c7ae683</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Fjm701255b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701255b%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26atitle%3DLigand%2520binding%2520efficiency%253A%2520trends%252C%2520physical%2520basis%252C%2520and%2520implications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2432%26epage%3D2438%26doi%3D10.1021%2Fjm701255b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perola, E.</span><span> </span><span class="NLM_article-title">An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2986</span><span class="NLM_x">–</span> <span class="NLM_lpage">2997</span><span class="refDoi"> DOI: 10.1021/jm100118x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100118x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlWqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2986-2997&author=E.+Perola&title=An+analysis+of+the+binding+efficiencies+of+drugs+and+their+leads+in+successful+drug+discovery+programs&doi=10.1021%2Fjm100118x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">An Analysis of the Binding Efficiencies of Drugs and their Leads in Successful Drug Discovery Programs</span></div><div class="casAuthors">Perola, Emanuele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2986-2997</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to investigate the evolution of binding efficiency in successful drug discovery programs, a data set of 60 lead/drug pairs with known binding affinities has been compiled and analyzed.  Low-end thresholds for the binding efficiencies of viable leads and drugs have been derived.  On av., the drugs in the set are significantly larger and more potent but have similar lipophilicity relative to their originating leads, suggesting that the ability to maintain low levels of lipophilicity while increasing mol. wt. is one of the keys to a successful drug discovery program.  A no. of examples demonstrate that large increases in binding efficiency from leads to more elaborate drugs sharing the same scaffold can be achieved.  The importance of dissecting a lead structure to identify the most efficient fragments and the option of sacrificing binding efficiency to optimize other properties are discussed, and relevant examples are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRqzYFBuX2Q7Vg90H21EOLACvtfcHk0ljHQXm3z4WMVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlWqu7o%253D&md5=a7eaad792f1518d093588951df64d22f</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1021%2Fjm100118x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100118x%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520efficiencies%2520of%2520drugs%2520and%2520their%2520leads%2520in%2520successful%2520drug%2520discovery%2520programs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2986%26epage%3D2997%26doi%3D10.1021%2Fjm100118x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Fragment-based drug design: how big is too big?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6972</span><span class="NLM_x">–</span> <span class="NLM_lpage">6976</span><span class="refDoi"> DOI: 10.1021/jm060511h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060511h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6972-6976&author=P.+J.+Hajduk&title=Fragment-based+drug+design%3A+how+big+is+too+big%3F&doi=10.1021%2Fjm060511h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Design: How Big Is Too Big?</span></div><div class="casAuthors">Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6972-6976</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Much has been discussed about the proper physicochem. properties (e.g., mol. wt., hydrophobicity, etc.) that should be considered when utilizing fragment leads in drug design.  However, little has been reported as to what emphasis, if any, should be placed on the potency of the resulting fragment leads.  In this report, a retrospective anal. of 18 highly optimized inhibitors is described in which the compds. were systematically deconstructed until the minimal binding elements could be identified.  An anal. of the potency changes that were obsd. as the leads were reduced in size indicate that a nearly linear relationship exists between mol. wt. and binding affinity over the entire range of sizes and potencies represented in the dataset.  On the basis of these observations, prediction maps can be constructed that enable crit. and quant. assessments of the process of lead identification and optimization.  These data place well-defined limits on the ideal size and potency of fragment leads that are being considered for use in fragment-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCz9NMtBgNrVg90H21EOLACvtfcHk0ljHQXm3z4WMVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLbJ&md5=b27d4ca6446a033b82e0ea223da5e6de</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1021%2Fjm060511h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060511h%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DFragment-based%2520drug%2520design%253A%2520how%2520big%2520is%2520too%2520big%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6972%26epage%3D6976%26doi%3D10.1021%2Fjm060511h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitive assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitive+assessment+of+hERG+liability+as+a+function+of+lipophilicity&doi=10.1016%2Fj.bmcl.2006.12.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitive%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764%26doi%3D10.1016%2Fj.bmcl.2006.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><div class="note"><p class="first last">The analysis was based on ten matched molecular pairs. When the hERG inhibition data are determined in the same assay in the same laboratory, a minimum of four matched pairs can be sufficient to identify an activity difference, see:</p></div><span class="NLM_contrib-group">Kramer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitebread, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liedl, K. R.</span><span> </span><span class="NLM_article-title">Matched molecular pair analysis: significance and the impact of experimental uncertainty</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3786</span><span class="NLM_x">–</span> <span class="NLM_lpage">3802</span><span class="refDoi"> DOI: 10.1021/jm500317a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500317a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlyhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3786-3802&author=C.+Kramerauthor=J.+E.+Fuchsauthor=S.+Whitebreadauthor=P.+Gedeckauthor=K.+R.+Liedl&title=Matched+molecular+pair+analysis%3A+significance+and+the+impact+of+experimental+uncertainty&doi=10.1021%2Fjm500317a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pair Analysis: Significance and the Impact of Experimental Uncertainty</span></div><div class="casAuthors">Kramer, Christian; Fuchs, Julian E.; Whitebread, Steven; Gedeck, Peter; Liedl, Klaus R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3786-3802</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matched mol. pair anal. (MMPA) has become a major tool for analyzing large chem. data sets for promising chem. transformations.  However, the dependence of MMPA predictions on data constraints such as the no. of pairs involved, exptl. uncertainty, source of the expts., and variability of the true phys. effect has not yet been described.  In this contribution the statistical basics for judging MMPA are analyzed.  We illustrate the connection between overall MMPA statistics and individual pairs with a detailed comparison of av. CHEMBL hERG MMPA results vs. pairs with extreme transformation effects.  Comparing the CHEMBL results to Novartis data, we find that significant transformation effects agree very well if the exptl. uncertainty is considered.  This indicates that caution must be exercised for predictions from insignificant MMPAs, yet highlights the robustness of statistically validated MMPA and shows that MMPA on public databases can yield results that are very useful for medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozfisWGl9ewLVg90H21EOLACvtfcHk0ljHQXm3z4WMVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlyhurc%253D&md5=345def0f0a3e533e44b069b77ce0b185</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm500317a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500317a%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DFuchs%26aufirst%3DJ.%2BE.%26aulast%3DWhitebread%26aufirst%3DS.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DLiedl%26aufirst%3DK.%2BR.%26atitle%3DMatched%2520molecular%2520pair%2520analysis%253A%2520significance%2520and%2520the%2520impact%2520of%2520experimental%2520uncertainty%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3786%26epage%3D3802%26doi%3D10.1021%2Fjm500317a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conder, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span> </span><span class="NLM_article-title">Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6182</span><span class="NLM_x">–</span> <span class="NLM_lpage">6192</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmc.2007.06.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6182-6192&author=S.+R.+Johnsonauthor=H.+Yueauthor=M.+L.+Conderauthor=H.+Shiauthor=A.+M.+Doweykoauthor=J.+Lloydauthor=P.+Levesque&title=Estimation+of+hERG+inhibition+of+drug+candidates+using+multivariate+property+and+pharmacophore+SAR&doi=10.1016%2Fj.bmc.2007.06.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DYue%26aufirst%3DH.%26aulast%3DConder%26aufirst%3DM.%2BL.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DLloyd%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DP.%26atitle%3DEstimation%2520of%2520hERG%2520inhibition%2520of%2520drug%2520candidates%2520using%2520multivariate%2520property%2520and%2520pharmacophore%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D6182%26epage%3D6192%26doi%3D10.1016%2Fj.bmc.2007.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Tomasi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennucci</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammi, R.</span><span> </span><span class="NLM_article-title">Quantum mechanical continuum solvation models</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2999</span><span class="NLM_x">–</span> <span class="NLM_lpage">3093</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1021/cr9904009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9904009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVynurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2999-3093&author=J.+Tomasiauthor=+Mennucciauthor=R.+Cammi&title=Quantum+mechanical+continuum+solvation+models&doi=10.1021%2Fcr9904009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Quantum Mechanical Continuum Solvation Models</span></div><div class="casAuthors">Tomasi, Jacopo; Mennucci, Benedetta; Cammi, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2999-3093</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkWabJEwaQ7LVg90H21EOLACvtfcHk0lhknJMYr-zYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVynurc%253D&md5=462420dd18b3006ee63d1298b66db247</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fcr9904009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9904009%26sid%3Dliteratum%253Aachs%26aulast%3DTomasi%26aufirst%3DJ.%26aulast%3DMennucci%26aulast%3DCammi%26aufirst%3DR.%26atitle%3DQuantum%2520mechanical%2520continuum%2520solvation%2520models%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D2999%26epage%3D3093%26doi%3D10.1021%2Fcr9904009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8315</span><span class="NLM_x">–</span> <span class="NLM_lpage">8359</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lhknJMYr-zYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="note"><p class="first last">The details of pharmacokinetic studies will be the subject of a separate publication.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Rumondor, A. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhareshwar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesisoglou, F.</span><span> </span><span class="NLM_article-title">Amorphous solid dispersions or prodrugs: complementary strategies to increase drug absorption</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2498</span><span class="NLM_x">–</span> <span class="NLM_lpage">2508</span><span class="refDoi"> DOI: 10.1016/j.xphs.2015.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.xphs.2015.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=26886316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWjtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=2498-2508&author=A.+C.+F.+Rumondorauthor=S.+S.+Dhareshwarauthor=F.+Kesisoglou&title=Amorphous+solid+dispersions+or+prodrugs%3A+complementary+strategies+to+increase+drug+absorption&doi=10.1016%2Fj.xphs.2015.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption</span></div><div class="casAuthors">Rumondor, Alfred C. F.; Dhareshwar, Sundeep S.; Kesisoglou, Filippos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2498-2508</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Maximizing oral bioavailability of drug candidates represents a challenge in the pharmaceutical industry.  In recent years, there has been an increase in the use of amorphous solid dispersions (ASDs) to address this issue, where a growing no. of solid dispersion formulations have been introduced to the market.  However, an increase in soly. or dissoln. rate through ASD does not always result in sufficient improvement of oral absorption because soly. limitations may still exist at high doses.  Chem. modification in the form of a prodrug may offer an alternative approach for these cases.  Although prodrugs have been primarily used to improve membrane permeability, examples are available in which prodrugs have been used to increase drug soly. beyond what can be achieved via formulation approaches.  In this mini review, the role of ASDs and prodrugs as 2 complementary approaches in improving oral bioavailability of drug candidates is discussed.  We discuss the fundamental principles of absorption and bioavailability, and review available literature on both solid dispersions and prodrugs, providing a summary of their use and examples of successful applications, and cover some of the biopharmaceutics evaluation aspects for these approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKdZFZ1pSCdrVg90H21EOLACvtfcHk0lhknJMYr-zYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWjtbrE&md5=32d2cd7a5d8b624d0d303c6c8e3601a3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2015.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2015.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DRumondor%26aufirst%3DA.%2BC.%2BF.%26aulast%3DDhareshwar%26aufirst%3DS.%2BS.%26aulast%3DKesisoglou%26aufirst%3DF.%26atitle%3DAmorphous%2520solid%2520dispersions%2520or%2520prodrugs%253A%2520complementary%2520strategies%2520to%2520increase%2520drug%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26spage%3D2498%26epage%3D2508%26doi%3D10.1016%2Fj.xphs.2015.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span><span class="refDoi"> DOI: 10.1021/tx200211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&author=N.+A.+Meanwell&title=Improving+drug+candidates+by+design%3A+a+focus+on+physicochemical+properties+as+a+means+of+improving+compound+disposition+and+safety&doi=10.1021%2Ftx200211v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0lj7S5zVKBGbuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520candidates%2520by%2520design%253A%2520a%2520focus%2520on%2520physicochemical%2520properties%2520as%2520a%2520means%2520of%2520improving%2520compound%2520disposition%2520and%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1420%26epage%3D1456%26doi%3D10.1021%2Ftx200211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Manuscript in preparation</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit51b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eastman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parcella, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, K.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant-Young, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredup, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jardel, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanumegowda, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donoso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuttle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvyaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haarhoff, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soars, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">796</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span><span class="refDoi"> DOI: 10.1039/C6MD00636A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1039%2FC6MD00636A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=796-806&author=K.+J.+Eastmanauthor=K.+Parcellaauthor=K.-S.+Yeungauthor=K.+A.+Grant-Youngauthor=J.+Zhuauthor=T.+Wangauthor=Z.+Zhangauthor=Z.+Yinauthor=B.+R.+Benoauthor=S.+Sheriffauthor=K.+Kishauthor=J.+Tredupauthor=A.+G.+Jardelauthor=V.+Halanauthor=K.+Ghoshauthor=D.+Parkerauthor=K.+Mosureauthor=H.+Fangauthor=Y.-K.+Wangauthor=J.+Lemmauthor=X.+Zhuoauthor=U.+Hanumegowdaauthor=K.+Rigatauthor=M.+Donosoauthor=M.+Tuttleauthor=T.+Zvyagaauthor=Z.+Haarhoffauthor=N.+A.+Meanwellauthor=M.+G.+Soarsauthor=S.+B.+Robertsauthor=J.+F.+Kadow&title=The+discovery+of+a+pan-genotypic%2C+primer+grip+inhibitor+of+HCV+NS5B+polymerase&doi=10.1039%2FC6MD00636A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51b&amp;dbid=16384&amp;doi=10.1039%2FC6MD00636A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00636A%26sid%3Dliteratum%253Aachs%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DParcella%26aufirst%3DK.%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DGrant-Young%26aufirst%3DK.%2BA.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DTredup%26aufirst%3DJ.%26aulast%3DJardel%26aufirst%3DA.%2BG.%26aulast%3DHalan%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DK.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DHanumegowda%26aufirst%3DU.%26aulast%3DRigat%26aufirst%3DK.%26aulast%3DDonoso%26aufirst%3DM.%26aulast%3DTuttle%26aufirst%3DM.%26aulast%3DZvyaga%26aufirst%3DT.%26aulast%3DHaarhoff%26aufirst%3DZ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520discovery%2520of%2520a%2520pan-genotypic%252C%2520primer%2520grip%2520inhibitor%2520of%2520HCV%2520NS5B%2520polymerase%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D796%26epage%3D806%26doi%3D10.1039%2FC6MD00636A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Corsi, M.; Faiferman, I.; Merlo-Pich, E.; Ratti, E.; Wren, P. B.</span><span> </span><span class="NLM_article-title">2-Amino-7,8- dihydropyrido[2, 3- <i>d</i>] pyrimidin-7-one derivatives as CSBP/RK/p38 kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. World Patent Application WO 2007/147103 A2, December 21,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+Corsi&author=I.+Faiferman&author=E.+Merlo-Pich&author=E.+Ratti&author=P.+B.+Wren&title=2-Amino-7%2C8-+dihydropyrido%5B2%2C+3-+d%5D+pyrimidin-7-one+derivatives+as+CSBP%2FRK%2Fp38+kinase+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorsi%26aufirst%3DM.%26atitle%3D2-Amino-7%252C8-%2520dihydropyrido%255B2%252C%25203-%2520d%255D%2520pyrimidin-7-one%2520derivatives%2520as%2520CSBP%252FRK%252Fp38%2520kinase%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Lemieux, R. M.; Barbosa, A. J. d. M.; Bentzien, J. M.; Brunette, S.; Richard; Chen, Z.; Cogan, D.; Gao, D. A.; Heim-Riether, A.; Horan, J. C.; Kowalski, J. A.; Lawlor, M. D.; Liu, W.; McKibben, B.; Miller, C. A.; Moss, N.; Tschantz, M. A.; Xiong, Z.; Yu, Hui; Yu, Y.</span><span> </span><span class="NLM_article-title">Derivatives of 6,7-dihydro-5<i>H</i>-imidazo[1,2-α]imidazole-carboxylic acid amides as inhibitors of the interaction of CAMs and leukointegrins, and their preparation and use in the treatment of inflammatory diseases</span>. World Patent Application WO 2009/070485 A1, June 4,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+M.+Lemieux&author=A.+J.+d.+M.+Barbosa&author=J.+M.+Bentzien&author=S.+Brunette&author=+Richard&author=Z.+Chen&author=D.+Cogan&author=D.+A.+Gao&author=A.+Heim-Riether&author=J.+C.+Horan&author=J.+A.+Kowalski&author=M.+D.+Lawlor&author=W.+Liu&author=B.+McKibben&author=C.+A.+Miller&author=N.+Moss&author=M.+A.+Tschantz&author=Z.+Xiong&author=Hui+Yu&author=Y.+Yu&title=Derivatives+of+6%2C7-dihydro-5H-imidazo%5B1%2C2-%CE%B1%5Dimidazole-carboxylic+acid+amides+as+inhibitors+of+the+interaction+of+CAMs+and+leukointegrins%2C+and+their+preparation+and+use+in+the+treatment+of+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DDerivatives%2520of%25206%252C7-dihydro-5H-imidazo%255B1%252C2-%25CE%25B1%255Dimidazole-carboxylic%2520acid%2520amides%2520as%2520inhibitors%2520of%2520the%2520interaction%2520of%2520CAMs%2520and%2520leukointegrins%252C%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A.,  Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, O.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J.</span> <span class="citation_source-book">Gaussian 09</span>, revision D.01; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=T.+Keith&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=J.+M.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=O.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26btitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55a"><span><span class="NLM_label">(a) </span> <span class="citation_source-book">Schrödinger Release 2016-2: Maestro</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2016-2%3A+Maestro%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202016-2%253A%2520Maestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">MacroModel</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacroModel%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55c"><span><span class="NLM_label">(c) </span> <span class="citation_source-book">Protein Preparation Wizard; Epik</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Preparation+Wizard%3B+Epik%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DProtein%2520Preparation%2520Wizard%253B%2520Epik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55d"><span><span class="NLM_label">(d) </span> <span class="citation_source-book">Impact</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Impact%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DImpact%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55e"><span><span class="NLM_label">(e) </span> <span class="citation_source-book">Prime</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Harder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maple, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupyan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerutti, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krilov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">OPLS3: A force field providing broad coverage of drug-like small molecules and proteins</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0liyaYaXY3cSPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':[],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41a','cit41b'],'ref42':['cit42a','cit42b'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':[],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51a','cit51b'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55a','cit55b','cit55c','cit55d','cit55e'],'ref56':['cit56']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lewis D. Pennington, Brian M. Aquila, Younggi Choi, Roman A. Valiulin, <span class="NLM_string-name hlFld-ContribAuthor">Ingo Muegge</span>. </span><span class="cited-content_cbyCitation_article-title">Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 8956-8976. <a href="https://doi.org/10.1021/acs.jmedchem.9b02092" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositional%252BAnalogue%252BScanning%25253A%252BAn%252BEffective%252BStrategy%252Bfor%252BMultiparameter%252BOptimization%252Bin%252BDrug%252BDesign%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D24042020%26volume%3D63%26issue%3D17%26spage%3D8956%26epage%3D8976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel Smith, Subramaniam Krishnananthan, Nicholas A. Meanwell, Arvind Mathur, <span class="NLM_string-name hlFld-ContribAuthor">Jianqing Li</span>. </span><span class="cited-content_cbyCitation_article-title">Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (6)
                                     , 1157-1163. <a href="https://doi.org/10.1021/acs.oprd.0c00198" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00198%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DMultigram%252BSynthesis%252Bof%252BBMS-929075%25252C%252Ban%252BAllosteric%25252C%252BPalm%252BSite%252BInhibitor%252Bof%252BHCV%252BNS5B%252BReplicase%25252C%252BInvolving%252Bthe%252BSynthesis%252Bof%252Ba%252BHighly%252BFunctionalized%252BBenzofuran%252Bthrough%252Ba%252BTelescoped%252BProcess%26aulast%3DSmith%26aufirst%3DDaniel%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D04062020%26date%3D27052020%26volume%3D24%26issue%3D6%26spage%3D1157%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pek Y. Chong, J. Brad Shotwell, John Miller, Daniel J. Price, Andy Maynard, Christian Voitenleitner, Amanda Mathis, Shawn Williams, Jeffrey J. Pouliot, Katrina Creech, Feng Wang, Jing Fang, Huichang Zhang, Vincent W.-F. Tai, Elizabeth Turner, Kirsten M. Kahler, Renae Crosby, <span class="NLM_string-name hlFld-ContribAuthor">Andrew J. Peat</span>. </span><span class="cited-content_cbyCitation_article-title">Design of N-Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3254-3267. <a href="https://doi.org/10.1021/acs.jmedchem.8b01719" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01719%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BN-Benzoxaborole%252BBenzofuran%252BGSK8175%2525E2%252580%252594Optimization%252Bof%252BHuman%252BPharmacokinetics%252BInspired%252Bby%252BMetabolites%252Bof%252Ba%252BFailed%252BClinical%252BHCV%252BInhibitor%26aulast%3DChong%26aufirst%3DPek%2BY.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D02112018%26date%3D07032019%26date%3D14022019%26volume%3D62%26issue%3D7%26spage%3D3254%26epage%3D3267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kap-Sun Yeung, Brett R. Beno, Kathy Mosure, Juliang Zhu, Katherine A. Grant-Young, Kyle Parcella, Prakash Anjanappa, Rajesh Onkardas Bora, Kumaravel Selvakumar, Ying-Kai Wang, Hua Fang, Rudolph Krause, Karen Rigat, Mengping Liu, Julie Lemm, Steven Sheriff, Mark Witmer, Jeffrey Tredup, Adam Jardel, Kevin Kish, Dawn Parker, Roy Haskell, Kenneth Santone, Nicholas A. Meanwell, Matthew G. Soars, Susan B. Roberts, <span class="NLM_string-name hlFld-ContribAuthor">John F. Kadow</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Property Basis for Solving Transporter-Mediated Efflux and Pan-Genotypic Inhibition in HCV NS5B Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (12)
                                     , 1217-1222. <a href="https://doi.org/10.1021/acsmedchemlett.8b00379" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00379</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00379%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Property%252BBasis%252Bfor%252BSolving%252BTransporter-Mediated%252BEfflux%252Band%252BPan-Genotypic%252BInhibition%252Bin%252BHCV%252BNS5B%252BInhibitors%26aulast%3DYeung%26aufirst%3DKap-Sun%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16082018%26date%3D05112018%26date%3D08112018%26date%3D05112018%26volume%3D9%26issue%3D12%26spage%3D1217%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyle  Parcella</span>, <span class="hlFld-ContribAuthor ">Kyle  Eastman</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Katharine A.  Grant-Young</span>, <span class="hlFld-ContribAuthor ">Juliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongxing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Yin</span>, <span class="hlFld-ContribAuthor ">Dawn  Parker</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Julie  Lemm</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Zhuo</span>, <span class="hlFld-ContribAuthor ">Umesh  Hanumegowda</span>, <span class="hlFld-ContribAuthor ">Mengping  Liu</span>, <span class="hlFld-ContribAuthor ">Karen  Rigat</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Maria  Tuttle</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Zuzana  Haarhoff</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Soars</span>, <span class="hlFld-ContribAuthor ">Susan B.  Roberts</span>, and <span class="hlFld-ContribAuthor ">John F.  Kadow</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Metabolic Stability with Deuterium: The Discovery of BMT-052, a Pan-genotypic HCV NS5B Polymerase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 771-774. <a href="https://doi.org/10.1021/acsmedchemlett.7b00211" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00211%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImproving%252BMetabolic%252BStability%252Bwith%252BDeuterium%25253A%252BThe%252BDiscovery%252Bof%252BBMT-052%25252C%252Ba%252BPan-genotypic%252BHCV%252BNS5B%252BPolymerase%252BInhibitor%26aulast%3DParcella%26aufirst%3DKyle%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18052017%26date%3D29062017%26date%3D03072017%26date%3D13072017%26date%3D29062017%26volume%3D8%26issue%3D7%26spage%3D771%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed K.  Oraby</span>, <span class="hlFld-ContribAuthor ">Cassandra L.  Gardner</span>, <span class="hlFld-ContribAuthor ">Robert F.  Needle</span>, <span class="hlFld-ContribAuthor ">Hassan M.  Kofahi</span>, <span class="hlFld-ContribAuthor ">Kylie R.  Everard</span>, <span class="hlFld-ContribAuthor ">Nathan G. A.  Taylor</span>, <span class="hlFld-ContribAuthor ">Suzette G.  Rutihinda</span>, <span class="hlFld-ContribAuthor ">Jacqueline P.  Barry</span>, <span class="hlFld-ContribAuthor ">Kensuke  Hirasawa</span>, <span class="hlFld-ContribAuthor ">Paris E.  Georghiou</span>, <span class="hlFld-ContribAuthor ">Rodney S.  Russell</span>, . </span><span class="cited-content_cbyCitation_article-title">A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture. </span><span class="cited-content_cbyCitation_journal-name">Microbiology Spectrum</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1128/Spectrum.00439-21" title="DOI URL">https://doi.org/10.1128/Spectrum.00439-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/Spectrum.00439-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FSpectrum.00439-21%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiology%2520Spectrum%26atitle%3DA%252BNovel%252BSmall%252BMolecule%252BInhibits%252BHepatitis%252BC%252BVirus%252BPropagation%252Bin%252BCell%252BCulture%26aulast%3DOraby%26aufirst%3DAhmed%2BK.%26date%3D2021%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aijaz Ahmad  Malik</span>, <span class="hlFld-ContribAuthor ">Chuleeporn  Phanus‐umporn</span>, <span class="hlFld-ContribAuthor ">Nalini  Schaduangrat</span>, <span class="hlFld-ContribAuthor ">Watshara  Shoombuatong</span>, <span class="hlFld-ContribAuthor ">Chartchalerm  Isarankura‐Na‐Ayudhya</span>, <span class="hlFld-ContribAuthor ">Chanin  Nantasenamat</span>. </span><span class="cited-content_cbyCitation_article-title">HCVpred
              : A web server for predicting the bioactivity of hepatitis C virus
              NS5B
              inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2020,</strong> <em>41 </em>
                                    (20)
                                     , 1820-1834. <a href="https://doi.org/10.1002/jcc.26223" title="DOI URL">https://doi.org/10.1002/jcc.26223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.26223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.26223%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DHCVpred%252B%25253A%252BA%252Bweb%252Bserver%252Bfor%252Bpredicting%252Bthe%252Bbioactivity%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS5B%252Binhibitors%26aulast%3DMalik%26aufirst%3DAijaz%2BAhmad%26date%3D2020%26date%3D2020%26volume%3D41%26issue%3D20%26spage%3D1820%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Xiao</span>, <span class="hlFld-ContribAuthor ">Xing  Dai</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Shuwen  He</span>, <span class="hlFld-ContribAuthor ">Zhi-Cai  Shi</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Fangbiao  Li</span>, <span class="hlFld-ContribAuthor ">Ravi  Nargund</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (7)
                                     , 127004. <a href="https://doi.org/10.1016/j.bmcl.2020.127004" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMulti-step%252Bparallel%252Bsynthesis%252Benabled%252Boptimization%252Bof%252Bbenzofuran%252Bderivatives%252Bas%252Bpan-genotypic%252Bnon-nucleoside%252Binhibitors%252Bof%252BHCV%252BNS5B%26aulast%3DXiao%26aufirst%3DDong%26date%3D2020%26volume%3D30%26issue%3D7%26spage%3D127004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phillip R.  Lazzara</span>, <span class="hlFld-ContribAuthor ">Terry W.  Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 18-29. <a href="https://doi.org/10.1039/C9MD00396G" title="DOI URL">https://doi.org/10.1039/C9MD00396G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00396G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00396G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DScaffold-hopping%252Bas%252Ba%252Bstrategy%252Bto%252Baddress%252Bmetabolic%252Bliabilities%252Bof%252Baromatic%252Bcompounds%26aulast%3DLazzara%26aufirst%3DPhillip%2BR.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D18%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narayana Murthy  Ganta</span>, <span class="hlFld-ContribAuthor ">Gangaraju  Gedda</span>, <span class="hlFld-ContribAuthor ">Bethi  Rathnakar</span>, <span class="hlFld-ContribAuthor ">Mavurapu  Satyanarayana</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Yamajala</span>, <span class="hlFld-ContribAuthor ">Mohamed Jawed  Ahsan</span>, <span class="hlFld-ContribAuthor ">Surender Singh  Jadav</span>, <span class="hlFld-ContribAuthor ">Tuniki  Balaraju</span>. </span><span class="cited-content_cbyCitation_article-title">A review on HCV inhibitors: Significance of non-structural polyproteins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 576-601. <a href="https://doi.org/10.1016/j.ejmech.2018.12.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Breview%252Bon%252BHCV%252Binhibitors%25253A%252BSignificance%252Bof%252Bnon-structural%252Bpolyproteins%26aulast%3DGanta%26aufirst%3DNarayana%2BMurthy%26date%3D2019%26volume%3D164%26spage%3D576%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William J.  Watkins</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of HCV NS5B Non-nucleoside Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 171-191. <a href="https://doi.org/10.1007/7355_2018_35" title="DOI URL">https://doi.org/10.1007/7355_2018_35</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_35%26sid%3Dliteratum%253Aachs%26atitle%3DEvolution%252Bof%252BHCV%252BNS5B%252BNon-nucleoside%252BInhibitors%26aulast%3DWatkins%26aufirst%3DWilliam%2BJ.%26date%3D2019%26date%3D2019%26spage%3D171%26epage%3D191%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kohei  Watanabe</span>, <span class="hlFld-ContribAuthor ">Takashi  Mino</span>, <span class="hlFld-ContribAuthor ">Eri  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Chihiro  Masuda</span>, <span class="hlFld-ContribAuthor ">Yasushi  Yoshida</span>, <span class="hlFld-ContribAuthor ">Masami  Sakamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrazone–Pd-catalyzed direct intermolecular reaction of
              o
              -alkynylphenols with allylic acetates. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (4)
                                     , 575-584. <a href="https://doi.org/10.1039/C7OB02873C" title="DOI URL">https://doi.org/10.1039/C7OB02873C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02873C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02873C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DHydrazone%2525E2%252580%252593Pd-catalyzed%252Bdirect%252Bintermolecular%252Breaction%252Bof%252Bo%252B-alkynylphenols%252Bwith%252Ballylic%252Bacetates%26aulast%3DWatanabe%26aufirst%3DKohei%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D4%26spage%3D575%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Casey C.  McComas</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>, <span class="hlFld-ContribAuthor ">Wei  Chang</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Nigel  Liverton</span>, <span class="hlFld-ContribAuthor ">Peter T.  Meinke</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Xuanjia  Peng</span>, <span class="hlFld-ContribAuthor ">Richard M.  Soll</span>, <span class="hlFld-ContribAuthor ">Ajay  Ummat</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>, <span class="hlFld-ContribAuthor ">Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Nicolas  Zorn</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a New Structural Class of Broadly Acting HCV Non‐Nucleoside Inhibitors Leading to the Discovery of MK‐8876. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (17)
                                     , 1436-1448. <a href="https://doi.org/10.1002/cmdc.201700228" title="DOI URL">https://doi.org/10.1002/cmdc.201700228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700228%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDevelopment%252Bof%252Ba%252BNew%252BStructural%252BClass%252Bof%252BBroadly%252BActing%252BHCV%252BNon%2525E2%252580%252590Nucleoside%252BInhibitors%252BLeading%252Bto%252Bthe%252BDiscovery%252Bof%252BMK%2525E2%252580%2525908876%26aulast%3DMcComas%26aufirst%3DCasey%2BC.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D17%26spage%3D1436%26epage%3D1448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structure of the HCV NS5B protein.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The finger loops are colored cyan, and the fingers, palm, thumb, and C-terminal domains are depicted in green, blue, red, and white, respectively. The “primer grip” and active site GDD motif are shown in yellow and orange, respectively, and the location of the palm site is denoted with a magenta sphere. (b) Close-up view of the HCV NS5B active site and palm binding pocket highlighting key residues and structural features. α-Helices are labeled according to the nomenclature in ref <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>. Image generated with The PyMol Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of benzofuran NS5B palm site inhibitors <b>1</b>–<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of NS5B palm site inhibitors <b>4</b>–<b>7</b> and HCV inhibitory potency toward gt-1b NS5B enzyme (IC<sub>50</sub>) and replicons (EC<sub>50</sub>) for <b>4</b> and <b>7</b> (the IC<sub>50</sub> value for <b>4</b> was the average of <i>n</i> ≥ 2 independent experiments; values for <b>7</b> were from a single experiment performed in duplicate).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Overlay of the bound structures of anthranilic acid <b>4</b> (magenta), benzofuran <b>5</b> (orange), and benzothiadiazine <b>6</b> (green) in the palm site of the wild-type (WT) gt-1b NS5B protein. (b) X-ray structure of <b>5</b> bound to the gt-1b NS5B WT protein illustrating key interactions of <b>5</b> with palm site residues. Images generated with The PyMol Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) X-ray crystal structure of <b>18</b> bound to gt-1b NS5B WT protein showing direct and water-bridged hydrogen bonds between the protein and ligand. Hydrogen bonds are indicated with blue dashes. (b) Overlay of cocrystal structures of NS5B complexed with <b>8</b> (green) and <b>18</b> (orange) highlighting the Y448 loop, C-terminal region, and F551, which adopt different conformations depending on the identity of the benzofuran C5 substituent. (c) The hydrophobic cavity proximal to the 2′-position of the inhibitor amide phenyl ring and formed by the side chains from F193, C316, C366, and Y448 as illustrated in the close-up view of that region in the NS5B/<b>18</b> complex structure in (a). Images generated with The PyMol Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Six hour rat pharmacokinetic screen of 2-pyridyl analogue <b>29</b> (IV, 2 mg/kg; PO, 6 mg/kg; 9:1 PEG400/EtOH; <i>n</i> = 2); PO exposure at the 6 h time point: plasma = 1.64 μM and liver = 15.7 μM. The open and filled circles and diamonds indicate IV data obtained from two individual rats; the open and filled squares and triangles indicate PO data obtained from two individual rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Relative energies of aryl-cyclopropyl bond rotamers for model systems (left) and bisected and perpendicular conformers of the 2-pyridyl model (right) calculated at the MP2/-6-31+G** level of theory.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Computer model of a 4-fluorobenzofuran analogue in complex with N316 mutant enzyme based on a cocrystal structure of gt-1bC316N/inhibitor complex. Image generated with The PyMol Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ligand efficiency of HCV NS5B inhibitors <b>7</b>, <b>18</b>, and <b>37</b> with the % increase in HAC indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) gt-1b NS5B/<b>37</b> complex cocrystal structure with key interacting residues highlighted (see text). The omit Fo-Fc electron density is contoured at 3 RMSD in magenta mesh, and hydrogen bonding, π-cation, and π-stacking interactions are denoted with blue, red, and cyan dashes, respectively. (b) Small molecule crystal structure of the unsolvated neat form of <b>37</b>, showing the two conformers per asymmetric unit. Images generated with The PyMOL Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Comparison of electrostatic potentials for similar conformers of the comparably substituted benzofuran (top) and 4-F-benzofuran (bottom) moieties calculated at the MP2/6-31+G** level including PCM H<sub>2</sub>O solvation and contoured at 0.001 au.<a onclick="showRef(event, 'ref32 ref46'); return false;" href="javascript:void(0);" class="ref ref32 ref46">(32, 46)</a> Areas of negative and positive potential are indicated by red and blue, respectively. Image generated with The PyMOL Molecular Graphics System (v. 1.8, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/medium/jm-2017-00328w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Discovery Synthesis of <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00328/20170519/images/large/jm-2017-00328w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00328&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Selectfluor (1.2 equiv), MeCN, rt, 24 h; (b) NaOH (1N, aq), 1:1 MeOH/THF, 90 °C, 24% 2 steps; (c) MeNH<sub>2</sub>·HCl, HOBT·H<sub>2</sub>O, EDC, <i>i</i>-Pr<sub>2</sub>NEt, DMF, rt, 93%; (d) PhN(OTf)<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 98%, (e) (PPh<sub>3</sub>)<sub>4</sub>Pd, Cs<sub>2</sub>CO<sub>3</sub>, 1:10 H<sub>2</sub>O/Dioxane, 95 °C, 58%; (f) TBTU, <i>i</i>-Pr<sub>2</sub>NEt, DMF, rt 79%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">WHO</span><span class="NLM_x"> Hepatitis C Fact Sheet No. 164, </span><a href="http://www.who.int/mediacentre/factsheets/fs164/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs164/en/</a> (updated July 2016; accessed February 5,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO+Hepatitis+C+Fact+Sheet+No.+164%2C+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs164%2Fen%2F+%28updated+July+2016%3B+accessed+February+5%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>Centers for Diseases Control and Prevention: Viral Hepatitis - Hepatitis C Information, <a href="http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm" class="extLink">http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm</a> (updated January 27, 2017; accessed February 5,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Centers+for+Diseases+Control+and+Prevention%3A+Viral+Hepatitis+-+Hepatitis+C+Information%2C+http%3A%2F%2Fwww.cdc.gov%2Fhepatitis%2Fhcv%2Fhcvfaq.htm+%28updated+January+27%2C+2017%3B+accessed+February+5%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1126/science.2523562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood+borne+non-A%2C+non-B+viral+hepatitis+genome&doi=10.1126%2Fscience.2523562"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood%2520borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362%26doi%3D10.1126%2Fscience.2523562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuiken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muerhoff, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonds, P.</span><span> </span><span class="NLM_article-title">Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1002/hep.26744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1002%2Fhep.26744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=24115039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FktFWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=318-327&author=D.+B.+Smithauthor=J.+Bukhauthor=C.+Kuikenauthor=A.+S.+Muerhoffauthor=C.+M.+Riceauthor=J.+T.+Stapletonauthor=P.+Simmonds&title=Expanded+classification+of+hepatitis+C+virus+into+7+genotypes+and+67+subtypes%3A+updated+criteria+and+genotype+assignment+web+resource&doi=10.1002%2Fhep.26744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource</span></div><div class="casAuthors">Smith Donald B; Bukh Jens; Kuiken Carla; Muerhoff A Scott; Rice Charles M; Stapleton Jack T; Simmonds Peter</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Baltimore, Md.)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">318-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  The 2005 consensus proposal for the classification of hepatitis C virus (HCV) presented an agreed and uniform nomenclature for HCV variants and the criteria for their assignment into genotypes and subtypes.  Since its publication, the available dataset of HCV sequences has vastly expanded through advancement in nucleotide sequencing technologies and an increasing focus on the role of HCV genetic variation in disease and treatment outcomes.  The current study represents a major update to the previous consensus HCV classification, incorporating additional sequence information derived from over 1,300 (near-)complete genome sequences of HCV available on public databases in May 2013.  Analysis resolved several nomenclature conflicts between genotype designations and using consensus criteria created a classification of HCV into seven confirmed genotypes and 67 subtypes.  There are 21 additional complete coding region sequences of unassigned subtype.  The study additionally describes the development of a Web resource hosted by the International Committee for Taxonomy of Viruses (ICTV) that maintains and regularly updates tables of reference isolates, accession numbers, and annotated alignments (http://talk.ictvonline.org/links/hcv/hcv-classification.htm).  The Flaviviridae Study Group urges those who need to check or propose new genotypes or subtypes of HCV to contact the Study Group in advance of publication to avoid nomenclature conflicts appearing in the literature.  While the criteria for assigning genotypes and subtypes remain unchanged from previous consensus proposals, changes are proposed in the assignment of provisional subtypes, subtype numbering beyond "w," and the nomenclature of intergenotypic recombinant.  CONCLUSION:  This study represents an important reference point for the consensus classification of HCV variants that will be of value to researchers working in clinical and basic science fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgofAQo7eS9BWfpMXQLRstfW6udTcc2eYiupFT1MJVbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FktFWnsg%253D%253D&md5=b0bfea063822f132a1204a8973081876</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fhep.26744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26744%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DBukh%26aufirst%3DJ.%26aulast%3DKuiken%26aufirst%3DC.%26aulast%3DMuerhoff%26aufirst%3DA.%2BS.%26aulast%3DRice%26aufirst%3DC.%2BM.%26aulast%3DStapleton%26aufirst%3DJ.%2BT.%26aulast%3DSimmonds%26aufirst%3DP.%26atitle%3DExpanded%2520classification%2520of%2520hepatitis%2520C%2520virus%2520into%25207%2520genotypes%2520and%252067%2520subtypes%253A%2520updated%2520criteria%2520and%2520genotype%2520assignment%2520web%2520resource%26jtitle%3DHepatology%26date%3D2014%26volume%3D59%26spage%3D318%26epage%3D327%26doi%3D10.1002%2Fhep.26744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Scheel, T. K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span><span class="refDoi"> DOI: 10.1038/nm.3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2Fnm.3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=23836234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=837-849&author=T.+K.+H.+Scheelauthor=C.+M.+Rice&title=Understanding+the+hepatitis+C+virus+life+cycle+paves+the+way+for+highly+effective+therapies&doi=10.1038%2Fnm.3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span></div><div class="casAuthors">Scheel, Troels K. H.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">837-849</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  More than two decades of intense research has provided a detailed understanding of hepatitis C virus (HCV), which chronically infects 2% of the world's population.  This effort has paved the way for the development of antiviral compds. to spare patients from life-threatening liver disease.  An exciting new era in HCV therapy dawned with the recent approval of two viral protease inhibitors, used in combination with pegylated interferon-α and ribavirin; however, this is just the beginning.  Multiple classes of antivirals with distinct targets promise highly efficient combinations, and interferon-free regimens with short treatment duration and fewer side effects are the future of HCV therapy.  Ongoing and future trials will det. the best antiviral combinations and whether the current seemingly rich pipeline is sufficient for successful treatment of all patients in the face of major challenges, such as HCV diversity, viral resistance, the influence of host genetics, advanced liver disease and other co-morbidities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpde8altGxkeLVg90H21EOLACvtfcHk0lhf2r1w2qHu-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI&md5=dabc9fbc7dc0bc56115d5ede0d8ae072</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnm.3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3248%26sid%3Dliteratum%253Aachs%26aulast%3DScheel%26aufirst%3DT.%2BK.%2BH.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnderstanding%2520the%2520hepatitis%2520C%2520virus%2520life%2520cycle%2520paves%2520the%2520way%2520for%2520highly%2520effective%2520therapies%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D837%26epage%3D849%26doi%3D10.1038%2Fnm.3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penin, F.</span><span> </span><span class="NLM_article-title">The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1038/nrmicro3046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2Fnrmicro3046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=23748342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVamtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=482-496&author=R.+Bartenschlagerauthor=V.+Lohmannauthor=F.+Penin&title=The+molecular+and+structural+basis+of+advanced+antiviral+therapy+for+hepatitis+C+virus+infection&doi=10.1038%2Fnrmicro3046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection</span></div><div class="casAuthors">Bartenschlager, Ralf; Lohmann, Volker; Penin, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">482-496</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The availability of the first mol. clone of the hepatitis C virus (HCV) genome allowed the identification and biochem. characterization of two viral enzymes that are targets for antiviral therapy: the protease NS3-4A and the RNA-dependent RNA polymerase NS5B.  With the advent of cell culture systems that can recapitulate either the intracellular steps of the viral replication cycle or the complete cycle, addnl. drug targets have been identified, most notably the phosphoprotein NS5A, but also host cell factors that promote viral replication, such as cyclophilin A.  Here, we review insights into the structures of these proteins and the mechanisms by which they contribute to the HCV replication cycle, and discuss how these insights have facilitated the development of new, directly acting antiviral compds. that have started to enter the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_HJeAAUvvrVg90H21EOLACvtfcHk0lhf2r1w2qHu-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVamtbs%253D&md5=3be643822234ebc9e4773c78ec9f3ee5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3046%26sid%3Dliteratum%253Aachs%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DPenin%26aufirst%3DF.%26atitle%3DThe%2520molecular%2520and%2520structural%2520basis%2520of%2520advanced%2520antiviral%2520therapy%2520for%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2013%26volume%3D11%26spage%3D482%26epage%3D496%26doi%3D10.1038%2Fnrmicro3046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span>2015 Hepatitis C Online, <span class="NLM_publisher-name">University of Washington</span>; <a href="http://www.hepatitisc.uw.edu/page/treatment/drugs" class="extLink">http://www.hepatitisc.uw.edu/page/treatment/drugs</a> (accessed October 7,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2015+Hepatitis+C+Online%2C+University+of+Washington%3B+http%3A%2F%2Fwww.hepatitisc.uw.edu%2Fpage%2Ftreatment%2Fdrugs+%28accessed+October+7%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DUniversity%2520of%2520Washington%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Götte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feld, J. J.</span><span> </span><span class="NLM_article-title">Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1038/nrgastro.2016.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2Fnrgastro.2016.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=27147491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1artbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=338-351&author=M.+G%C3%B6tteauthor=J.+J.+Feld&title=Direct-acting+antiviral+agents+for+hepatitis+C%3A+structural+and+mechanistic+insights&doi=10.1038%2Fnrgastro.2016.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights</span></div><div class="casAuthors">Gotte, Matthias; Feld, Jordan J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Gastroenterology & Hepatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">338-351</span>CODEN:
                <span class="NLM_cas:coden">NRGHA9</span>;
        ISSN:<span class="NLM_cas:issn">1759-5045</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The treatment of HCV infection has evolved at an extremely rapid pace over the past few years.  The development of direct-acting antiviral agents, which potently inhibit different stages in the viral life cycle, has led to the replacement of interferon with well-tolerated oral therapies with cure rates of >90% in most patient populations.  Understanding the mechanisms of action of the various agents as well as related issues, including the mol. basis for resistance, helps to guide drug development and clin. use.  In this Review, we provide a mechanistic description of NS3/4A protease inhibitors, nucleotide and non-nucleotide inhibitors of the NS5B viral polymerase and inhibitors of the NS5A protein, followed by a summary of clin. data from studies of each drug class alone and in combination.  Remaining challenges in drug development efforts are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIGsNzAYth1LVg90H21EOLACvtfcHk0lhf2r1w2qHu-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1artbs%253D&md5=76c5779393707d1b993fe0146884d7ed</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2016.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2016.60%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DFeld%26aufirst%3DJ.%2BJ.%26atitle%3DDirect-acting%2520antiviral%2520agents%2520for%2520hepatitis%2520C%253A%2520structural%2520and%2520mechanistic%2520insights%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2016%26volume%3D13%26spage%3D338%26epage%3D351%26doi%3D10.1038%2Fnrgastro.2016.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing hepatitis C virus infection with direct-acting antiviral agents: The arc of a medicinal chemistry triumph</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7311</span><span class="NLM_x">–</span> <span class="NLM_lpage">7351</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00915</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12itr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7311-7351&author=N.+A.+Meanwell&title=2015+Philip+S.+Portoghese+Medicinal+Chemistry+Lectureship.+Curing+hepatitis+C+virus+infection+with+direct-acting+antiviral+agents%3A+The+arc+of+a+medicinal+chemistry+triumph&doi=10.1021%2Facs.jmedchem.6b00915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7311-7351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of direct-acting antiviral agents that can cure a chronic hepatitis C virus (HCV) infection after 8-12 wk of daily, well-tolerated therapy has revolutionized the treatment of this insidious disease.  In this article, three of Bristol-Myers Squibb's HCV programs are summarized, each of which produced a clin. candidate: the NS3 protease inhibitor asunaprevir (64), marketed as Sunvepra, the NS5A replication complex inhibitor daclatasvir (117), marketed as Daklinza, and the allosteric NS5B polymerase inhibitor beclabuvir (142), which is in late stage clin. studies.  A clin. study with 64 and 117 established for the first time that a chronic HCV infection could be cured by treatment with direct-acting antiviral agents alone in the absence of interferon.  The development of small mol. HCV therapeutics, designed by medicinal chemists, has been hailed as "the arc of a medical triumph" but may equally well be described as "the arc of a medicinal chem. triumph".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-IMg2ReRMArVg90H21EOLACvtfcHk0ljyArkuv8Ri3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12itr%252FO&md5=c8232aba85caf67bf38494bc5ddeb508</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00915%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3D2015%2520Philip%2520S.%2520Portoghese%2520Medicinal%2520Chemistry%2520Lectureship.%2520Curing%2520hepatitis%2520C%2520virus%2520infection%2520with%2520direct-acting%2520antiviral%2520agents%253A%2520The%2520arc%2520of%2520a%2520medicinal%2520chemistry%2520triumph%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7311%26epage%3D7351%26doi%3D10.1021%2Facs.jmedchem.6b00915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannarino, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span><span class="refDoi"> DOI: 10.1038/13305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2F13305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10504728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADyaK1MXmslCktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=937-943&author=C.+A.+Lesburgauthor=M.+B.+Cableauthor=E.+Ferrariauthor=Z.+Hongauthor=A.+F.+Mannarinoauthor=P.+C.+Weber&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+from+hepatitis+C+virus+reveals+a+fully+encircled+active+site&doi=10.1038%2F13305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span></div><div class="casAuthors">Lesburg, Charles A.; Cable, Michael B.; Ferrari, Eric; Hong, Zhi; Mannarino, Anthony F.; Weber, Patricia C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">937-943</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Various classes of nucleotidyl polymerases with different transcriptional roles contain a conserved core structure.  Less is known, however, about the distinguishing features of these enzymes, particularly those of the RNA-dependent RNA polymerase class.  The 1.9 Å resoln. crystal structure of hepatitis C virus (HCV) nonstructural protein 5B (NS5B) presented here provides the first complete and detailed view of an RNA-dependent RNA polymerase.  While canonical polymerase features exist in the structure, NS5B adopts a unique shape due to extensive interactions between the fingers and thumb polymerase subdomains that serve to encircle the enzyme active site.  Several insertions in the fingers subdomain account for intersubdomain linkages that include two extended loops and a pair of antiparallel α-helixes.  The HCV NS5B apoenzyme structure reported here can accommodate a template:primer duplex without global conformational changes, supporting the hypothesis that this structure is essentially preserved during the reaction pathway.  This NS5B template:primer model also allows identification of a new structural motif involved in stabilizing the nascent base pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnLsPABmT0XbVg90H21EOLACvtfcHk0ljyArkuv8Ri3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslCktLo%253D&md5=210fd9e96e7ca8d342ed1ae87f0b4acc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F13305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F13305%26sid%3Dliteratum%253Aachs%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DCable%26aufirst%3DM.%2BB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DMannarino%26aufirst%3DA.%2BF.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520hepatitis%2520C%2520virus%2520reveals%2520a%2520fully%2520encircled%2520active%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D937%26epage%3D943%26doi%3D10.1038%2F13305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsunami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span><span class="refDoi"> DOI: 10.1016/S0969-2126(00)80031-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2FS0969-2126%2800%2980031-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10574802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1417-1426&author=H.+Agoauthor=T.+Adachiauthor=A.+Yoshidaauthor=M.+Yamamotoauthor=N.+Habukaauthor=K.+Yatsunamiauthor=M.+Miyano&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus&doi=10.1016%2FS0969-2126%2800%2980031-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Ago, Hideo; Adachi, Tsuyoshi; Yoshida, Atsuhito; Yamamoto, Masaki; Habuka, Noriyuki; Yatsunami, Kimio; Miyano, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1417-1426</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is the major etiol. agent of hepatocellular carcinoma, and HCV RNA-dependent RNA polymerase (RNA replicase) (I) is one of the main potential targets for anti-HCV agents.  HCV I performs run-off copying replication in an RNA-selective manner for the template-primer duplex and the substrate, but the structural basis of this reaction mechanism has still to be elucidated.  Here, the 3-dimensional structure of HCV I was detd. by x-ray crystallog. at 2.5 Å resoln.  The compact HCV I structure resembled a right hand, but had more complicated fingers and thumb domains than those of the other known polymerases, with a novel α-helix-rich subdomain (α fingers) as an addn. to the fingers domain.  The other fingers subdomain (β fingers) was folded in the same manner as the fingers domain of HIV virus reverse transcriptase, another RNA-dependent polymerase.  The ribose-recognition site of HCV I was constructed of hydrophilic residues, unlike those of DNA polymerases.  The C-terminal region of HCV I occupied the putative RNA-duplex-binding cleft.  The structural basis of the RNA selectivity of HCV I was elucidated from its crystal structure.  The putative substrate-binding site with a shallow hydrophilic cavity should have ribonucleoside triphosphate as the preferred substrate.  The authors propose that the unique α fingers might represent a common structural discriminator of the template-primer duplex that distinguishes between RNA and DNA during the replication of pos. single-stranded RNA by viral I enzymes.  The C-terminal region might exert a regulatory function on the initiation and activity of HCV I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKp1aOmXjMKLVg90H21EOLACvtfcHk0ljyArkuv8Ri3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D&md5=95fcc20ce2f28dab4d76d8dfac0aa4ee</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2800%2980031-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252800%252980031-3%26sid%3Dliteratum%253Aachs%26aulast%3DAgo%26aufirst%3DH.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DYatsunami%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D1417%26epage%3D1426%26doi%3D10.1016%2FS0969-2126%2800%2980031-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bressanelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incitti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, F. A.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">13034</span><span class="NLM_x">–</span> <span class="NLM_lpage">13039</span><span class="refDoi"> DOI: 10.1073/pnas.96.23.13034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1073%2Fpnas.96.23.13034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10557268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13034-13039&author=S.+Bressanelliauthor=L.+Tomeiauthor=A.+Rousselauthor=I.+Incittiauthor=R.+L.+Vitaleauthor=M.+Mathieuauthor=R.+De+Francescoauthor=F.+A.+Rey&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus&doi=10.1073%2Fpnas.96.23.13034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Bressanelli, Stephane; Tomei, Licia; Roussel, Alain; Incitti, Ilario; Vitale, Rosa Letizia; Mathieu, Magali; De Francesco, Raffaele; Rey, Felix A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13034-13039</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The crystal structure of the RNA-dependent RNA polymerase (RNA replicase) (I) of hepatitis C virus, a major human pathogen, is reported to 2.8 Å resoln.  I is a key target for developing specific antiviral therapy.  The structure of the catalytic domain contained 531 residues folded in the characteristic fingers, palm, and thumb subdomains.  The fingers subdomain contained a region, the "fingertips," that shared the same fold with reverse transcriptases.  Superposition to the available structures of the latter showed that residues from the palm and fingertips were structurally equiv.  In addn., it showed that hepatitis C virus I was crystd. in a closed fingers conformation, similar to HIV-1 reverse transcriptase in ternary complex with DNA and dTTP.  This superposition revealed the majority of the amino acid residues of the hepatitis C virus enzyme that are likely to be implicated in binding to the replicating RNA mol. and to the incoming NTP.  It also suggested a rearrangement of the thumb domain as well as a possible concerted movement of thumb and fingertips during translocation of the RNA template-primer in successive polymn. rounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMMlZvielKLVg90H21EOLACvtfcHk0lhOUnz7hMjxOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D&md5=2ba97997c8a8e24c0db560260fb5ea9a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.23.13034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.23.13034%26sid%3Dliteratum%253Aachs%26aulast%3DBressanelli%26aufirst%3DS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DRoussel%26aufirst%3DA.%26aulast%3DIncitti%26aufirst%3DI.%26aulast%3DVitale%26aufirst%3DR.%2BL.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRey%26aufirst%3DF.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D13034%26epage%3D13039%26doi%3D10.1073%2Fpnas.96.23.13034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span> </span><span class="NLM_article-title">Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2481</span><span class="NLM_x">–</span> <span class="NLM_lpage">2531</span><span class="refDoi"> DOI: 10.1021/jm201384j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201384j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1aqu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2481-2531&author=M.+J.+Sofiaauthor=W.+Changauthor=P.+A.+Furmanauthor=R.+T.+Mosleyauthor=B.+S.+Ross&title=Nucleoside%2C+nucleotide%2C+and+non-nucleoside+inhibitors+of+hepatitis+C+virus+NS5B+RNA-dependent+RNA-polymerase&doi=10.1021%2Fjm201384j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase</span></div><div class="casAuthors">Sofia, Michael J.; Chang, Wonsuk; Furman, Phillip A.; Mosley, Ralph T.; Ross, Bruce S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2481-2531</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This is a Perspectives review and does not require an abstr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWh0maPUC6grVg90H21EOLACvtfcHk0lhOUnz7hMjxOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1aqu7rF&md5=3236ff10d16104b1a39d77f04774ac77</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm201384j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201384j%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26atitle%3DNucleoside%252C%2520nucleotide%252C%2520and%2520non-nucleoside%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA-polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2481%26epage%3D2531%26doi%3D10.1021%2Fjm201384j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV Polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+Polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520Polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Beaulieu, P.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the HCV NS5B polymerase: Progress in the discovery and development of novel agents for the treatment of HCV infections</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=17668364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+Beaulieu&title=Non-nucleoside+inhibitors+of+the+HCV+NS5B+polymerase%3A+Progress+in+the+discovery+and+development+of+novel+agents+for+the+treatment+of+HCV+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">614-634</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The severe health conditions assocd. with chronic HCV infection remain a global concern.  Small-mol. drugs that specifically target essential virally encoded enzymes have not yet progressed to market, and the current std. of care continues to rely on a combination of pegylated IFN with ribavirin.  This therapy has serious side effects and a significant proportion of patients infected with HCV genotype 1 (the major genotype in industrialized countries) have an unsatisfactory outcome with this therapy.  Major advances have been realized in the development of specific non-nucleoside inhibitors of the viral NS5B RNA-dependent RNA polymerase.  This well-characterized replicative enzyme is a highly drugable target that, in addn. to its active site, features at least three known allosteric binding pockets that regulate RNA synthesis and are suitable for inhibitor design.  Clin. proof-of-concept for allosteric non-nucleoside HCV polymerase inhibitors has been reported and several compds. have progressed into preclin. studies.  It is likely that in the future NS5B inhibitors will form an integral part of more effective anti-HCV therapies, combining the use of small-mol. antiviral drugs with or without the assistance of immune modulators such as IFNs in order to minimize the emergence of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTl5U1TLVJ57Vg90H21EOLACvtfcHk0lhOUnz7hMjxOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK&md5=347a7983497b1b50bba61a455783f302</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520Progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520agents%2520for%2520the%2520treatment%2520of%2520HCV%2520infections%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span> </span><span class="NLM_article-title">HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span><span class="refDoi"> DOI: 10.1002/hep.22717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1002%2Fhep.22717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=19072827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=745-752&author=N.+M.+Knetemanauthor=A.+Y.+M.+Howeauthor=T.+Gaoauthor=J.+Lewisauthor=D.+Pevearauthor=G.+Lundauthor=D.+Douglasauthor=D.+F.+Mercerauthor=D.+L.+J.+Tyrrellauthor=F.+Immermannauthor=I.+Chaudharyauthor=J.+Spethauthor=S.+A.+Villanoauthor=J.+O%E2%80%99Connellauthor=M.+Collett&title=HCV796%3A+A+selective+nonstructural+protein+5B+polymerase+inhibitor+with+potent+anti-hepatitis+C+virus+activity+in+vitro%2C+in+mice+with+chimeric+human+livers%2C+and+in+humans+infected+with+hepatitis+C+virus&doi=10.1002%2Fhep.22717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">HCCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span></div><div class="casAuthors">Kneteman, Norman M.; Howe, Anita Y. M.; Gao, Tiejun; Lewis, Jamie; Pevear, Dan; Lund, Gary; Douglas, Donna; Mercer, David F.; Tyrrell, D. Lorne J.; Immermann, Frederick; Chaudhary, Inder; Speth, John; Villano, Stephen A.; O'Connell, John; Collett, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clin. study.  This manuscript outlines activity and correlation across such a spectrum of models and into clin. trials with a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, HCV796.  Enzyme assays yielded median inhibitory concn. (IC50) values of 0.01 to 0.14 μM for genotype 1, with half maximal effective concn. (EC50s) of 5 nM and 9 nM against genotype 1a and 1b replicons.  In the chimeric mouse model, a 2.02 ± 0.55 log redn. in HCV titer was seen with monotherapy, whereas a suboptimal dose of 30 mg/kg three times per day in combination with interferon demonstrated a 2.44 log redn. (P = 0.001 vs. interferon alone) Clin. outcomes in combination with pegylated interferon and ribavirin have revealed additive efficacy in treatment naive patients.  Abnormal liver function test results were obsd. in 8% of HCV-796 patients treated for over 8 wk, resulting in suspension of further trial activity.  Conclusion: The RNA-dependent RNA polymerase inhibitor HCV796 demonstrated potent anti-HCV activity consistently through enzyme inhibition assays, subgenomic replicon, and chimeric mouse studies.  Strong correlations of outcomes in the mouse model were seen with subsequent clin. trials, including a plateau in dose-related antiviral activity and additive impact from combination therapy with interferon.  These outcomes demonstrate the utility of the range of in vitro and in vivo models now available for anti-HCV drug development and support the potential utility of polymerase inhibitors in future combination therapies for HCV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ZCtNeI0RLLVg90H21EOLACvtfcHk0liCC-Gf9YKuzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D&md5=0dcebc9c1e93051ad46eae43b352e7cf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fhep.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22717%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DHowe%26aufirst%3DA.%2BY.%2BM.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DMercer%26aufirst%3DD.%2BF.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%2BJ.%26aulast%3DImmermann%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DSpeth%26aufirst%3DJ.%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26atitle%3DHCV796%253A%2520A%2520selective%2520nonstructural%2520protein%25205B%2520polymerase%2520inhibitor%2520with%2520potent%2520anti-hepatitis%2520C%2520virus%2520activity%2520in%2520vitro%252C%2520in%2520mice%2520with%2520chimeric%2520human%2520livers%252C%2520and%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D745%26epage%3D752%26doi%3D10.1002%2Fhep.22717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Maynard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koble, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leivers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leivers, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouliot, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thommes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voitenleitner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waitt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shotwell, J. B.</span><span> </span><span class="NLM_article-title">Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1902</span><span class="NLM_x">–</span> <span class="NLM_lpage">1913</span><span class="refDoi"> DOI: 10.1021/jm400317w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400317w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1902-1913&author=A.+Maynardauthor=R.+M.+Crosbyauthor=B.+Ellisauthor=R.+Hamatakeauthor=Z.+Hongauthor=B.+A.+Johnsauthor=K.+M.+Kahlerauthor=C.+Kobleauthor=A.+Leiversauthor=M.+R.+Leiversauthor=A.+Mathisauthor=A.+J.+Peatauthor=J.+J.+Pouliotauthor=C.+D.+Robertsauthor=V.+Samanoauthor=R.+M.+Schmidtauthor=G.+K.+Smithauthor=A.+Spaltensteinauthor=E.+L.+Stewartauthor=P.+Thommesauthor=E.+M.+Turnerauthor=C.+Voitenleitnerauthor=J.+T.+Walkerauthor=G.+Waittauthor=J.+Weatherheadauthor=K.+Weaverauthor=S.+Williamsauthor=L.+Wrightauthor=Z.+Z.+Xiongauthor=D.+Haighauthor=J.+B.+Shotwell&title=Discovery+of+a+potent+boronic+acid+derived+inhibitor+of+the+HCV+RNA-dependent+RNA+polymerase&doi=10.1021%2Fjm400317w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400317w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400317w%26sid%3Dliteratum%253Aachs%26aulast%3DMaynard%26aufirst%3DA.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DKoble%26aufirst%3DC.%26aulast%3DLeivers%26aufirst%3DA.%26aulast%3DLeivers%26aufirst%3DM.%2BR.%26aulast%3DMathis%26aufirst%3DA.%26aulast%3DPeat%26aufirst%3DA.%2BJ.%26aulast%3DPouliot%26aufirst%3DJ.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BD.%26aulast%3DSamano%26aufirst%3DV.%26aulast%3DSchmidt%26aufirst%3DR.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DThommes%26aufirst%3DP.%26aulast%3DTurner%26aufirst%3DE.%2BM.%26aulast%3DVoitenleitner%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DJ.%2BT.%26aulast%3DWaitt%26aufirst%3DG.%26aulast%3DWeatherhead%26aufirst%3DJ.%26aulast%3DWeaver%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DXiong%26aufirst%3DZ.%2BZ.%26aulast%3DHaigh%26aufirst%3DD.%26aulast%3DShotwell%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520boronic%2520acid%2520derived%2520inhibitor%2520of%2520the%2520HCV%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1902%26epage%3D1913%26doi%3D10.1021%2Fjm400317w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McComas, C. C.; Liverton, N. J.; Habermann, J.; Koch, U.; Narjes, F.; Li, P.; Peng, X.; Soll, R.; Wu, H.; Palani, A.; He, S.; Dai, X.; Liu, H.; Lai, Z.; London, C.; Xiao, D.; Zorn, N.; Nargund, R.</span><span> </span><span class="NLM_article-title">Preparation of pyridooxazinoindole derivatives and analogs for use as antiviral agents</span>. World Patent Application WO 2013/033971 A1, March 14,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+C.+McComas&author=N.+J.+Liverton&author=J.+Habermann&author=U.+Koch&author=F.+Narjes&author=P.+Li&author=X.+Peng&author=R.+Soll&author=H.+Wu&author=A.+Palani&author=S.+He&author=X.+Dai&author=H.+Liu&author=Z.+Lai&author=C.+London&author=D.+Xiao&author=N.+Zorn&author=R.+Nargund&title=Preparation+of+pyridooxazinoindole+derivatives+and+analogs+for+use+as+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26atitle%3DPreparation%2520of%2520pyridooxazinoindole%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520antiviral%2520agents%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McComas, C. C.; Liverton, N. J.; Habermann, J.; Koch, U.; Narjes, F.; Li, P.; Peng, X.; Soll, R.; Wu, H.</span><span> </span><span class="NLM_article-title">Preparation of tetracyclic heterocycle compounds for the treatment of HCV infection</span>. World Patent Application WO 2013/033900 A1, March 14,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+C.+McComas&author=N.+J.+Liverton&author=J.+Habermann&author=U.+Koch&author=F.+Narjes&author=P.+Li&author=X.+Peng&author=R.+Soll&author=H.+Wu&title=Preparation+of+tetracyclic+heterocycle+compounds+for+the+treatment+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26atitle%3DPreparation%2520of%2520tetracyclic%2520heterocycle%2520compounds%2520for%2520the%2520treatment%2520of%2520HCV%2520infection%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">A class of analogues of benzofuran <b>1</b> with extension from the 2-(4-fluorophenyl) substituent can be found in</p></div><span class="NLM_contrib-group">Labadie, S. S.; Lin, C. J. J.; Talamas, F. X.; Weikert, R. J.</span><span> </span><span class="NLM_article-title">Heterocyclic antiviral compounds</span>. World Patent Application WO 2009/101022 Al, August 20,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+S.+Labadie&author=C.+J.+J.+Lin&author=F.+X.+Talamas&author=R.+J.+Weikert&title=Heterocyclic+antiviral+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLabadie%26aufirst%3DS.%2BS.%26atitle%3DHeterocyclic%2520antiviral%2520compounds%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Parcella, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2016.11.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=295-298&author=K.+Parcellaauthor=A.+Nickelauthor=B.+R.+Benoauthor=S.+Sheriffauthor=C.+Wanauthor=Y.-K.+Wangauthor=S.+B.+Robertsauthor=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Discovery+and+initial+optimization+of+alkoxyanthranilic+acid+derivatives+as+inhibitors+of+HCV+NS5B+polymerase&doi=10.1016%2Fj.bmcl.2016.11.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.054%26sid%3Dliteratum%253Aachs%26aulast%3DParcella%26aufirst%3DK.%26aulast%3DNickel%26aufirst%3DA.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520and%2520initial%2520optimization%2520of%2520alkoxyanthranilic%2520acid%2520derivatives%2520as%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D295%26epage%3D298%26doi%3D10.1016%2Fj.bmcl.2016.11.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Burns, C. J.; Del Vecchio, A. M.; Bailey, T. R.; Kulkarni, B. A.; Faitg, T. H.; Sherk, S. R.; BlackLedge, C. W.; Rys, D. J.; Lessen, T. A.; Swestock, J.; Deng, Y.; Nitz, T. J.; Reinhardt, J. A.; Feng, H.; Saha, A. K.</span><span> </span><span class="NLM_article-title">Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases</span>. World Patent Application WO 2004/041201 A2, May 21,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+J.+Burns&author=A.+M.+Del+Vecchio&author=T.+R.+Bailey&author=B.+A.+Kulkarni&author=T.+H.+Faitg&author=S.+R.+Sherk&author=C.+W.+BlackLedge&author=D.+J.+Rys&author=T.+A.+Lessen&author=J.+Swestock&author=Y.+Deng&author=T.+J.+Nitz&author=J.+A.+Reinhardt&author=H.+Feng&author=A.+K.+Saha&title=Benzofuran+compounds%2C+compositions+and+methods+for+treatment+and+prophylaxis+of+hepatitis+C+viral+infections+and+associated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBenzofuran%2520compounds%252C%2520compositions%2520and%2520methods%2520for%2520treatment%2520and%2520prophylaxis%2520of%2520hepatitis%2520C%2520viral%2520infections%2520and%2520associated%2520diseases%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Shaw, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin-Goerke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarisky, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiggall, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, M. N.</span><span> </span><span class="NLM_article-title">Substituted benzothiadizine inhibitors of hepatitis C virus polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4350</span><span class="NLM_x">–</span> <span class="NLM_lpage">4353</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2009.05.091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4350-4353&author=A.+N.+Shawauthor=R.+Tedescoauthor=R.+Bambalauthor=D.+Chaiauthor=N.+O.+Conchaauthor=M.+G.+Darcyauthor=D.+Dhanakauthor=K.+J.+Duffyauthor=D.+M.+Fitchauthor=A.+Gatesauthor=V.+K.+Johnstonauthor=R.+M.+Keenanauthor=J.+Lin-Goerkeauthor=N.+Liuauthor=R.+T.+Sariskyauthor=K.+J.+Wiggallauthor=M.+N.+Zimmerman&title=Substituted+benzothiadizine+inhibitors+of+hepatitis+C+virus+polymerase&doi=10.1016%2Fj.bmcl.2009.05.091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.091%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BN.%26aulast%3DTedesco%26aufirst%3DR.%26aulast%3DBambal%26aufirst%3DR.%26aulast%3DChai%26aufirst%3DD.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26aulast%3DFitch%26aufirst%3DD.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DJohnston%26aufirst%3DV.%2BK.%26aulast%3DKeenan%26aufirst%3DR.%2BM.%26aulast%3DLin-Goerke%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DSarisky%26aufirst%3DR.%2BT.%26aulast%3DWiggall%26aufirst%3DK.%2BJ.%26aulast%3DZimmerman%26aufirst%3DM.%2BN.%26atitle%3DSubstituted%2520benzothiadizine%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4350%26epage%3D4353%26doi%3D10.1016%2Fj.bmcl.2009.05.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Howe, A. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span> </span><span class="NLM_article-title">Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3327</span><span class="NLM_x">–</span> <span class="NLM_lpage">3338</span><span class="refDoi"> DOI: 10.1128/AAC.00238-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1128%2FAAC.00238-08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3327-3338&author=A.+Y.+M.+Howeauthor=H.+Chengauthor=S.+Johannauthor=S.+Mullenauthor=S.+K.+Chunduruauthor=D.+C.+Youngauthor=J.+Bardauthor=R.+Chopraauthor=G.+Krishnamurthyauthor=T.+Mansourauthor=J.+O%E2%80%99Connell&title=Molecular+mechanism+of+hepatitis+C+virus+replicon+variants+with+reduced+susceptibility+to+a+benzofuran+inhibitor%2C+HCV-796&doi=10.1128%2FAAC.00238-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FAAC.00238-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00238-08%26sid%3Dliteratum%253Aachs%26aulast%3DHowe%26aufirst%3DA.%2BY.%2BM.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DJohann%26aufirst%3DS.%26aulast%3DMullen%26aufirst%3DS.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DYoung%26aufirst%3DD.%2BC.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanism%2520of%2520hepatitis%2520C%2520virus%2520replicon%2520variants%2520with%2520reduced%2520susceptibility%2520to%2520a%2520benzofuran%2520inhibitor%252C%2520HCV-796%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3327%26epage%3D3338%26doi%3D10.1128%2FAAC.00238-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span> </span><span class="NLM_article-title">Recent developments in fragment-based drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3661</span><span class="NLM_x">–</span> <span class="NLM_lpage">3680</span><span class="refDoi"> DOI: 10.1021/jm8000373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8000373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotFKisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3661-3680&author=M.+Congreveauthor=G.+Chessariauthor=D.+Tisiauthor=A.+J.+Woodhead&title=Recent+developments+in+fragment-based+drug+discovery&doi=10.1021%2Fjm8000373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in fragment-based drug discovery</span></div><div class="casAuthors">Congreve, Miles; Chessari, Gianni; Tisi, Dominic; Woodhead, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3661-3680</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of fragment-based drug discovery (FBDD) has developed significantly over the past 10 years and is now recognized as a tangible alternative to more traditional methods of hit identification, such as high throughput screening (HTS).  The authors discuss trends and developments of FBDD over the past 4 years.  Addnl., this review looks in some detail at representative protein-ligand complexes obsd. between fragment-sized mols. and their protein targets from the Protein Data Bank (PDB).  More than the underlying technol. itself, the legacy of FBDD will be conceptual and that "less is more"; breaking down the problem of finding a drug mol. into its smallest component parts opens up new opportunities to solve challenging problems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_YtOS7_glD7Vg90H21EOLACvtfcHk0lgCB1uc94WFeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotFKisLg%253D&md5=41dbcf884305a190bffc683ae5ed9e45</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm8000373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8000373%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520developments%2520in%2520fragment-based%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3661%26epage%3D3680%26doi%3D10.1021%2Fjm8000373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ebHDQtQGL39e7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keserü, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keser%C3%BCauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lh2ViakpgfZLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span><span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0lh2ViakpgfZLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">A synopsis of the properties and applications of heteroaromatic rings in medicinal chemistry</span> <span class="citation_source-journal">Adv. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1016/bs.aihch.2016.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fbs.aihch.2016.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1yiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2017&pages=245-361&author=N.+A.+Meanwell&title=A+synopsis+of+the+properties+and+applications+of+heteroaromatic+rings+in+medicinal+chemistry&doi=10.1016%2Fbs.aihch.2016.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A synopsis of the properties and applications of heteroaromatic rings in medicinal chemistry</span></div><div class="casAuthors">Meanwell, N. A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245-361</span>CODEN:
                <span class="NLM_cas:coden">AHTCAG</span>;
        ISSN:<span class="NLM_cas:issn">0065-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Five- and six-membered heteroarom. rings and their benzo-fused homologues are well established as important structural elements in drug design and are well represented in approved drugs.  The key properties of these heterocycles that are of interest to medicinal chemists Include lipophilicity, pKa, aromaticity, ionization potential, H-bond acceptor, and H-bond donor (N-H, 0-H, C-H) capability, electron withdrawing effects, dipole values, and bond angles.  The judicious and productive application of azoles and azines in drug design requires an understanding of the intrinsic phys. chem. properties of the individual heterocycles and how these interact with substituents.  In this article. the key properties of azole and azine heterocycles are summarized followed by a synopsis of applications where some of these factors play a role in drug-target interactions and/or potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqctUtT-Yo4X7Vg90H21EOLACvtfcHk0lh2ViakpgfZLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1yiu7k%253D&md5=5ba7462bcd75ed022f4ea6b800ccef9d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fbs.aihch.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.aihch.2016.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DA%2520synopsis%2520of%2520the%2520properties%2520and%2520applications%2520of%2520heteroaromatic%2520rings%2520in%2520medicinal%2520chemistry%26jtitle%3DAdv.%2520Heterocycl.%2520Chem.%26date%3D2017%26volume%3D123%26spage%3D245%26epage%3D361%26doi%3D10.1016%2Fbs.aihch.2016.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Laurence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Questel, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, E.</span><span> </span><span class="NLM_article-title">The pK<sub>BHX</sub> Database: Toward a better understanding of hydrogen-bond basicity for medicinal chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4073</span><span class="NLM_x">–</span> <span class="NLM_lpage">4086</span><span class="refDoi"> DOI: 10.1021/jm801331y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801331y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4073-4086&author=C.+Laurenceauthor=K.+A.+Brameldauthor=J.+Gratonauthor=J.-Y.+Le+Questelauthor=E.+Renault&title=The+pKBHX+Database%3A+Toward+a+better+understanding+of+hydrogen-bond+basicity+for+medicinal+chemists&doi=10.1021%2Fjm801331y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists</span></div><div class="casAuthors">Laurence, Christian; Brameld, Ken A.; Graton, Jerome; Le Questel, Jean-Yves; Renault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4073-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pKBHX database is presented, which corresponds to three main fields of data: hydrogen bond donor identification, thermodn. data and spectroscopic data.  The pKBHX scale of hydrogen donor basicity differs considerable from the pKBH+ scale of proton transfer basicity.  The hydrogen bond basicities of functional groups relevant to medicinal chem. and drug design is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9OhmMu2VILVg90H21EOLACvtfcHk0li9Qws3o3t_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D&md5=9ce4bea3e810752baba6ea5784b55ea0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm801331y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801331y%26sid%3Dliteratum%253Aachs%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DGraton%26aufirst%3DJ.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.-Y.%26aulast%3DRenault%26aufirst%3DE.%26atitle%3DThe%2520pKBHX%2520Database%253A%2520Toward%2520a%2520better%2520understanding%2520of%2520hydrogen-bond%2520basicity%2520for%2520medicinal%2520chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4073%26epage%3D4086%26doi%3D10.1021%2Fjm801331y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">cLog<i>P</i> and p<i>K</i><sub>a</sub> were calculated by using the molecular property calculator JChem-15.9.7.0 from ChemAxon.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao-Ieong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannetti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talamas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span> </span><span class="NLM_article-title">Slow binding inhibition and mechanism of resistance of nonnucleoside polymerase inhibitors of hepatitis C virus</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">15517</span><span class="NLM_x">–</span> <span class="NLM_lpage">15529</span><span class="refDoi"> DOI: 10.1074/jbc.M808889200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1074%2Fjbc.M808889200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=15517-15529&author=J.+Q.+Hangauthor=Y.+Yangauthor=S.+F.+Harrisauthor=V.+Levequeauthor=H.+J.+Whittingtonauthor=S.+Rajyaguruauthor=G.+Ao-Ieongauthor=M.+F.+McCownauthor=A.+Wongauthor=A.+M.+Giannettiauthor=S.+Le+Pogamauthor=F.+Talamasauthor=N.+Cammackauthor=I.+Najeraauthor=K.+Klumpp&title=Slow+binding+inhibition+and+mechanism+of+resistance+of+nonnucleoside+polymerase+inhibitors+of+hepatitis+C+virus&doi=10.1074%2Fjbc.M808889200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M808889200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M808889200%26sid%3Dliteratum%253Aachs%26aulast%3DHang%26aufirst%3DJ.%2BQ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DWhittington%26aufirst%3DH.%2BJ.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DAo-Ieong%26aufirst%3DG.%26aulast%3DMcCown%26aufirst%3DM.%2BF.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DTalamas%26aufirst%3DF.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26atitle%3DSlow%2520binding%2520inhibition%2520and%2520mechanism%2520of%2520resistance%2520of%2520nonnucleoside%2520polymerase%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D15517%26epage%3D15529%26doi%3D10.1074%2Fjbc.M808889200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hehre, W. J.; Radom, L.; Schleyer, P. v. R.; Pople, J. A.</span> <span class="citation_source-book">Ab Initio Molecular Orbital Theory</span>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">, </span>and references cited therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&author=W.+J.+Hehre&author=L.+Radom&author=P.+v.+R.+Schleyer&author=J.+A.+Pople&title=Ab+Initio+Molecular+Orbital+Theory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHehre%26aufirst%3DW.%2BJ.%26btitle%3DAb%2520Initio%2520Molecular%2520Orbital%2520Theory%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Qiao, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span> </span><span class="NLM_article-title">Achieving structural diversity using the perpendicular conformation of <i>alpha</i>-substituted phenylcyclopropanes to mimic the bioactive conformation of <i>ortho</i>-substituted biphenyl P4 moieties: Discovery of novel, highly potent inhibitors of Factor Xa</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4118</span><span class="NLM_x">–</span> <span class="NLM_lpage">4123</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.05.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2008.05.095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=18550370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslequ7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4118-4123&author=J.+X.+Qiaoauthor=D.+L.+Cheneyauthor=R.+S.+Alexanderauthor=A.+M.+Smallwoodauthor=S.+R.+Kingauthor=K.+Heauthor=A.+R.+Rendinaauthor=J.+M.+Luettgenauthor=R.+M.+Knabbauthor=R.+R.+Wexlerauthor=P.+Y.+S.+Lam&title=Achieving+structural+diversity+using+the+perpendicular+conformation+of+alpha-substituted+phenylcyclopropanes+to+mimic+the+bioactive+conformation+of+ortho-substituted+biphenyl+P4+moieties%3A+Discovery+of+novel%2C+highly+potent+inhibitors+of+Factor+Xa&doi=10.1016%2Fj.bmcl.2008.05.095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: Discovery of novel, highly potent inhibitors of Factor Xa</span></div><div class="casAuthors">Qiao, Jennifer X.; Cheney, Daniel L.; Alexander, Richard S.; Smallwood, Angela M.; King, Sarah R.; He, Kan; Rendina, Alan R.; Luettgen, Joseph M.; Knabb, Robert M.; Wexler, Ruth R.; Lam, Patrick Y. S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4118-4123</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ortho-substituted biphenyl moieties are widely used in drug design.  We herein report a successful use of the perpendicular conformation of the alpha-substituted phenylcyclopropyl groups to mimic the aplanar, biol. active conformation of the ortho-substituted biphenyl moieties to achieve structural diversity.  This is exemplified by the design and synthesis of a series of highly potent pyrazole bicyclic-based Factor Xa (FXa) inhibitors bearing alpha-substituted phenylcyclopropyl P4 moieties.  The designed perpendicular conformation was confirmed by the X-ray structure of FXa-bound compd. I.  The potential structural basis for the high FXa potency in the phenylcyclopropyl P4 analogs and their improved FXa inhibitory activities compared with the biphenyl P4 counterparts are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2wNc7asx8bVg90H21EOLACvtfcHk0li9Qws3o3t_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslequ7o%253D&md5=4c06af32c061accffbed26a39031108e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.095%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DJ.%2BX.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DKing%26aufirst%3DS.%2BR.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26atitle%3DAchieving%2520structural%2520diversity%2520using%2520the%2520perpendicular%2520conformation%2520of%2520alpha-substituted%2520phenylcyclopropanes%2520to%2520mimic%2520the%2520bioactive%2520conformation%2520of%2520ortho-substituted%2520biphenyl%2520P4%2520moieties%253A%2520Discovery%2520of%2520novel%252C%2520highly%2520potent%2520inhibitors%2520of%2520Factor%2520Xa%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4118%26epage%3D4123%26doi%3D10.1016%2Fj.bmcl.2008.05.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span> </span><span class="NLM_article-title">Heterocyclic replacements for benzene: Maximising ADME benefits by considering individual ring isomers</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.ejmech.2016.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=27783976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKgu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=1057-1068&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonald&title=Heterocyclic+replacements+for+benzene%3A+Maximising+ADME+benefits+by+considering+individual+ring+isomers&doi=10.1016%2Fj.ejmech.2016.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic replacements for benzene: Maximizing ADME benefits by considering individual ring isomers</span></div><div class="casAuthors">Ritchie, Timothy J.; Macdonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1057-1068</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The impact of replacing a monosubstituted benzene (phenyl) ring with thirty three arom. and nine aliph. heterocycles on nine ADME-related screens (soly., lipophilicity, permeability, protein binding CYP450 inhibition and metabolic clearance) was assessed using matched mol. pair anal.  The results indicate that the influence on the ADME profile can differ significantly depending on the ring identity and importantly on the individual regioisomers that are possible for some rings.  This information enables the medicinal chemist to make an informed choice about which rings and regioisomers to employ as monosubstituted benzene replacements, based upon the knowledge of how such replacements are likely to influence ADME-related parameters, for example to target higher soly. while avoiding CYP450 liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWSOM3yUz8kbVg90H21EOLACvtfcHk0liSYlrouX6qBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKgu7bP&md5=127e1316b7bff0db030226548f96045c</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DHeterocyclic%2520replacements%2520for%2520benzene%253A%2520Maximising%2520ADME%2520benefits%2520by%2520considering%2520individual%2520ring%2520isomers%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D1057%26epage%3D1068%26doi%3D10.1016%2Fj.ejmech.2016.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gleeson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D.</span><span> </span><span class="NLM_article-title">ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5906</span><span class="NLM_x">–</span> <span class="NLM_lpage">5919</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmc.2009.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=19632124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Crs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=5906-5919&author=P.+Gleesonauthor=G.+Braviauthor=S.+Modiauthor=D.+Lowe&title=ADMET+rules+of+thumb+II%3A+A+comparison+of+the+effects+of+common+substituents+on+a+range+of+ADMET+parameters&doi=10.1016%2Fj.bmc.2009.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters</span></div><div class="casAuthors">Gleeson, Paul; Bravi, Gianpaolo; Modi, Sandeep; Lowe, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5906-5919</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A systematic anal. of data generated in key in vitro assays within GSK has been undertaken to identify what impact a range of common substituents have on a range of ADMET parameters.  These include; P 450 1A2, 2C9, 2C19, 2D6 and 3A4 inhibition, hERG inhibition, phosphate buffer soly. and artificial membrane permeability.  We do this by identifying all matched mol. pairs, differing by the replacement of a hydrogen atom with a list of predefined substituents.  For each substituent we calc. the mean difference in the ADMET parameter for all the matched mol. pairs identified, making a statistical assessment of the difference, as well as assessing the diversity for each example to ensure that the results can be generalized.  We also relate the change in activity obsd. for each substituent to differences in their mol. properties in an effort to identify any structural alerts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk7HA_bqdilrVg90H21EOLACvtfcHk0liSYlrouX6qBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Crs7o%253D&md5=fce672cbaadb66c4d7212aa1b92bd7d2</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DP.%26aulast%3DBravi%26aufirst%3DG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DLowe%26aufirst%3DD.%26atitle%3DADMET%2520rules%2520of%2520thumb%2520II%253A%2520A%2520comparison%2520of%2520the%2520effects%2520of%2520common%2520substituents%2520on%2520a%2520range%2520of%2520ADMET%2520parameters%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D5906%26epage%3D5919%26doi%3D10.1016%2Fj.bmc.2009.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Yeung, K.-S.; Parcella, K. E.; Bender, J. A.; Beno, B. R.; Grant-Young, K. A.; Han, Y.; Hewawasam, P.; Kadow, J. F.; Nickel, A.</span><span> </span><span class="NLM_article-title">Compounds for the treatment of hepatitis C</span>. World Patent Application WO 2010/030592 A1, March 18,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.-S.+Yeung&author=K.+E.+Parcella&author=J.+A.+Bender&author=B.+R.+Beno&author=K.+A.+Grant-Young&author=Y.+Han&author=P.+Hewawasam&author=J.+F.+Kadow&author=A.+Nickel&title=Compounds+for+the+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DK.-S.%26atitle%3DCompounds%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Olsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, U. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F···C═O interactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2511</span><span class="refDoi"> DOI: 10.1002/anie.200351268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1002%2Fanie.200351268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFCrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2507-2511&author=J.+A.+Olsenauthor=D.+W.+Bannerauthor=P.+Seilerauthor=U.+O.+Sanderauthor=A.+D%E2%80%99Arcyauthor=M.+Stihleauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=A+fluorine+scan+of+thrombin+inhibitors+to+map+the+fluorophilicity%2Ffluorophobicity+of+an+enzyme+active+site%3A+evidence+for+C-F%C2%B7%C2%B7%C2%B7C%E2%95%90O+interactions&doi=10.1002%2Fanie.200351268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: Evidence for C-F···C=O interactions</span></div><div class="casAuthors">Olsen, Jacob A.; Banner, David W.; Seiler, Paul; Sander, Ulrike Obst; D'Arcy, Allan; Stihle, Martine; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2507-2511</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A highly fluorophilic environment comprising the H-Cα-C=O unit of Asn 98 in the active site of thrombin was identified by X-ray crystallog. of a complex formed between the enzyme and a synthetic inhibitor (see partial X-ray structure, distances are in Angstroms).  Short C-F···H-Cα and C-F···C=O contacts involving H-Cα-C=O fragments were also frequently obsd. in small-mol. X-ray crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojeeRuEw83aLVg90H21EOLACvtfcHk0liSYlrouX6qBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFCrt7k%253D&md5=f9851cb27f3e9d10152ad10abcd5c965</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351268%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DJ.%2BA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DSeiler%26aufirst%3DP.%26aulast%3DSander%26aufirst%3DU.%2BO.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DA%2520fluorine%2520scan%2520of%2520thrombin%2520inhibitors%2520to%2520map%2520the%2520fluorophilicity%252Ffluorophobicity%2520of%2520an%2520enzyme%2520active%2520site%253A%2520evidence%2520for%2520C-F%25C2%25B7%25C2%25B7%25C2%25B7C%25E2%2595%2590O%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2507%26epage%3D2511%26doi%3D10.1002%2Fanie.200351268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span> </span><span class="NLM_article-title">Fluorine multipolar interaction: Toward elucidating its energetics in binding recognition</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1016/j.jfluchem.2016.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.jfluchem.2016.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Xingauthor=C.+Keeferauthor=M.+F.+Brown&title=Fluorine+multipolar+interaction%3A+Toward+elucidating+its+energetics+in+binding+recognition&doi=10.1016%2Fj.jfluchem.2016.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2016.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2016.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DKeefer%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26atitle%3DFluorine%2520multipolar%2520interaction%253A%2520Toward%2520elucidating%2520its%2520energetics%2520in%2520binding%2520recognition%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2017%26doi%3D10.1016%2Fj.jfluchem.2016.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Discovery of daclatasvir, a pan-genotypic hepatitis C virus NS5A replication complex inhibitor with potent clinical effect</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5057</span><span class="NLM_x">–</span> <span class="NLM_lpage">5071</span><span class="refDoi"> DOI: 10.1021/jm500335h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500335h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5057-5071&author=M.+Belemaauthor=N.+A.+Meanwell&title=Discovery+of+daclatasvir%2C+a+pan-genotypic+hepatitis+C+virus+NS5A+replication+complex+inhibitor+with+potent+clinical+effect&doi=10.1021%2Fjm500335h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect</span></div><div class="casAuthors">Belema, Makonen; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5057-5071</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review. The discovery and development of the first-in-class hepatitis C virus (HCV) NS5A replication complex inhibitor daclatasvir provides a compelling example of the power of phenotypic screening to identify leads engaging novel targets in mechanistically unique ways.  HCV NS5A replication complex inhibitors are pan-genotypic in spectrum, and this mechanistic class provides the most potent HCV inhibitors in vitro that have been described to date.  Clin. trials with daclatasvir demonstrated a potent effect on reducing plasma viral load and, in combination with mechanistically orthogonal HCV inhibitors, established the ability to cure even the most difficult infections without the need for immune stimulation.  In this Drug Annotation, the authors describe the discovery of the original high-throughput screening lead BMS-858 and the chem. conundrum and challenges resolved in optimizing to daclatasvir as a clin. candidate and finally the authors summarize the results of select clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiU5qkfNyqXLVg90H21EOLACvtfcHk0ljJXuNax217qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurs%253D&md5=1428746b49ba356ce6993a58b143e5dc</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500335h%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520of%2520daclatasvir%252C%2520a%2520pan-genotypic%2520hepatitis%2520C%2520virus%2520NS5A%2520replication%2520complex%2520inhibitor%2520with%2520potent%2520clinical%2520effect%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5057%26epage%3D5071%26doi%3D10.1021%2Fjm500335h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Scola, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sit, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocuzza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilder, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewawasam, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friborg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schartman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donoso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvyaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredup, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span> </span><span class="NLM_article-title">The Discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1730</span><span class="NLM_x">–</span> <span class="NLM_lpage">1752</span><span class="refDoi"> DOI: 10.1021/jm500297k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500297k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1730-1752&author=P.+M.+Scolaauthor=L.-Q.+Sunauthor=A.+X.+Wangauthor=J.+Chenauthor=N.+Sinauthor=B.+L.+Venablesauthor=S.-Y.+Sitauthor=Y.+Chenauthor=A.+Cocuzzaauthor=D.+M.+Bilderauthor=S.+V.+D%E2%80%99Andreaauthor=B.+Zhengauthor=P.+Hewawasamauthor=Y.+Tuauthor=J.+Friborgauthor=P.+Falkauthor=D.+Hernandezauthor=S.+Levineauthor=C.+Chenauthor=F.+Yuauthor=A.+K.+Sheafferauthor=G.+Zhaiauthor=D.+Barryauthor=J.+O.+Knipeauthor=Y.-H.+Hanauthor=R.+Schartmanauthor=M.+Donosoauthor=K.+Mosureauthor=M.+W.+Sinzauthor=T.+Zvyagaauthor=A.+C.+Goodauthor=R.+Rajamaniauthor=K.+Kishauthor=J.+Tredupauthor=H.+E.+Kleiauthor=Q.+Gaoauthor=L.+Muellerauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=S.+P.+Adamsauthor=J.+Loyauthor=P.+C.+Levesqueauthor=H.+Sunauthor=H.+Shiauthor=L.+Sunauthor=W.+Warnerauthor=D.+Liauthor=J.+Zhuauthor=N.+A.+Meanwellauthor=F.+McPhee&title=The+Discovery+of+asunaprevir+%28BMS-650032%29%2C+an+orally+efficacious+NS3+protease+inhibitor+for+the+treatment+of+hepatitis+C+virus+infection&doi=10.1021%2Fjm500297k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span></div><div class="casAuthors">Scola, Paul M.; Sun, Li-Qiang; Wang, Alan Xiangdong; Chen, Jie; Sin, Ny; Venables, Brian L.; Sit, Sing-Yuen; Chen, Yan; Cocuzza, Anthony; Bilder, Donna M.; D'Andrea, Stanley V.; Zheng, Barbara; Hewawasam, Piyasena; Tu, Yong; Friborg, Jacques; Falk, Paul; Hernandez, Dennis; Levine, Steven; Chen, Chaoqun; Yu, Fei; Sheaffer, Amy K.; Zhai, Guangzhi; Barry, Diana; Knipe, Jay O.; Han, Yong-Hae; Schartman, Richard; Donoso, Maria; Mosure, Kathy; Sinz, Michael W.; Zvyaga, Tatyana; Good, Andrew C.; Rajamani, Ramkumar; Kish, Kevin; Tredup, Jeffrey; Klei, Herbert E.; Gao, Qi; Mueller, Luciano; Colonno, Richard J.; Grasela, Dennis M.; Adams, Stephen P.; Loy, James; Levesque, Paul C.; Sun, Huabin; Shi, Hong; Sun, Lucy; Warner, William; Li, Danshi; Zhu, Jialong; Meanwell, Nicholas A.; McPhee, Fiona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1730-1752</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of asunaprevir (BMS-650032) is described.  This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clin. trials for the treatment of hepatitis C virus infection.  The discovery of Asunaprevir was enabled by employing an isolated rabbit heart model to screen for the cardiovascular (CV) liabilities (changes to HR and SNRT) that were responsible for the discontinuation of an earlier lead from this chem. series, BMS-605339, from clin. trials.  The structure-activity relationships (SARs) developed with respect to CV effects established that small structural changes to the P2* subsite of the mol. had a significant impact on the CV profile of a given compd.  The antiviral activity, preclin. PK profile, and toxicol. studies in rat and dog supported clin. development of BMS-650032.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCzMFiXs8YO7Vg90H21EOLACvtfcHk0limlW5MGi3Mvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsLc%253D&md5=e8015d3874b80be645a9b80b5bd05865</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm500297k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500297k%26sid%3Dliteratum%253Aachs%26aulast%3DScola%26aufirst%3DP.%2BM.%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DWang%26aufirst%3DA.%2BX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSin%26aufirst%3DN.%26aulast%3DVenables%26aufirst%3DB.%2BL.%26aulast%3DSit%26aufirst%3DS.-Y.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCocuzza%26aufirst%3DA.%26aulast%3DBilder%26aufirst%3DD.%2BM.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DS.%2BV.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DHewawasam%26aufirst%3DP.%26aulast%3DTu%26aufirst%3DY.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DZhai%26aufirst%3DG.%26aulast%3DBarry%26aufirst%3DD.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DHan%26aufirst%3DY.-H.%26aulast%3DSchartman%26aufirst%3DR.%26aulast%3DDonoso%26aufirst%3DM.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSinz%26aufirst%3DM.%2BW.%26aulast%3DZvyaga%26aufirst%3DT.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DTredup%26aufirst%3DJ.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DAdams%26aufirst%3DS.%2BP.%26aulast%3DLoy%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWarner%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DMcPhee%26aufirst%3DF.%26atitle%3DThe%2520Discovery%2520of%2520asunaprevir%2520%2528BMS-650032%2529%252C%2520an%2520orally%2520efficacious%2520NS3%2520protease%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1730%26epage%3D1752%26doi%3D10.1021%2Fjm500297k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuttle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span> </span><span class="NLM_article-title">Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypes</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7416</span><span class="NLM_x">–</span> <span class="NLM_lpage">7423</span><span class="refDoi"> DOI: 10.1128/AAC.03851-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1128%2FAAC.03851-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=25267677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVymsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=7416-7423&author=M.+Liuauthor=M.+Tuttleauthor=M.+Gaoauthor=J.+A.+Lemm&title=Potency+and+resistance+analysis+of+hepatitis+C+virus+NS5B+polymerase+inhibitor+BMS-791325+on+all+major+genotypes&doi=10.1128%2FAAC.03851-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypes</span></div><div class="casAuthors">Liu, Mengping; Tuttle, Maria; Gao, Min; Lemm, Julie A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7416-7423, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">BMS-791325 is a hepatitis C virus (HCV) inhibitor binding to the thumb domain of the NS5B RNA-dependent RNA polymerase.  BMS-791325 is well characterized in genotype 1 (GT1) and exhibits good inhibitory activity (50% effective concn. [EC50], <10 nM) against hybrid replicons contg. patient NS5B sequences from GT3a, -4a, and -5a while potency against GT2 is significantly reduced.  BMS-791325 potency against GT6a hybrid replicons is more variable, with two of three hybrid clones having EC50s similar to that for GT1 while a third patient clone was ∼10 times less susceptible to BMS-791325.  To characterize the resistance profile of BMS-791325 beyond GT1, curing studies were performed across GT1a and -3a to -6a and demonstrated that GT1a has the highest resistance barrier vs. BMS-791325 while GT6a has the lowest.  Selection of GT3 to -6 NS5B chimeric replicon cells at different concns. of BMS-791325 revealed substitutions in the thumb domain of NS5B at residues 494 and 495 that conferred different levels of resistance to BMS-791325 but remained susceptible to NS5A or NS3 protease inhibitors.  In addn., we demonstrate that the reduced potency of BMS-791325 against one GT6a patient is due to an A494 polymorphism present in ∼21% of sequences in the European HCV database.  The results from this report suggest that BMS-791325 is a candidate for combination treatment of HCV GT3 to -6 chronic infections, and the resistance profiles identified will provide useful information for future clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5_mdXydNNWLVg90H21EOLACvtfcHk0limlW5MGi3Mvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVymsLzL&md5=8c28943f5323ac850671503c57974cb0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FAAC.03851-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03851-14%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DTuttle%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26atitle%3DPotency%2520and%2520resistance%2520analysis%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520inhibitor%2520BMS-791325%2520on%2520all%2520major%2520genotypes%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D7416%26epage%3D7423%26doi%3D10.1128%2FAAC.03851-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span> </span><span class="NLM_article-title">The role of molecular size in ligand efficiency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4258</span><span class="NLM_x">–</span> <span class="NLM_lpage">4261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2007.05.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=17532632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4258-4261&author=C.+H.+Reynoldsauthor=S.+D.+Bembenekauthor=B.+A.+Tounge&title=The+role+of+molecular+size+in+ligand+efficiency&doi=10.1016%2Fj.bmcl.2007.05.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of molecular size in ligand efficiency</span></div><div class="casAuthors">Reynolds, Charles H.; Bembenek, Scott D.; Tounge, Brett A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4258-4261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ligand efficiency is a simple metric for assessing whether a ligand derives its potency from optimal fit with the protein target or simply by virtue of making many contacts.  Comparison of protein-ligand binding affinities for over 8000 ligands with 28 protein targets shows conclusively that the av. ligand binding affinities are not linear with mol. size.  It is therefore important to scale ligand efficiencies by the size of the ligand, particularly where small ligands (e.g., fragments) are involved.  The authors propose a simple 'fit quality' metric that removes this dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnIaZs8-gK1rVg90H21EOLACvtfcHk0limlW5MGi3Mvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D&md5=2f95a0b64b1da0755d7f624dad18b2bc</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26atitle%3DThe%2520role%2520of%2520molecular%2520size%2520in%2520ligand%2520efficiency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4258%26epage%3D4261%26doi%3D10.1016%2Fj.bmcl.2007.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span> </span><span class="NLM_article-title">Ligand binding efficiency: trends, physical basis, and implications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2432</span><span class="NLM_x">–</span> <span class="NLM_lpage">2438</span><span class="refDoi"> DOI: 10.1021/jm701255b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701255b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2432-2438&author=C.+H.+Reynoldsauthor=B.+A.+Toungeauthor=S.+D.+Bembenek&title=Ligand+binding+efficiency%3A+trends%2C+physical+basis%2C+and+implications&doi=10.1021%2Fjm701255b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand binding efficiency: trends, physical basis, and implications</span></div><div class="casAuthors">Reynolds, Charles H.; Tounge, Brett A.; Bembenek, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2432-2438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand efficiency (i.e., potency/size) has emerged as an important metric in drug discovery.  In general, smaller, more efficient ligands are believed to have improved prospects for good drug properties (e.g., bioavailability).  Our anal. of thousands of ligands across a variety of targets shows that ligand efficiency is dependent on ligand size with smaller ligands having greater efficiencies, on av., than larger ligands.  We propose two primary causes for this size dependence: the inevitable redn. in the quality of fit between ligand and receptor as the ligand becomes larger and more complex and the redn. in accessible ligand surface area on a per atom basis as size increases.  These results have far-ranging implications for anal. of high-throughput screening hits, fragment-based approaches to drug discovery, and even computational models of potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkrPWFEZZEMrVg90H21EOLACvtfcHk0ljNZr3yMaIB5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFSgsbw%253D&md5=a9a41b44dbca7f34562c40b56c7ae683</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Fjm701255b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701255b%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26atitle%3DLigand%2520binding%2520efficiency%253A%2520trends%252C%2520physical%2520basis%252C%2520and%2520implications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2432%26epage%3D2438%26doi%3D10.1021%2Fjm701255b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perola, E.</span><span> </span><span class="NLM_article-title">An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2986</span><span class="NLM_x">–</span> <span class="NLM_lpage">2997</span><span class="refDoi"> DOI: 10.1021/jm100118x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100118x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlWqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2986-2997&author=E.+Perola&title=An+analysis+of+the+binding+efficiencies+of+drugs+and+their+leads+in+successful+drug+discovery+programs&doi=10.1021%2Fjm100118x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">An Analysis of the Binding Efficiencies of Drugs and their Leads in Successful Drug Discovery Programs</span></div><div class="casAuthors">Perola, Emanuele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2986-2997</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to investigate the evolution of binding efficiency in successful drug discovery programs, a data set of 60 lead/drug pairs with known binding affinities has been compiled and analyzed.  Low-end thresholds for the binding efficiencies of viable leads and drugs have been derived.  On av., the drugs in the set are significantly larger and more potent but have similar lipophilicity relative to their originating leads, suggesting that the ability to maintain low levels of lipophilicity while increasing mol. wt. is one of the keys to a successful drug discovery program.  A no. of examples demonstrate that large increases in binding efficiency from leads to more elaborate drugs sharing the same scaffold can be achieved.  The importance of dissecting a lead structure to identify the most efficient fragments and the option of sacrificing binding efficiency to optimize other properties are discussed, and relevant examples are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRqzYFBuX2Q7Vg90H21EOLACvtfcHk0ljNZr3yMaIB5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlWqu7o%253D&md5=a7eaad792f1518d093588951df64d22f</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1021%2Fjm100118x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100118x%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520efficiencies%2520of%2520drugs%2520and%2520their%2520leads%2520in%2520successful%2520drug%2520discovery%2520programs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2986%26epage%3D2997%26doi%3D10.1021%2Fjm100118x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Fragment-based drug design: how big is too big?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6972</span><span class="NLM_x">–</span> <span class="NLM_lpage">6976</span><span class="refDoi"> DOI: 10.1021/jm060511h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060511h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6972-6976&author=P.+J.+Hajduk&title=Fragment-based+drug+design%3A+how+big+is+too+big%3F&doi=10.1021%2Fjm060511h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Design: How Big Is Too Big?</span></div><div class="casAuthors">Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6972-6976</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Much has been discussed about the proper physicochem. properties (e.g., mol. wt., hydrophobicity, etc.) that should be considered when utilizing fragment leads in drug design.  However, little has been reported as to what emphasis, if any, should be placed on the potency of the resulting fragment leads.  In this report, a retrospective anal. of 18 highly optimized inhibitors is described in which the compds. were systematically deconstructed until the minimal binding elements could be identified.  An anal. of the potency changes that were obsd. as the leads were reduced in size indicate that a nearly linear relationship exists between mol. wt. and binding affinity over the entire range of sizes and potencies represented in the dataset.  On the basis of these observations, prediction maps can be constructed that enable crit. and quant. assessments of the process of lead identification and optimization.  These data place well-defined limits on the ideal size and potency of fragment leads that are being considered for use in fragment-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCz9NMtBgNrVg90H21EOLACvtfcHk0ljNZr3yMaIB5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLbJ&md5=b27d4ca6446a033b82e0ea223da5e6de</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1021%2Fjm060511h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060511h%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DFragment-based%2520drug%2520design%253A%2520how%2520big%2520is%2520too%2520big%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6972%26epage%3D6976%26doi%3D10.1021%2Fjm060511h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitive assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitive+assessment+of+hERG+liability+as+a+function+of+lipophilicity&doi=10.1016%2Fj.bmcl.2006.12.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitive%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764%26doi%3D10.1016%2Fj.bmcl.2006.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><div class="note"><p class="first last">The analysis was based on ten matched molecular pairs. When the hERG inhibition data are determined in the same assay in the same laboratory, a minimum of four matched pairs can be sufficient to identify an activity difference, see:</p></div><span class="NLM_contrib-group">Kramer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitebread, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liedl, K. R.</span><span> </span><span class="NLM_article-title">Matched molecular pair analysis: significance and the impact of experimental uncertainty</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3786</span><span class="NLM_x">–</span> <span class="NLM_lpage">3802</span><span class="refDoi"> DOI: 10.1021/jm500317a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500317a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlyhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3786-3802&author=C.+Kramerauthor=J.+E.+Fuchsauthor=S.+Whitebreadauthor=P.+Gedeckauthor=K.+R.+Liedl&title=Matched+molecular+pair+analysis%3A+significance+and+the+impact+of+experimental+uncertainty&doi=10.1021%2Fjm500317a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pair Analysis: Significance and the Impact of Experimental Uncertainty</span></div><div class="casAuthors">Kramer, Christian; Fuchs, Julian E.; Whitebread, Steven; Gedeck, Peter; Liedl, Klaus R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3786-3802</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matched mol. pair anal. (MMPA) has become a major tool for analyzing large chem. data sets for promising chem. transformations.  However, the dependence of MMPA predictions on data constraints such as the no. of pairs involved, exptl. uncertainty, source of the expts., and variability of the true phys. effect has not yet been described.  In this contribution the statistical basics for judging MMPA are analyzed.  We illustrate the connection between overall MMPA statistics and individual pairs with a detailed comparison of av. CHEMBL hERG MMPA results vs. pairs with extreme transformation effects.  Comparing the CHEMBL results to Novartis data, we find that significant transformation effects agree very well if the exptl. uncertainty is considered.  This indicates that caution must be exercised for predictions from insignificant MMPAs, yet highlights the robustness of statistically validated MMPA and shows that MMPA on public databases can yield results that are very useful for medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozfisWGl9ewLVg90H21EOLACvtfcHk0lhVdAeW02ScCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlyhurc%253D&md5=345def0f0a3e533e44b069b77ce0b185</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm500317a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500317a%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DFuchs%26aufirst%3DJ.%2BE.%26aulast%3DWhitebread%26aufirst%3DS.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DLiedl%26aufirst%3DK.%2BR.%26atitle%3DMatched%2520molecular%2520pair%2520analysis%253A%2520significance%2520and%2520the%2520impact%2520of%2520experimental%2520uncertainty%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3786%26epage%3D3802%26doi%3D10.1021%2Fjm500317a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conder, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span> </span><span class="NLM_article-title">Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6182</span><span class="NLM_x">–</span> <span class="NLM_lpage">6192</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.bmc.2007.06.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6182-6192&author=S.+R.+Johnsonauthor=H.+Yueauthor=M.+L.+Conderauthor=H.+Shiauthor=A.+M.+Doweykoauthor=J.+Lloydauthor=P.+Levesque&title=Estimation+of+hERG+inhibition+of+drug+candidates+using+multivariate+property+and+pharmacophore+SAR&doi=10.1016%2Fj.bmc.2007.06.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DYue%26aufirst%3DH.%26aulast%3DConder%26aufirst%3DM.%2BL.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DLloyd%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DP.%26atitle%3DEstimation%2520of%2520hERG%2520inhibition%2520of%2520drug%2520candidates%2520using%2520multivariate%2520property%2520and%2520pharmacophore%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D6182%26epage%3D6192%26doi%3D10.1016%2Fj.bmc.2007.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Tomasi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennucci</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammi, R.</span><span> </span><span class="NLM_article-title">Quantum mechanical continuum solvation models</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2999</span><span class="NLM_x">–</span> <span class="NLM_lpage">3093</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1021/cr9904009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9904009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVynurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2999-3093&author=J.+Tomasiauthor=+Mennucciauthor=R.+Cammi&title=Quantum+mechanical+continuum+solvation+models&doi=10.1021%2Fcr9904009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Quantum Mechanical Continuum Solvation Models</span></div><div class="casAuthors">Tomasi, Jacopo; Mennucci, Benedetta; Cammi, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2999-3093</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkWabJEwaQ7LVg90H21EOLACvtfcHk0lhVdAeW02ScCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVynurc%253D&md5=462420dd18b3006ee63d1298b66db247</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fcr9904009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9904009%26sid%3Dliteratum%253Aachs%26aulast%3DTomasi%26aufirst%3DJ.%26aulast%3DMennucci%26aulast%3DCammi%26aufirst%3DR.%26atitle%3DQuantum%2520mechanical%2520continuum%2520solvation%2520models%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D2999%26epage%3D3093%26doi%3D10.1021%2Fcr9904009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8315</span><span class="NLM_x">–</span> <span class="NLM_lpage">8359</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lhVdAeW02ScCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="note"><p class="first last">The details of pharmacokinetic studies will be the subject of a separate publication.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Rumondor, A. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhareshwar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesisoglou, F.</span><span> </span><span class="NLM_article-title">Amorphous solid dispersions or prodrugs: complementary strategies to increase drug absorption</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2498</span><span class="NLM_x">–</span> <span class="NLM_lpage">2508</span><span class="refDoi"> DOI: 10.1016/j.xphs.2015.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1016%2Fj.xphs.2015.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=26886316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWjtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=2498-2508&author=A.+C.+F.+Rumondorauthor=S.+S.+Dhareshwarauthor=F.+Kesisoglou&title=Amorphous+solid+dispersions+or+prodrugs%3A+complementary+strategies+to+increase+drug+absorption&doi=10.1016%2Fj.xphs.2015.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption</span></div><div class="casAuthors">Rumondor, Alfred C. F.; Dhareshwar, Sundeep S.; Kesisoglou, Filippos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2498-2508</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Maximizing oral bioavailability of drug candidates represents a challenge in the pharmaceutical industry.  In recent years, there has been an increase in the use of amorphous solid dispersions (ASDs) to address this issue, where a growing no. of solid dispersion formulations have been introduced to the market.  However, an increase in soly. or dissoln. rate through ASD does not always result in sufficient improvement of oral absorption because soly. limitations may still exist at high doses.  Chem. modification in the form of a prodrug may offer an alternative approach for these cases.  Although prodrugs have been primarily used to improve membrane permeability, examples are available in which prodrugs have been used to increase drug soly. beyond what can be achieved via formulation approaches.  In this mini review, the role of ASDs and prodrugs as 2 complementary approaches in improving oral bioavailability of drug candidates is discussed.  We discuss the fundamental principles of absorption and bioavailability, and review available literature on both solid dispersions and prodrugs, providing a summary of their use and examples of successful applications, and cover some of the biopharmaceutics evaluation aspects for these approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKdZFZ1pSCdrVg90H21EOLACvtfcHk0lhs5PuNvO5ReA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWjtbrE&md5=32d2cd7a5d8b624d0d303c6c8e3601a3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2015.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2015.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DRumondor%26aufirst%3DA.%2BC.%2BF.%26aulast%3DDhareshwar%26aufirst%3DS.%2BS.%26aulast%3DKesisoglou%26aufirst%3DF.%26atitle%3DAmorphous%2520solid%2520dispersions%2520or%2520prodrugs%253A%2520complementary%2520strategies%2520to%2520increase%2520drug%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26spage%3D2498%26epage%3D2508%26doi%3D10.1016%2Fj.xphs.2015.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span><span class="refDoi"> DOI: 10.1021/tx200211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&author=N.+A.+Meanwell&title=Improving+drug+candidates+by+design%3A+a+focus+on+physicochemical+properties+as+a+means+of+improving+compound+disposition+and+safety&doi=10.1021%2Ftx200211v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0lhs5PuNvO5ReA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520candidates%2520by%2520design%253A%2520a%2520focus%2520on%2520physicochemical%2520properties%2520as%2520a%2520means%2520of%2520improving%2520compound%2520disposition%2520and%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1420%26epage%3D1456%26doi%3D10.1021%2Ftx200211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Manuscript in preparation</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit51b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eastman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parcella, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, K.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant-Young, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredup, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jardel, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanumegowda, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donoso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuttle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvyaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haarhoff, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soars, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">796</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span><span class="refDoi"> DOI: 10.1039/C6MD00636A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=10.1039%2FC6MD00636A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=796-806&author=K.+J.+Eastmanauthor=K.+Parcellaauthor=K.-S.+Yeungauthor=K.+A.+Grant-Youngauthor=J.+Zhuauthor=T.+Wangauthor=Z.+Zhangauthor=Z.+Yinauthor=B.+R.+Benoauthor=S.+Sheriffauthor=K.+Kishauthor=J.+Tredupauthor=A.+G.+Jardelauthor=V.+Halanauthor=K.+Ghoshauthor=D.+Parkerauthor=K.+Mosureauthor=H.+Fangauthor=Y.-K.+Wangauthor=J.+Lemmauthor=X.+Zhuoauthor=U.+Hanumegowdaauthor=K.+Rigatauthor=M.+Donosoauthor=M.+Tuttleauthor=T.+Zvyagaauthor=Z.+Haarhoffauthor=N.+A.+Meanwellauthor=M.+G.+Soarsauthor=S.+B.+Robertsauthor=J.+F.+Kadow&title=The+discovery+of+a+pan-genotypic%2C+primer+grip+inhibitor+of+HCV+NS5B+polymerase&doi=10.1039%2FC6MD00636A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51b&amp;dbid=16384&amp;doi=10.1039%2FC6MD00636A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00636A%26sid%3Dliteratum%253Aachs%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DParcella%26aufirst%3DK.%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DGrant-Young%26aufirst%3DK.%2BA.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DTredup%26aufirst%3DJ.%26aulast%3DJardel%26aufirst%3DA.%2BG.%26aulast%3DHalan%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DK.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DHanumegowda%26aufirst%3DU.%26aulast%3DRigat%26aufirst%3DK.%26aulast%3DDonoso%26aufirst%3DM.%26aulast%3DTuttle%26aufirst%3DM.%26aulast%3DZvyaga%26aufirst%3DT.%26aulast%3DHaarhoff%26aufirst%3DZ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520discovery%2520of%2520a%2520pan-genotypic%252C%2520primer%2520grip%2520inhibitor%2520of%2520HCV%2520NS5B%2520polymerase%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D796%26epage%3D806%26doi%3D10.1039%2FC6MD00636A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Corsi, M.; Faiferman, I.; Merlo-Pich, E.; Ratti, E.; Wren, P. B.</span><span> </span><span class="NLM_article-title">2-Amino-7,8- dihydropyrido[2, 3- <i>d</i>] pyrimidin-7-one derivatives as CSBP/RK/p38 kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. World Patent Application WO 2007/147103 A2, December 21,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+Corsi&author=I.+Faiferman&author=E.+Merlo-Pich&author=E.+Ratti&author=P.+B.+Wren&title=2-Amino-7%2C8-+dihydropyrido%5B2%2C+3-+d%5D+pyrimidin-7-one+derivatives+as+CSBP%2FRK%2Fp38+kinase+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorsi%26aufirst%3DM.%26atitle%3D2-Amino-7%252C8-%2520dihydropyrido%255B2%252C%25203-%2520d%255D%2520pyrimidin-7-one%2520derivatives%2520as%2520CSBP%252FRK%252Fp38%2520kinase%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Lemieux, R. M.; Barbosa, A. J. d. M.; Bentzien, J. M.; Brunette, S.; Richard; Chen, Z.; Cogan, D.; Gao, D. A.; Heim-Riether, A.; Horan, J. C.; Kowalski, J. A.; Lawlor, M. D.; Liu, W.; McKibben, B.; Miller, C. A.; Moss, N.; Tschantz, M. A.; Xiong, Z.; Yu, Hui; Yu, Y.</span><span> </span><span class="NLM_article-title">Derivatives of 6,7-dihydro-5<i>H</i>-imidazo[1,2-α]imidazole-carboxylic acid amides as inhibitors of the interaction of CAMs and leukointegrins, and their preparation and use in the treatment of inflammatory diseases</span>. World Patent Application WO 2009/070485 A1, June 4,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+M.+Lemieux&author=A.+J.+d.+M.+Barbosa&author=J.+M.+Bentzien&author=S.+Brunette&author=+Richard&author=Z.+Chen&author=D.+Cogan&author=D.+A.+Gao&author=A.+Heim-Riether&author=J.+C.+Horan&author=J.+A.+Kowalski&author=M.+D.+Lawlor&author=W.+Liu&author=B.+McKibben&author=C.+A.+Miller&author=N.+Moss&author=M.+A.+Tschantz&author=Z.+Xiong&author=Hui+Yu&author=Y.+Yu&title=Derivatives+of+6%2C7-dihydro-5H-imidazo%5B1%2C2-%CE%B1%5Dimidazole-carboxylic+acid+amides+as+inhibitors+of+the+interaction+of+CAMs+and+leukointegrins%2C+and+their+preparation+and+use+in+the+treatment+of+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DDerivatives%2520of%25206%252C7-dihydro-5H-imidazo%255B1%252C2-%25CE%25B1%255Dimidazole-carboxylic%2520acid%2520amides%2520as%2520inhibitors%2520of%2520the%2520interaction%2520of%2520CAMs%2520and%2520leukointegrins%252C%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A.,  Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, O.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J.</span> <span class="citation_source-book">Gaussian 09</span>, revision D.01; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=T.+Keith&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=J.+M.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=O.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26btitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55a"><span><span class="NLM_label">(a) </span> <span class="citation_source-book">Schrödinger Release 2016-2: Maestro</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2016-2%3A+Maestro%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202016-2%253A%2520Maestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">MacroModel</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacroModel%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55c"><span><span class="NLM_label">(c) </span> <span class="citation_source-book">Protein Preparation Wizard; Epik</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Preparation+Wizard%3B+Epik%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DProtein%2520Preparation%2520Wizard%253B%2520Epik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55d"><span><span class="NLM_label">(d) </span> <span class="citation_source-book">Impact</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Impact%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DImpact%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55e"><span><span class="NLM_label">(e) </span> <span class="citation_source-book">Prime</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Harder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maple, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupyan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerutti, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krilov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">OPLS3: A force field providing broad coverage of drug-like small molecules and proteins</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lhlH83ZaqCy5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3Q0Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3Q0Z','PDB','3Q0Z'); return false;">PDB: 3Q0Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZK','PDB','5PZK'); return false;">PDB: 5PZK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZL','PDB','5PZL'); return false;">PDB: 5PZL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZM','PDB','5PZM'); return false;">PDB: 5PZM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZN','PDB','5PZN'); return false;">PDB: 5PZN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZP','PDB','5PZP'); return false;">PDB: 5PZP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZO','PDB','5PZO'); return false;">PDB: 5PZO</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00328">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47671"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00328">10.1021/acs.jmedchem.7b00328</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Production of the recombinant protein, crystallization conditions, crystallographic methods, and crystallographic statistics for complexes of HCV gt-1b NS5B protein (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_001.pdf">jm7b00328_si_001.pdf (311.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00328/suppl_file/jm7b00328_si_002.csv">jm7b00328_si_002.csv (3.05 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code for <b>5</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZK">5PZK</a>, <b>6</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZL">5PZL</a>, <b>8</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZM">5PZM</a>, <b>18</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZN">5PZN</a>, <b>37</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZP">5PZP</a>, and <b>46</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5PZO">5PZO</a>. CCDC 1541557 contains the supplementary crystallographic data for the unsolvated neat form of <b>37</b>. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via <a href="http://www.ccdc.cam.ac.uk/structures" class="extLink">www.ccdc.cam.ac.uk/structures</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-10%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00328%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00328" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a42a6a323c46","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
